Getinge makes a provision of SEK 1.8 billion related to Atrium Medical Corporation surgical mesh claims

The surgical mesh implants are manufactured by Getinge’s subsidiary Atrium Medical, which was acquired by Getinge in 2011. Polypropylene mesh is the established standard for hernia repair. The mesh product liability claims currently involve approximately 900 pending lawsuits in the U.S. and in Canada. Patients are claiming damages for complications and injuries allegedly sustained after receiving surgical mesh implants. The suits consist of individual lawsuits, consolidated state cases and consolidated multi-district federal litigation. A material uptick in the number of claims filed began in late 2017, following the consolidation of the mass tort litigation. The claims are being vigorously defended and there have been no adverse verdicts against Atrium Medical. The first trials are expected late 2019 and early 2020. “The provision is based on the information available today and is intended to cover every sort of cost related to the claims, including defense and handling of claims”, says Mattias Perjos, President & CEO Getinge. Getinge predicts that future cashflows will be sufficient to cover the expenses related to the claims. Due to the uncertainty relating to loss reserve estimates, additional provisions may be required and actual costs may be materially higher or lower than the related provisions made. The company is simultaneously making a write-down mainly of its intangible assets, which brings a negative group impact of SEK 90 M on the result of the third quarter 2018. Atrium Medical is evaluating the future of the surgical mesh business. The group holds related product liability insurance and is in continuing discussions with its insurance carriers regarding the scope of its insurance coverage. If those discussions are not productive, the group may commence litigation against its carriers.   Telephone conference Fund managers, analysts and the media are invited to participate in the conference call Monday October 15, 2018, at 09:00-09:30 CET. Please see dial in details below to join the conference: SE: +46 8 566 426 97UK: +44 20 300 898 07US: +1 855 831 5947 During the telephone conference a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/2018-10-15-getinge-pressconference Alternatively, use the following link to download the presentation: https://www.getinge.com/int/about-us/investors/reports-presentations/2018/ Media contact: Lars Mattsson, Head of Investor RelationsPhone: +46 (0)10 335 0043E-mail: lars.mattsson@getinge.com Jeanette Hedén Carlsson, Executive Vice President Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: jeanette.hedencarlsson@getinge.com This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8:45 p.m. CET on October 14, 2018.

Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer

Oslo, Norway, 15 October 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, today announces the full data set from the 32-patient phase I/II clinical trial evaluating TG01 in resected pancreatic cancer in combination with standard of care chemotherapy (gemcitabine). Median DFS for all 32 patients in the trial was 16.1 months, and 19.5 months for the 2nd patient cohort who received an optimized dosing regimen. DFS was measured from time of surgery. This DFS outcome is encouraging when compared to historical controls for gemcitabine monotherapy, such as the ESPAC4 and PRODIGE trials, which reported a median DFS of around 13 months in similar patient populations. The trial enrolled a total of 32 patients, split in two patient cohorts receiving different dosing regimens. The 1st cohort (n=19) received most TG01 injections before and during chemotherapy, whereas the 2nd cohort (n=13) received more injections after completing the chemotherapy regimen. This is believed to be a more optimal dosing schedule for therapeutic cancer vaccines such as TG01. In May 2018, encouraging two-year survival rate and median overall survival (mOS) was reported for the 2nd patient cohort, and for all 32 patients in the trial combined, see press release . Summarizing the data from the trial published to date: Full trial, 32 patients (both cohorts combined) ·  16.1 months median disease-free survival (mDFS) ·  33.4 months median overall survival (mOS) ·  72% of patients (23/32) were alive two years after surgery ·  94% of patients (30/32) demonstrated mutant RAS-specific immune activation First cohort, 19 patients ·  13.9 months median disease-free survival (mDFS) ·  33.1 months median overall survival (mOS) ·  68% of patients (13/19) were alive two years after surgery Second cohort, 13 patients ·  19.5 months median disease-free survival (mDFS) ·  Median overall survival not yet reached at time of analysis ·  77% of patients (10/13) were alive two years after surgery The full phase I/II data set will be presented by the trial Principal Investigator, Professor Daniel Palmer from University of Liverpool in the UK, at the Targovax capital markets update in Oslo, October 15th at 8:30am CET. The presentation will also be available via webcast. Please see here for more information . Dr. Magnus Jäderberg, CMO of Targovax, said: “We have previously reported strong immune activation and signal of efficacy for TG01 in resected pancreatic cancer. The median DFS data now presented further strengthens our confidence that TG01 provides a clinically meaningful benefit for this patient population, especially when in the context of historical controls. The DFS benefit appears to be more pronounced in the second cohort, which indicates that the post-chemo vaccination schedule is an optimal dosing regimen that we should select in subsequent development. It is also worth noting that median overall survival has not yet been reached in the second patient cohort, and we will continue to track how these patients perform with great interest”. About the study CTTG01-01 is an open label phase I/II trial of TG01/GM-CSF in combination with gemcitabine as adjuvant therapy for treating patients with resected adenocarcinoma of the pancreas. The main objectives of the trail are an assessment of safety and immune activation. The secondary objective is to assess efficacy (disease-free survival and overall survival) at two years. The Company has received consent to enable the reporting of overall survival for all patients in the trial. The trial has been conducted in four centres in the UK and Norway.   The first cohort of 19 patients each received up to 36 injections of TG01/GM-CSF, before, during and after six cycles of gemcitabine. The second cohort consists of 13 patients, who received up to 15 injections of TG01/GM-CSF before and after, but not during, gemcitabine treatment. The second cohort received on average 7 injections after chemotherapy, compared to only one for the first cohort. Overall, the treatment is well tolerated in both dosing regimens. Although manageable, some allergic reactions were seen in patients in the first cohort when treating with TG01 and gemcitabine in parallel. No such allergic reactions were seen in the second cohort.  TG01 is Targovax’s lead product candidate from its mutRAS neoantigen cancer vaccine program. The product is an injectable peptide-based immunotherapy designed to treat patients with mutant RAS solid tumors. RAS mutations are the most frequently found oncogenic mutations in cancer overall, and are associated with poor prognosis. Published data suggests that more than 90% of pancreatic cancer patients have mutant RAS.

Clas Ohlson increase sales in September

September sales increased by 6 per cent to 677 MSEK (640). Organic sales increased by 2 per cent compared with the preceding year. Sales in September in comparable units and local currency decreased by 2 per cent. In September sales were negatively impacted by a calendar effect of approximately 2 percentage points due to a lower number of trading days than in the year-earlier period. Online sales in September increased by 38 per cent to 30 MSEK (22). Compared with September last year, the store portfolio was expanded net by 15 stores. At the end of the period, the total number of stores was 235. +--------------------------+---------+---------+-----------------+--------------+|Countries, MSEK |September|September|Percentage change|Organic growth|| |2018/19 |2017/18 | | |+--------------------------+---------+---------+-----------------+--------------+|Sweden |292 |289 |1 |1 |+--------------------------+---------+---------+-----------------+--------------+|Norway |278 |251 |11 |4 |+--------------------------+---------+---------+-----------------+--------------+|Finland |84 |78 |8 |-2 |+--------------------------+---------+---------+-----------------+--------------+|Outside Nordic Countries**|23 |22 |6 |-3 |+--------------------------+---------+---------+-----------------+--------------+| |677* |640 |6 |2 |+--------------------------+---------+---------+-----------------+--------------+ * of which 30 MSEK (22) comprises online sales.** Effected by store optimization in the UK, the store in Croydon closed 180816  Total sales for the first five months of fiscal year 2018/19 (May to September 2018) increased by 9 per cent to 3,360 MSEK (3,094). Organic sales increased by 5 per cent. Sales in comparable units and local currency increased by 1 per cent. Online sales for the period increased by 49 per cent to 148 MSEK (99). The interim report for the second quarter of 2018/19 will be published at 7:00 CET on Wednesday5 December 2018. The report will be presented at 8:30 CET the same day. For further information, please contact: Elisabet Johansson, Interim IR manager, tel +46 72 22 11 650, elisabet.johanssson@clasohlson.se  This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:00 am CET on 15 October 2018.

Share buy-backs in Telia Company during week 41 2018

During the period October 08, 2018 - October 12, 2018, shares in Telia Company have been repurchased as follows. Date Aggregated daily Weighted average Total daily volume (number of share price per day transaction value shares) (SEK) (SEK)October 500 000 41.0049 20 502 45008, 2018October 350 000 40.9886 14 346 01009, 2018October 550 000 42.0151 23 108 30510, 2018October 1 400 000 41.4309 58 003 26011, 2018October 1 900 000 40.5784 77 098 96012, 2018 All acquisitions have been carried out on Nasdaq Stockholm by Danske Bank A/S, Danmark, Sverige Filial on behalf of Telia Company. Following the above acquisitions, Telia Company’s holding of own shares amounts to 65 803 000 shares as of October 12, 2018. The total number of shares in Telia Company is 4,330,084,781. A full breakdown of the transactions pursuant to article 5.3 of MAR and article 2.3 of the Safe Harbour Regulation is attached to this announcement. The total volume of Telia Company shares which have been bought back within the share buy-back programme from April 23, 2018 until and including October 12, 2018 amounts to 65 803 000 shares. In total a maximum of 433,008,478 shares may be repurchased. For information about all transactions in the buy-back programme see the following link to Nasdaq Stockholm's website: http://www.nasdaqomx.com/transactions/markets/nordic/corporate-actions/stockholm/repurchases-of-own-shares  For any queries about the buy-back program, please contact: InvestorsAndreas Joelsson, Head of Investor RelationsTel: +46(0)70 863 33 27andreas.joelsson@teliacompany.com Media Ralf Bagner, Press Officer Johanna Hansson, Press OfficerTel: +46(0)70 338 72 48 +46(0)73 086 47 14ralf.bagner@teliacompany.com johanna.hansson@teliacompany.com This information is information that Telia Company AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.30 CET on October 15, 2018. For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany . We’re Telia Company, the New Generation Telco. Our approximately 20,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com.

Nexam Chemical automates and improve production efficiency in Lomma

The project is a consequence of the analysis that was made of the material flow in conjunction with the installation of the latest production line during the winter of 2017/2018. On this basis, the company decided to install two new robots, one is used for unloading raw materials from bags into the production line and the other for packaging of finished products onto transport pallets. At the same time, an overall optimization of the product area and the working processes with a focus on lean manufacturing has been implemented. The investment amounts to approx. 2 MSEK, with a short financial payback time. At the same time the automatization will contribute to a better work environment and reduced sick leave, thus reducing the need for manual lifting. Moreover, operators will release time to focus on further developing and streamlining the work. “A very successful and profitable project”, says Anders Dahlqvist, project manager, and gains support from Susanne Thygesson, COO Nexam Chemical. ” The project that was completed is part of our continuous efforts to improve on our working methods and to motivate our employees using lean manufacturing. The goal is to improve efficiency, automate and improve the working environment at our production plants. Our next big project will be to complete the installation of a new production line at our plant in Hungary, alongside a continuous reconstruction of existing production lines in Lomma that will enhance our production flexibility”, says Susanne Thygesson, COO Nexam Chemical. För mer information, kontakta: Anders Spetz, VD, +46-703 47 97 00, anders.spetz@nexamchemical.com  ___________________________________________________________________________ Om Nexam Chemical Nexam Chemical utvecklar teknologi och produkter som gör det möjligt att kostnadseffektivt och med bibehållen produktionsteknik avsevärt förbättra tillverkningsprocess och egenskaper hos de flesta typer av plaster. Till de egenskaper som förbättras hör bland andra styrka, seghet, temperaturtålighet, kemikalieresistens och livslängd. De förbättrade egenskaperna gör det i sin tur möjligt att ersätta metaller och andra, ofta tyngre och dyrare konstruktionsmaterial inom en rad olika tillämpningsområden. Även i applikationer där plast redan används förbättras tillverkningsprocess, minskar materialanvändning och möjliggörs användningen av mer miljövänliga alternativ. Exempel på kommersiella applikationer: rörtillverkning, skumtillverkning och högprestandaplaster. Mer information om verksamheten finns på www.nexamchemical.com. Bolagets Certified Adviser är FNCA Sweden AB.

Cxense appoints Jørgen Evjen as Chief Financial Officer

Oslo, Norway – 15 October 2018 - Cxense ASA (OSE: CXENSE) today announced that Jørgen Evjen has been appointed Chief Financial Officer (CFO) of the company. He is expected to join the company in February 2019.  Jørgen is an experienced finance manager and leader, having held senior positions at circular economy company Norsk Gjenvinning, smart grid technology provider Enfo Energy and mobile applications company Numo Solutions. He also has a background as corporate finance advisor at the Nordic investment bank Carnegie AB. Jørgen has worked extensively with business strategy, governance and external relations in addition to financial performance management and controlling.      "I'm thrilled to complement Cxense’s leadership team with Jørgen Evjen. He has broad experience from finance and combines business understanding with analytics and people skills“, says Christian Printzell Halvorsen, CEO of Cxense. "Jørgen has shown an ability to deliver results under challenging conditions and will play an important role in driving performance and scaling our business together with the rest the management team."  Following the appointments of new CTO, CCO and CPO earlier this year, as well as the appointment of Jørgen Evjen as CFO, the Cxense leadership team will consist of:   Christian Printzell Halvorsen, Chief Executive Officer  David Gosen, Chief Commercial Officer  Ben Graham, Chief Product Officer  Pankaj Saharan, Chief Technology Officer  Jørgen Evjen, Chief Financial Officer  Elisabeth Monrad-Hansen, Vice President, Human Resources  About Cxense:  Cxense helps publishers and marketers across the globe to transform their raw data into their most valuable resource. Cxense's leading Data Management Platform (DMP) with Intelligent Personalization, gives companies unprecedented insight into their individual customers, and enables them to action this insight in real-time in all marketing and sales channels. Cxense Conversion Engine empowers publishers to monetize insight into their audience's behaviour and preferences in order to increase subscription revenues. Cxense works with brands such as The Wall Street Journal, Aeon, Grupo Clarin, NBC Universal, The Mainichi Newspapers, Singapore Press Holdings and many more. Cxense is headquartered in Norway with offices worldwide and the company is listed on the Oslo Stock Exchange with the ticker 'CXENSE.'   Visit www.cxense.com for more information.  Investor Relations Contact:  Jørgen M. Loeng  Chief Financial Officer  Email: ir@cxense.com  Mobile: +47 906 60 062 

Duni acquires shares in BioPak Pty Ltd, the leading supplier of sustainable packaging in Australia and New Zealand

BioPak was started in 2006 with the aim of offering the most sustainable, environmentally adapted packaging on the Australian market. Owing to a highly demanded assortment built on fibers, cardboard and bioplastics as well as quick and efficient delivery process, BioPak has grown quickly to market leader in its field. Today the company employs 26, has an approximate turnover of SEK 385 m and exhibits strong growth. The company’s operating margin is well in line with Duni’s financial goals. The purchase price is approximately SEK 410 m for 75% of the company and is covered within existing loan facilities. There is a supplementary payment of approximately SEK 24 m for an additional 5% of the shares after two years, and a put and call option for the remaining 20% of shares after five years. The purchase price for the final 20% of shares is dependent on the company’s growth and profit performance in the next five years. BioPak Pty Ltd has three subsidiaries and will be consolidated under the Business Area New Markets as part of Duni Group. BioPak will however remain a separate company and continue to trade as BioPak. The founders will still be active in the company and part of the management team. Their long-term commitment is essential to continue the strong customer focused culture and its strong development. Kindtoo Ltd., trading as Biopac UK, was acquired by Duni on February 8, 2018. Due to the synergies in product assortment and market approach between the two companies, a decision has been made to transfer the shares of Biopac UK to BioPak Pty Ltd. Biopac UK will however continue to be consolidated into Business Area Meal Service, as it is a European business. “We have admired BioPak’s consistent promise to provide sustainable products to the food service industry, and are now looking forward to collaborating with Gary, Richard and their fantastic team in our common mission. This acquisition perfectly meets our strategic ambitions of growing in sustainable packaging and in building a stronger business in the APAC region”, says Johan Sundelin, CEO Duni. “BioPak is on a significant growth journey, and we look forward to partnering with Duni to grow both within and outside of the APAC region. Duni shares BioPak’s key values regarding sustainability and customer prioritization, which will allow for a fruitful partnership in coming years,” says Gary Smith, CEO BioPak Pty Ltd. :: For more information, please contact:Johan Sundelin, President and CEO, tel. +46 734 19 61 79Mats Lindroth, CFO, tel. +46 40 10 62 00 :: Duni is a leading supplier of attractive and convenient products for table setting and take-away. The Duni brand name is sold in more than 40 markets and enjoys a number one position in Central and Northern Europe. Duni has some 2,400 employees in 23 countries, headquarter in Malmö and production units in Sweden, Germany, Poland, Thailand and New Zealand. Duni is listed on NASDAQ Stockholm under the ticker name “DUNI”. ISIN-code is SE0000616716. Duni.com  This information is information that Duni AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on October 15, 2018. 

UBS Europe SE completes acquisition of Nordea’s Luxembourg-based private banking business

UBS and Nordea announced today that UBS has successfully acquired part of Nordea's Luxembourg-based private banking business.As announced in January 2018, the transaction covers the acquisition of part of Nordea Bank’s business and its integration onto UBS' platform, thereby providing clients access to its global offering and local expertise. The decision followed a thorough strategic review of Nordea’s Private Banking International activities. The strategic review was part of the transformation of Nordea with the aim to better manage risk, focus on the core business and deliver an even better bank for the clients. This led to the decision to concentrate Nordea’s private banking activities on the Nordics. The acquisition enables UBS to expand its presence in Europe and further build its position as a key wealth manager for Nordic clients in Europe. Christine Novakovic, Head of Wealth Management EMEA, said: “Today, we can announce the completion of this important acquisition which enables us to strengthen our business hub in Luxembourg and our position as the leading wealth manager in Europe. With our experienced colleagues from Nordea joining we can tap into our full potential allowing us to deliver the best possible performance to our clients and business partners.” Snorre Storset, Head of Asset & Wealth Management at Nordea, said: “Our aim is to offer the best and most relevant services to our customers, and we are currently increasing our focus on private banking activities in the Nordics. We are certain that with UBS we have found a partner that will deliver high quality and professional advice in line with the needs and requirements of our international private banking clients.” About UBS UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS’ strategy is centered on its leading global wealth management business and premier universal bank in Switzerland, enhanced by Asset Management and the Investment Bank. The bank focuses on businesses that have a strong competitive position in their targeted markets, are capital efficient, and have an attractive long-term structural growth or profitability outlook. UBS is present in all major financial centers worldwide. It has offices in 52 countries, with about 34% of its employees working in the Americas, 34% in Switzerland, 18% in the rest of Europe, the Middle East and Africa and 14% in Asia Pacific. UBS Group AG employs approximately 61,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).   For further information: NordeaRodney Alfvén, Head of Investor Relations, +46 722 350 515Roberta Alenius, Head of Group External Communications, +46 702707217  UBS Group AGSwitzerland: +41-44-234 85 00UK: +44-207-567 47 14Americas: +1-212-882 58 57APAC: +852-297-1 82 00 

New supplementary Strangvac study demonstrates immunological memory with long duration

The Swedish biotechnology company Intervacc has now taken another step towards confirming the effect of its vaccine, one of the company's development development projects, against the infamous streptococcal infection strangles in the horse. A new supplementary study shows that horses vaccinated with the vaccine Strangvac maintain an "immunological memory" against the disease 12 months after vaccination. The result of the study means that a re-vaccination within 12 months, instead of previously shown 6 months, after basic vaccination very quickly restores a protection. Strangles is a highly contagious respiratory tract infection in horses - especially feared within trotting and gallop activities as well as at riding schools, as risk exposure increases when horses come into contact with hidden carriers. Getting rid of strangles infection involves extensive work. The infection leads to severe suffering for the horses, and the financial consequences are often high for affected facilities due to inhibited business and sanitation measures. - The new study, in combination with previous studies, shows that intramuscular vaccination with the Strangvac vaccine provides effective protection and also a rapid immune response (booster effect) at revaccination up to one year after basic vaccination. These are pleasing results that are of great importance in the development of guidelines and vaccination programs for how Strangvac will be used. Today there is no fully safe and satisfactory vaccine against strangles on the world market, as shown by current reported outbreaks from around the world, says Jan-Ingmar Flock, CEO Intervacc AB. Strangles is a notifiable disease in Sweden. In Sweden, the annual number of recorded index cases has been around 100 in recent years, which usually means that many more horses in a stable will be affected. The problem with strangles in the horse industry is global, with only one exception for Iceland - where other horses are never allowed to enter the country due to risks with disease dissemination. The current results are yet another important incentive for horse owners to first give the two basic vaccinations in order to prevent strangles in horses. A re-vaccination (booster) with only one dose within 12 months can then provide a rapid renewed protection within one week. Such a booster dose will be recommended at times of an increased risk of exposure to the horses, such as at competitions, transportation or identification of a case of strangles. This harmonises with recommendations for vaccination against horse influenza. Strangvac has undergone clinical trials and safety tests with good results. Intervacc intends to submit a registration application for Strangvac at the end of 2019, a new recombinant vaccine against equine strangles. For more information please contact:   Jan-Ingmar Flock, CEOE-mail: jan-ingmar.flock@intervacc.comPhone: +46-8-120 10 602 or +46-73-334 14 11 This information is information that Intervacc AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on October 15, 2018. About Intervacc Intervacc AB (publ) is a company within the Biotechnology sector. The Company´s main area is to develop modern sub-unit vaccines against economically important bacterial infections, mainly within animal health. The company´s vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the company´s research and development work. The Intervacc share has been listed on the NASDAQ First North market since April 2017 with Eminova Fondkommission AB as Certified Adviser.

Medivir to focus on its clinical development and appoints Uli Hacksell as acting CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company’s acting CEO. Dr. Hacksell, currently on the board of Medivir, succeeds Christine Lind as of today, October 15. “Medivir has a very strong clinical portfolio with inflection points in the near future that are crucial for optimizing its value. This calls for a firm management that is able to reinforce the focus on clinical development throughout the company,” says Anna Malm Bernsten, chairman of the Medivir board.“Uli is truly qualified to take over the leadership and his well-documented expertise in pharmaceutical R&D will be of great value to Medivir. Furthermore, he has a broad experience from building cost-efficient internationally leading biotech companies. At the same time, I want to thank Christine Lind for the dedicated work she has done for Medivir,” Anna Malm Bernsten continues. “I look forward to taking on this role at a very important stage for Medivir. The Board of Directors has worked on a plan that will concentrate Medivir’s attention on the company’s robust clinical pipeline composed of transformative cancer drugs with multi-billion dollar sales potential. I will come back within short to present the relevant measures,” says Dr. Hacksell. Medivir's clinical pipeline consists of four projects; remetinostat for cutaneous T-cell lymphoma (phase II), birinapant in combination with Keytruda® for solid tumors (phase I), MIV-818, a nucleotide prodrug for liver cancer that recently entered into a phase I clinical trial, and MIV-711, an osteoarthritis candidate drug with fresh and promising data from the recent phase IIa extension study. For further information, please contact: For media information:Cord CommunicationsLars Wahlström, phone: +46 (0)734 340 771. lars.wahlstrom@cordcom.se Anna Malm Bernsten, Chairman of the Board, Medivir AB, phone: +46 (0)8 5468 31 00 Medivir AB is obliged to make this information public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on October 15, 2018. About Dr. Uli HacksellDr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public, multi-billion dollar company. In the 1990s, he held senior positions at Astra AB, prior to which he was a Professor of Organic Chemistry at Uppsala University. He received a PhD in Medicinal Chemistry in 1981 and a Master of Pharmacy in 1976 from Uppsala University. About MedivirMedivir is a pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitors and nucleotide/nucleoside science and we are dedicated to innovative pharmaceuticals that meet great unmet medical needs. Medivir's clinical pipeline consists of remetinostat for cutaneous T-cell lymphoma, currently in phase II, birinapant in combination with Keytruda® for solid tumors, currently in phase I, MIV-818, a nucleotide prodrug drug for liver cancer that recently entered into a phase I clinical trial, and MIV-711, a potentially disease-modifying osteoarthritis candidate drug with fresh and promising data from the recent phase IIa extension study. Medivir is listed on the Nasdaq Stockholm Mid Cap List (ticker: MVIR). www.medivir.com.

Academic media group to address the urgency of employer branding in academia

The company behind the career network Academic Positions and the academic storytelling platform Academic Stories, is now launching Academic Media Group to address the increasing demand for employer branding in academia.The tradition of relying on reputation and university rankings is creating a gap in academia’s communication with future employees, and many organizations are still in early stages of presenting themselves as not only great academic institutions but also great employers. Still, the range of strategic employer branding partners for academia is limited, which was the catalyst for Academic Media Group.Leveraging nine years of experience of providing recruitment services to the academic institutions around the world, Academic Media Group is now creating a new segment in the employer branding industry by providing strategic employer branding solutions designed specifically for the academic sector.Erik Björkander, the CEO of Academic Media Group, explains why employer branding is crucial for the academic sector in his introductory blog post. Visit the link to read full article: https://bit.ly/2yyyXmB   For further information, please contact:Erik Björkander, CEOerik.bjorkander@academicmedia.groupArijana Duvnjak, Marketing Managerarijana.duvnjak@academicmedia.groupAbout Academic Media GroupAcademic Media Group is a digital media company and strategic partner that aims to support the internationalization of research and encourage people to pursue an academic career. By combining strategic communication, ingenuity, and cutting-edge technology, Academic Media Group delivers highly competitive employer branding services to the academic sector. Founded in 2009 and headquartered in Stockholm, we help universities and research organizations all over the world to not only be great academic institutions but also great employers. Academic Media Group International ABPhone: +46 840 835 000Email: info@academicmedia.groupAdress: Klarabergsviadukten 90D, 111 64 Stockholm, Sweden

Nomination Committee appointed in respect of AGM 2019 in Oncopeptides

The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination Committee in respect of the annual general meeting 2019 consists of the following persons who together represent approximately 55 percent of the number of shares and votes in the company based on the last known shareholder information at end September. Staffan Lindstrand, appointed by HealthCap VI L.P.Nina Rawal, appointed by Stiftelsen IndustrifondenMax Mitteregger, appointed by GLADIATORPer Wold-Olsen, the Chairman of the Board The Nomination Committee’s proposals will be presented in the Notice to the annual general meeting 2019 and on Oncopeptides’ web site, www.oncopeptides.com. Shareholders who wishes to submit proposals to the Nomination Committee can do so by sending an e-mail to info@oncopeptides.com (subject “Nomination Committee”) or by letter posted to Oncopeptides AB, Attn: Oncopeptides Nomination Committee, Luntmakargatan 46, SE-111 37 Stockholm, Sweden.A proposal must reach the nomination committee no later than by April 1st to be included in the notice to attend and the agenda for the annual general meeting. The information was submitted for publication at 09.00 CET on October 15, 2018. About Oncopeptides Oncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. The company focus on the development of the lead product candidate melflufen (Ygalo®), an alkylating peptide, Peptidase Enhanced Compounds (PEnCs). Melflufen (Ygalo®) is intended as an effective treatment of hematological cancers, and in particular multiple myeloma. The current clinical study program is intended to demonstrate better results from treatment with melflufen (Ygalo®) compared with established alternative drugs for patients with late-stage multiple myeloma. Melflufen (Ygalo®) will potentially provide physicians with a new treatment option for patients suffering from this serious disease.  Visit www.oncopeptides.com for more information.

Acquisition of GET and TDC Norway completed

Telia Company has today completed its acquisition of GET and TDC Norway. The transaction will position Telia Company as a strong challenger in mobile, TV and broadband on the Norwegian market. On July 17, Telia Company announced the acquisition of GET and TDC Norway at an enterprise value of NOK 21 billion on a cash and debt free basis. The purchase price corresponds to an EV/EBITDA multiple of 12.1x based on 2017, and 9.0x including expected synergies. Telia Company expects to generate full run rate synergies of NOK 0.7 billion by 2021 from B2C and B2B cross-sales, churn reduction, capex optimization and other cost efficiencies. The Norwegian competition authority approved the acquisition on October 5 and the transaction was closed today. GET and TDC Norway will be consolidated into Telia Company’s reporting as of today.  For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .  We’re Telia Company, the New Generation Telco. Our approximately 20,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com

Eyeonid Group AB (Publ) signs a reseller agreement with Mr. Sören Timm regarding Eyeonid’s products for the German market

During the last 12 months Eyeonid Group have focused a lot on the European market, where Germany is a key-market with great potential for all services provided by Eyeonid. Mr. Sören Timm, who recently left CPP Group where he was the Country CEO in Germany, Austria and Switzerland, is one of the most experienced persons on these markets when it comes to ID-theft protection solutions. Over the years, Mr. Sören Timm have gained great knowledge about the value added services market as well as a large network of potential customers. The two companies already have several mutual discussions with potential customers that are in the final stages and will continue to develop the offering based on the EyeOnID 360° Modules for the German market. "It is a pleasure, and in line with our strategy, that we today have increased our network of reselling partners regarding our products and services. To be able to sign an agreement with such an experienced person as Mr. Timm is very positive for Eyeonid Group as this, once more, validates our strength and uniqueness in our value proposition. We have seen tremendous positive feedback from the German market and it is clear there is a great opportunity for both our companies in Germany”, says Daniel Söderberg, CEO, Eyeonid Group AB (publ). For any further information, please contact: Daniel Söderberg, CEO, Eyeonid Group ABPhone +4673 422 79 30 Mail: daniel.soderberg@eyeonid.com

Fagerhult signs a Letter of Intent to acquire iGuzzini

AB Fagerhult (publ) (“Fagerhult”) has today signed a Letter of Intent (LOI) with the shareholders of iGuzzini illuminazione S.p.A (“iGuzzini”) to acquire 100% of the shares of iGuzzini. Based on this LOI, Fagerhult has exclusivity to conduct a customary due diligence and is targeting signing a Share Purchase Agreement before the end of 2018. The finalising of the transaction will be subject to Fagerhult board approval and any anti-competition approvals that may be required. The transaction will be funded from a combination of debt finance and a new rights issue in Fagerhult shares. Upon finalising the transaction, the Sellers (the Guzzini family through the legal entity Fimag S.p.A and Tipo TIP – PreIPO S.p.A) will receive a significant portion of the consideration in Fagerhult shares with the aim of becoming shareholders of the combined entity. Adolfo Guzzini (President of iGuzzini) and Andrea Sasso (CEO of iGuzzini) - in addition to remaining in their respective executive roles within iGuzzini - will assume important roles in the top management of Fagerhult. The addition of iGuzzini will significantly strengthen the Fagerhult Group’s position in the professional lighting market both in terms of the geographic presence and by adding leading complementary product ranges. iGuzzini is a very well-known and respected professional lighting brand with a high brand awareness particularly amongst specifiers. The company designs, manufactures and markets professional lighting solutions for both the indoor and outdoor application areas. Founded in 1959 the company is based in Recanati, Italy. In the financial year ending December 2017, the company had 1,300 employees, and sales of approximately 230 MEUR. More information on iGuzzini is available at www.iguzzini.com This information is inside information that AB Fagerhult (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 15.30 CET on October 15, 2018. Habo  October 15, 2018

SSM carries out investor transaction, sells 176 rental units Täby

SSM has carried out an investor transaction and sells 176 rental units in its Täby Turf project to property company Willhem. The selling price is 473.0 MSEK and revenue for the project is expected to be recognized during the period Q1 2019 to Q1 2021. The first tenants are expected to move in during Q4 2020. Täby Turf is a development based on a land allocation from the Municipality of Täby that SSM won in a competition. The project is part of the new Täby Park area that will include at least 6,000 new homes. Täby Turf is attractively located near Täby centrum and just 400 m from the Galoppfältet light rail station. The project is characterized by innovative architecture featuring buildings of various heights and facades of brick and plaster. The total floor space of the project is 8,666 m2 and the apartments will be one- to three-room units of 35 to 70 m2, of which 85 percent will be studio apartments and two-room units with floor space of 35 to 48 m2. There is also commercial space that includes three retail spaces and a daycare center for 40 to 60 children. - We’re very pleased that Willhem will be a long-term owner of the Täby Turf rental project. SSM’s strategy is to increase the share of rental units in production. Right now, about 40 percent of the Group’s building rights that are in the planning phase are suitable for rental units, says Mattias Roos, President & CEO of SSM. The city plan for the project has been approved and construction is expected to start during the first quarter 2019. The information in this press release is such, which SSM Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 16.00 CET on October 15, 2018.    For more information, please contact:Ann-Charlotte Johansson, Chief Communications & IR Officer      Phone: +46 761 65 17 71 Email: ann-charlotte.johansson@ssmliving.se Twitter: @anncharlotteSSM   About SSM Holding AB (publ)SSM produces functionally smart and affordable homes with attractive common areas, close to public transport and the city center for the company’s target group — the urbanites of tomorrow. The company envisions a housing market that is accessible to as many people as possible and aspires to produce 60 percent cooperative apartments, 30 percent rental units and 10 percent student housing. SSM is the leading property developer in its niche within the Greater Stockholm area and in June 2018, the company has approximately 6,500 building permits in its portfolio. SSM was listed on Nasdaq Stockholm (Mid-cap) April 6, 2017 www.ssmlivinggroup.se

Höegh LNG : Amendment of the Höegh Gallant time charter

Hamilton, Bermuda, 15 October 2018 – Höegh LNG Holdings Ltd. (“Höegh LNG”) and Egypt Natural Gas Holdings Company (“Egas”) have agreed to amend the Höegh Gallant time charter. Under the amended contract, the Höegh Gallant will be chartered as an LNG carrier to a third party, and Egas will compensate for the rate difference between the original FSRU contract and the new LNG carrier time charter. The amended contract is expected to become effective in October 2018 and will run to April 2020, the termination date of the original five-year FSRU contract.   As part of the original FSRU contract with Egas, Höegh LNG has certain equipment installed on the jetty in Ain Sokhna, Egypt. The book value of this equipment was approximately USD 9 million as of 30 June 2018, and since the market value and alternative use of such equipment is unclear, Höegh LNG expects to record an impairment for a corresponding amount for the third quarter of 2018. Sveinung J.S. Støhle, President and CEO of Höegh LNG, comments: “We are proud to have provided FSRU services to Egas since 2015, during a period in which Höegh Gallant’s regasification capacity has been fully utilized, contributing strongly to balancing supply with demand in the Egyptian natural gas market. Under this amended contract we maintain our highly valued relationship with Egas, which we hope to further expand in the future as Egypt emerges as a regional energy hub.” * * * About Höegh LNG: Höegh LNG operates world-wide with a leading position as owner and operator of floating LNG import terminals; floating storage and regasification units (FSRUs), and is one of the most experienced operators of LNG Carriers (LNGCs). Höegh LNG's vision is to be the industry leader of floating LNG solutions. Its strategy is to develop the business through an extended service offering, with large-scale FSRUs as the main product, and focus on establishing long-term contracts with attractive risk-adjusted returns involving credible counterparts. The company is publicly listed on the Oslo stock exchange under the ticker HLNG, and owns approximately 46% of Höegh LNG Partners LP (NYSE:HMLP). Höegh LNG is a Bermuda based company with established presence in Norway, Singapore, the UK, USA, South Korea, Indonesia, Lithuania, Egypt, Colombia and Turkey. The company employs approximately 125 office staff and 525 seafarers. Contacts: Sveinung J. S. Støhle, President and Chief Executive Officer, Telephone +47 975 57 402Steffen Føreid, Chief Financial Officer, Telephone +47 975 57 406Erik Folkeson, VP IR and Strategy, Telephone +47 414 21 769 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act or the Continuing Obligations of Oslo Børs. *

AVTECH communicates a business update

Avtech`s ambition to become an IT company where development and implimitation of effeciency and saftey features for Airlines, Airports and Air traffic Management continues. The cooperation of development of Met Office and Avtech have resulted in a unique weather forecast that can be delivered directly to the aircraft´s Flight Management System during flight. The accuracy of the forecast is based on a 10KM weathergrid compared to the standard 140KM resulotion. The significantly improved granularity enables Aventus to deliver forecasts with minimal deviations from factual weather. The accuracy of estimated arrival time will improve from minutes to seconds. The improved geographical accuracy of turbulence and jet streams will provide great benefits regarding fuel efficiency and comfort onboard by the opportunity to avoid turbulence and take advantage of the wind situation. The market for our products is increasing with the availability of more well-equiped aircraft. On top of fuel saving, the turbulence warning system SIGMA and Aventus OPTIMA products enhance the effect of the base product Aventus. Two of our major customers have during the autumn started the testing of these new products.So far, the tests have delivered better than expected result. The recently launched proFLIGHT-app, a visual presentation of the Aventus product family`s ability to give each pilot an improved decision support tool during flight is currently under practical testing of around 100 pilots from more than 10 different airlines. Over the past year, several of our customers have confirmed that our products deliver over and above what has been promised. Two of our existing customers have expressed their interest in actively participating in further development of the Aventus product family.They are asking for, among other things, a Windows-based PROFLIGHT app. There is also an interest adapting the proFLIGHT products to other airline decision-makers than pilots. Some airlines have requested a system for otimizing the entire flight path, from take-off to landing. In cooperation with one of our customers we recently initiated the development of a function to select the most economical cruising flight level based on forecasted winds like jet streams. In this context we are also in the process of developing improved possibilities to optimise the full flight in what is called Aventus OPTIMA. The result from the development o Aventus SIGMA and the pilot app ProFLIGHT means that a large parts of the necessary development work has alreade been achieved. Needed adaption to customers is part of the deployment process and is an intregated part of the joint efforts with our customers. The board has during 2018, followed the development work in detail and consider that Avtech now has a significantly improved and competitive product family, ready for environmentally friendly, safe and convenient flying. For more information, please contact Bo Redeborn, Styrelseordförande +46 (0) 8 544 104 80Christer Fehrling, CEO +46 (0) 8 544 104 80 This information is information that Avtech Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:45 CEST on October 15, 2018. About AVTECH Sweden AB (publ)AVTECH develops products and services for digital Air Traffic Management (ATM). Its customers include the global aviation industry; e.g. airlines, airports, aviation authorities, technology companies and airline manufacturers. By using AVTECH’s products and services, each individual flight as well as the entire airline operation can be optimized in terms of cost, noise and emission, efficiency, punctuality and safety. The head office is in Stockholm. AVTECH Sweden AB is listed on NASDAQ OMX First North and has appointed Redeye AB, tel: +46 8 545 013 30, as Certified Adviser.

LeoVegas hires Communications Director and strengthens the marketing department

LeoVegas Mobile Gaming Group is strengthening its internal organisation with an experienced Communications Director and has appointed two Marketing Directors, who will bring high-level expertise to the marketing department. New Communications Director Irena Busic has been recruited as new Communications Director for LeoVegas Mobile Gaming Group. Irena will have overarching responsibility for PR as well as for the Group’s press and internal communications. She will assume her position on October 15 2018. “LeoVegas is in an interesting stage right now. The much-needed upcoming regulation of the gaming market here in Sweden will lead to better transparency and a bigger need for communication. On a personal note I also like the company's focus on tech” says Irena Busic. Irena served most recently as Head of Global PR and Communications at Hyper Island. Prior to this she worked with communication consulting for fast-growing tech companies at the start-up hub SUP46. She has also spent more than four years in China, where she served as Head of Communications for Stora Enso and as Managing Director of the Swedish Chamber of Commerce. “The need to tell our story and who we are is becoming increasingly important while we also have a vision to change the perception to the industry. Irena’s broad experience will make her an important asset for the Group” says Gustaf Hagman, Group CEO Stronger marketing department In connection with Louise Nylén’s recent appointment as Deputy CEO of LeoVegas, the Chief Marketing Officer role (CMO) was eliminated. Responsibility has instead been split between two Marketing Directors, both based in Malta. Petra Blixt, previously Head of Acquisitions at LeoVegas, has advanced to become one of two Marketing Directors. During her time at LeoVegas Petra has successfully built up and structured the affiliation and online customer acquisition organisation. She will continue to have overarching responsibility for all of LeoVegas’ online marketing activities as well as the markets in which LeoVegas has these activities as their main focus. Claes af Burén has been recruited as Marketing Director with responsibility for the LeoVegas brand. Claes has a long and solid record of experience in brand-building, spending the last 14 years as CEO of various communications agencies. He served most recently as CEO and co-founder of DamnGoodAgency. In addition to the LeoVegas brand and related creative work, Claes will also have responsibility for markets in which LeoVegas is investing to build its brand. “I have a very positive view of our work on strengthening our marketing department and leadership with these two great people,” says Louise Nylén, Deputy CEO. “With this change we have more clearly defined the responsibilities in marketing and have added brand-building expertise, which gives us even better opportunities for sustainable growth.” For further information, please contact: Gustaf Hagman, Group CEO co-founder: +46 (0) 8 410 367 66, gustaf.hagman@leovegas.com Philip Doftvik, Head of Investor Relations: +46 73 512 07 20, philip.doftvik@leovegas.com Irena Busic, Communications Director: +46 73 151 16 15, irena.busic@leovegas.com About the LeoVegas mobile gaming group  LeoVegas’ passion is “Leading the way into the mobile future”. LeoVegas is Sweden’s premier GameTech company and is at the forefront of using state-of-the-art technology for mobile gaming. In 2017 the company passed the threshold for being classified as a unicorn, i.e., a start-up valued at more than USD 1 billion. A large part of this success can be credited to an extreme product and technology focus coupled with effective and data-driven marketing. Technology development is conducted in Sweden, while operations are based in Malta. LeoVegas offers casino, live casino and sports betting, and operates two global and scalable brands – LeoVegas and Royal Panda – as well as multiple, local brands in the UK. The company’s shares are listed on Nasdaq Stockholm. For more about LeoVegas, visit www.leovegasgroup.com.

Green Landscaping acquires Svensk Markservice – a nationwide ground maintenance & landscaping service provider in Sweden

Highlights · Green Landscaping has signed an agreement to acquire all outstanding shares in Svensk Markservice from Nalka and certain other minority sellers, including members of the management team of Svensk Markservice · Svensk Markservice is a nationwide ground maintenance and landscaping service provider in Sweden · The consideration amounts to SEK 398 million on a cash- and debt free basis (EV) and is fully financed through new credit facilities · Svensk Markservice reported adjusted total revenue of approximately SEK 879 million, adjusted EBITDA of approximately SEK 53 million and adjusted EBITA of approximately SEK 27 million for the last twelve months as of August 2018* · The acquisition strengthens Green Landscaping’s position in Sweden within the Ground Maintenance & Landscaping segment · Significant customer value is created by the acquisition through cost synergies, increased productivity and a stronger local presence. Run rate cost synergies of approximately SEK 25 million are expected · The acquisition is conditional upon the Swedish Competition Authority’s approval and is expected to be completed during the fourth quarter 2018 Transaction overview Svensk Markservice was founded in 1991 and is a Swedish provider of grounds maintenance services active across Sweden. The company develops and manages outdoor environments and offers year-round services to both private and public property owners. Services include gardening, cleaning, wood cutting, asphalting, drainage, snow clearance, among others. Svensk Markservice reported adjusted total revenue of approximately SEK 879 million, adjusted EBITDA of approximately SEK 53 million and adjusted EBITA of approximately SEK 27 million for the last twelve months as of August 20181. The acquisition will enable Green Landscaping to strengthen its market position within ground maintenance and landscaping services. A larger group brings benefits to the customers in terms of increased local presence, increased productivity and broader service offering. Going forward, the acquisition leaves further room for consolidation within a fragmented market. The consideration amounts to SEK 398m on a cash and debt free basis and is fully financed through new credit facilities. The acquisition is expected to be EPS accretive from 2019. Total annual run rate cost synergies are estimated to be approximately SEK 25 million through improved sourcing, better utilisation and increased efficiency. The synergies are expected to be fully realised by the end of 2020. Integration costs of approximately SEK 20 million are expected to have non-recurring EBITDA impact, with the main part of the non-recurring costs impacting 2019. Johan Nordström, CEO of Green Landscaping commented: “We are impressed with the quality of Svensk Markservice and have followed the company for some time. The combination of Green Landscaping and Svensk Markservice creates a nationwide ground maintenance and landscaping service provider and is a perfect match. The acquisition enables us to improve initiatives like Green Steps and deliver even greater value to our customers and society in large.” Per Sjöstrand, Chairman of the Board of Green Landscaping continued: “It is great to see that Green Landscaping continues to deliver on its acquisition strategy after the successful IPO earlier this year. This acquisition has a clear industrial rationale, and Svensk Markservice is a great company that will contribute significantly to the development of Green Landscaping and strengthen our delivery to customers.” Johan Hesser, CEO of Nalka Invest commented: ”We are both happy and proud of the development we have created for Svensk Markservice together with the management and employees. Together, Svensk Markservice and Green Landscaping will have a strong geographical presence in Sweden, in which the companies’ current businesses strategically complement each other well. We are convinced that the business has great potential to continue to develop in a positive way together with Green Landscaping.” Regulatory process The acquisition is conditional upon the Swedish Competition Authority’s approval and is expected to be completed during the fourth quarter 2018. Advisers SEB Corporate Finance has acted as sole financial adviser and Advokatfirman Cederquist has acted as legal adviser to Green Landscaping. For further information: Johan Nordström, CEO, Green Landscaping, +46 708 38 58 12johan.nordstrom@greenlandscaping.se Carl-Fredrik Meijer, CFO, Green Landscaping, +46 701 08 70 19carl-fredrik.meijer@greenlandscaping.se  This is information that Green Landscaping Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 17:45 CET on 15 October 2018. Green Landscaping Group is a leading landscaping service provider in Sweden. Our business idea is to refine our customers’ outdoor environments by offering services focused on high customer value, long-term sustainability and quality. The group has approximately 650 employees and sales amount to around SEK 1 billion. The company’s shares are listed on Nasdaq First North with ticker GREEN. Pareto Securities AB acts as Certified Adviser. For more information, please visit www.greenlandscapinggroup.se. Important information The figures reported in this press release have been rounded as appropriate. This implies that some figures and tables may not sum up correctly. Forward-looking information Statements in this press release relating to future status and circumstances, including statements regarding future performance, growth and other projections as well as benefits of the acquisition, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “expects”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Actual results may differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Green Landscaping. Such factors may include Green Landscaping’s ability to successfully complete the acquisition, integrate the Svensk Markservice into its operations and implement its acquisition strategy. You should not place undue reliance on forward-looking statements. They speak only as at the date of this press release and Green Landscaping undertakes no obligation to update these forward-looking statements. ---------------------------------------------------------------------- * Total revenue, EBITDA and EBITA adjusted for acquisitions, discontinued operations and non-recurring items

Ambea has entered into an agreement to acquire the care operations of Aleris

Ambea has entered into an agreement to acquire the care operations of Aleris in Norway, Sweden and Denmark (“Aleris Care”) at a purchase price of SEK 2.6 billion on a debt free cash free basis (enterprise value) (the “Transaction”). Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark[1]. The acquisition will create a stable platform for future organic growth and significant potential for synergies, purchasing coordination and exchange of experiences in the areas of business and quality development. The Transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019, however no later than in the second quarter of 2019. Ambea intends to finance the Transaction with existing credit facilities and new, secured bank financing. Thus, the Transaction is not conditioned upon financing. In order to repay part of the bank financing and to lower Ambea’s debt in line with the company’s long term financial targets, Ambea intends to propose that a general meeting resolves on a share issue, with preferential rights to existing shareholders, in the amount of approximately SEK 1.2 billion in (the “Rights Issue”). The larger shareholders ACTR Holding AB and ACTOR SCA, controlled by KKR and Triton and representing approximately 50.1 per cent of the total number of shares and votes in Ambea, intend to vote in favour of the Rights Issue at a general meeting and to subscribe for their respective pro-rata shares in the Rights Issue. The Rights Issue is expected to be resolved and completed during the first half of 2019. Today, Ambea is the second largest player in the private market for care services in Sweden and the seventh largest in Norway. Aleris Care is the leader in the private market for care services in Norway, the sixth largest private operator in Sweden and the largest private provider in the Denmark[2]. The annual sales for the new group for the period 1 July 2017 to 30 June 2018 amounted to approximately SEK 10,602 million, of which Ambea accounted for SEK 5,937 million and Aleris Care for SEK 4,665 million[3]. Adjusted EBITA[4] for the new group during the corresponding period amounted to approximately SEK 644 million, of which adjusted EBITA for Ambea accounted for SEK 498 million and Aleris Care for approximately SEK 146 million[5](reported SEK 96 million). The operations have a combined total of approximately 13,100 full time employees and 7,690 beds and placements in own management. In addition, the Transaction will offer the opportunity for increased organic growth within own management, since the number of new beds contracted and/or under construction amounts to 1,796, of which Aleris Care accounts for 758 beds. The proportion of care services conducted under own management by Ambea will increase from the current figure of 67 per cent to 71 per cent and is expected to increase further moving forward as a result of a strong combined pipeline. Fredrik Gren, President and CEO of Ambea:“The acquisition increases our capacity for organic growth under own management. We will gain a broader growth platform with leading positions in three countries and a strengthened pipeline with new beds. Furthermore, we will create major opportunities for synergies, purchasing coordination and exchange of experiences in the areas of operational and quality development. This will outlay the foundation for higher quality and thus also higher profitability in our operations.” Lena Hofsberger, Chairman of the Board of Ambea:“Through the acquisition of Aleris Care, Ambea will become the leader in the Nordic region and in several strategically important markets in the area of care provision. The companies complement each other and have corporate cultures that are well-matched. We can see significant opportunities for development and value growth for Ambea’s shareholders moving forward. This will enable Ambea to continue its journey of growth and create a more efficient organisation.” Synergies, integration costs and operational improvementsThe acquisition is expected to generate both direct cost synergies and opportunities for operational improvements. The expected direct cost synergies amount to SEK 90 million annually, of which half are expected to be realised in 2019 and the remainder in 2020. Identified operational improvements amount to SEK 30 million, which are expected to be achieved in 2020. In addition to direct cost synergies and identified operational improvements, Ambea believes that further efficiency enhancements can be realised over the next two to three years. Ambea’s financial targets remain unchanged, but these will only be achieved after the integration and synergies have been fully implemented. The Transaction is expected to give rise to transaction costs totalling SEK 35 million, which are expected to be reported in the fourth quarter of 2018 and integration costs totalling SEK 100 million, of which the majority are expected to be recognised in 2019. The TransactionAmbea has entered an agreement to acquire Aleris Care for a purchase price of SEK 2.6 billion on a debt free cash free basis, i.e. enterprise value. The purchase price corresponds to 14.0x adjusted EBITA before synergies, 9.4x adjusted EBITA after expected cost synergies and 8.5x adjusted EBITA after anticipated cost synergies and operational improvements, based on the last twelve months (October 2017 – September 2018). The final purchase price is expected to amount to approximately SEK 3 billion depending on Aleris Care’s net cash in connection with closing. The Transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019, however no later than in the second quarter of 2019. Financing and rights issueThe final purchase price of approximately SEK 3 billion[6] will be financed with existing credit facilities and new, secured bank financing from Danske Bank, DNB and Nordea. Thus, the Transaction is not conditioned upon financing. In order to repay part of the financing and to lower Ambea’s debt in line with the company’s long term financial targets, Ambea intends to, in connection with the Transaction, carry out a share issue, with preferential rights to existing shareholders, in the amount of approximately SEK 1.2 billion. The larger shareholders ACTR Holding AB and ACTOR SCA, controlled by KKR and Triton and representing approximately 50.1 per cent of the total number of shares and votes in Ambea, intend to vote in favour of the Rights Issue at a general meeting and to subscribe for their respective pro-rata shares in the Rights Issue. The Rights Issue is expected to be resolved and completed during the first half of 2019. General MeetingThe Rights Issue is contingent on the shareholders’ approval and thus, Ambea intends to propose that the shareholders resolve on the Rights Issue at a general meeting. Further details will follow and a notice of the general meeting will be published separately and also made available at www.ambea.se. AdvisorsNordea has acted as financial advisor, Vinge has acted as legal advisor and Alvarez and Marsal has acted as financial due diligence advisor to Ambea in connection with the Transaction. Press and analyst conferenceIn light of Ambea’s acquisition of Aleris Care, a press and analyst conference will be held on 16 October 2018 at 10:00 a.m. CET at Ambea’s head office, Evenemangsgatan 21 in Solna, Sweden. It will also be possible to participate via telephone and webcast. The conference will be held in English. For more information, please refer to the separate press release.  ---------------------------------------------------------------------- [1] Based on annual reports 2017, adjusted for material acquisitions and divestments. Attendo adjusted for the divestment of the Finnish healthcare operations and acquisition of Mikeva. [2] Excluding personal assistance. [3] Adjusted for discontinued units, units being phased out and items affecting comparability. [4] EBITA before depreciations on intangible assets, adjusted for items affecting the comparability with other periods’ results. [5] Adjusted for discontinued units, units being phased out and items affecting comparability. [6] Including enterprise value of SEK 2.6 billion and net cash.

NCC presents new path forward and preliminary Q3 earnings charged with provisions and revaluations

“Today NCC presents a new path forward. We are now lowering the risk level associated with the Group’s project portfolio and balance sheet, discontinuing certain unprofitable operations and focusing on NCC’s healthy core operations that can be found in all business areas and countries. With a new Executive Management Team in place, a consistent approach to risk management in projects and extensive measures to improve profitability to turnaround non-performing operations, we are creating a platform on which to build a strong future for NCC,” says Tomas Carlsson, CEO of NCC. NCC has initiated extensive measures in all business areas to strengthen profitability. These measures include: · Processes for the divestment and closure of unprofitable operations, such as divestment of the Road Services division in the Infrastructure business area and a number of smaller operations in the Industry business area and certain development properties in the Property Development business area. · Turnaround plans for the civil engineering operations in Norway and the Building Nordics business area · Strengthened organization with new recruitments to key positions, training initiatives and the development of control and follow-up processes to achieve a general improvement · Enhanced process for risk assessment of projects Earnings for Q3 were charged with: · Revaluation in ongoing claims and warranties of approximately SEK 693 M · Revaluation of certain development properties of SEK 365 M due to decisions to discontinue projects · Impairment losses in the project portfolio as a result of a revaluation of approximately SEK 225 M · Restructuring costs for discontinuation and restructuring of operations SEK 75 M · Other revaluation of SEK 207 M The measures that have now been decided will probably entail further restructuring costs of approximately SEK 200 M until the end of 2019. The measures are expected to have a limited effect on employment within the Group. Certain local changes may be made. The company still has a recruitment need. The assessment is that the market conditions remain favorable. The Board of Directors has decided to limit the number of objectives for the Group in order to give greater clarity and focus on profitability ahead of volume. The approved objectives and the dividend policy remain unchanged and are as follows: · Return on equity ≥20% · Operating margin ≥4% · Net indebtedness <2.5 times EBITDA · Dividend policy: The Group’s dividend policy is to distribute at least 40% of after-tax profit for the year. The financial objectives for the business areas are unchanged. NCC also has a number of non-financial objectives that the company will continue to work toward as part of its efforts to generate long-term profitability. “The demerger of NCC and Bonava in 2016 highlighted the need for increasing NCC’s profitability. The Board decided in October 2017 to replace NCC’s CEO. The reason was that the performance of the operations was too weak. The Board recruited an external CEO with a proven record of taking strong action and 20 years of experience in the construction industry – Tomas Carlsson – who was asked by the Board to perform a comprehensive review and to develop a robust action program, aiming at building long-term profitability. The result of this review is presented today and has the full support of the Board. The Board believes that we are now laying the foundation for future profitability at NCC,” says Tomas Billing, Chairman of NCC. The preliminary earnings for NCC and for each business area are presented in the appendix. The revaluations in addition to the current operations and the preliminary operating result were presented in a press release from NCC at 9:50 p.m. on October 15 in accordance with the EU Market Abuse Regulation (MAR).  A Capital Markets Meeting for representatives of the financial market and media will be held at 9:00 a.m. CET at the Scandic Anglais Hotel in Stockholm, Sweden. To follow the Capital Markets Meeting via webcast, visit ncc.group/cmd  UK: +442030089806, SE: +46856619353, US: +18558315945.

FDA Orphan Drug for Lynparza in pancreatic cancer

16 October 2018 07:00 BST US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer Fourth Orphan Drug Designation in the US for AstraZeneca and MSD's Lynparza AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that they were granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA) for Lynparza (olaparib) for the treatment of pancreatic cancer. Pancreatic cancer is a rare, life-threatening disease that accounts for about 3% of all cancers in the US.i Due to the late onset of symptoms, patients are often diagnosed after the cancer has progressed to locally advanced or metastatic stages of the disease.ii Five-year survival rates remain low in the US at 8.5%.iii Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer said: "Pancreatic cancer is an area of significant unmet medical need. This is especially true for patients with metastatic disease where the benefits of current treatment options are very limited." Roy Baynes, Senior Vice President and Head of Global Clinical Development, Chief Medical Officer, at MSD Research Laboratories, said: "Pancreatic cancer is a relatively less common, but life-threatening, form of cancer. The FDA granting Orphan Drug Designation is a positive step for patients with pancreatic cancer and continues to reinforce the importance of our collaboration in bringing Lynparza to more patients in need." ODD status was granted for the treatment of ovarian cancer in October 2013. Earlier this year an amended ODD status was granted to include both fallopian tube and primary peritoneal cancers following the expanded US approval of Lynparza in August 2017 for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy. The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. The use of Lynparza in pancreatic cancer is being assessed in the ongoing Phase III POLO trial, which is testing Lynparza as maintenance monotherapy vs placebo in patients with germline BRCA-mutated metastatic pancreatic cancer whose disease has not progressed following 1st-line platinum-based chemotherapy. Results from the POLO trial are expected in the first half of 2019. About the POLO Phase III trial POLO is a Phase III, randomised, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of Lynparza tablets (300 mg twice daily) as maintenance monotherapy compared with placebo, in patients with germline BRCA-mutated metastatic pancreatic cancer whose disease has not progressed following 1st-line platinum-based chemotherapy. The trial randomised 145 patients to receive Lynparza or placebo (3:2). The primary endpoint is progression-free survival. About Lynparza Lynparza (olaparib) was the first in class PARP inhibitor and the first targeted treatment to potentially exploit DNA damage response (DDR) pathway deficiencies, such as BRCA mutations, to preferentially kill cancer cells. Specifically, in vitro studies have shown that Lynparza-induced cytotoxicity may involve inhibition of PARP-enzymatic activity and increased formation of PARP-DNA complexes, resulting in DNA damage and cancer cell death. Lynparza, which has the broadest clinical development programme of any PARP inhibitor, is being investigated in a range of DDR-deficient tumour types, and is the foundation of AstraZeneca's industry-leading portfolio of compounds targeting DDR mechanisms in cancer cells. About the AstraZeneca and MSD Strategic Oncology Collaboration In July 2017, AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US, known as MSD outside the United States and Canada, announced a global strategic oncology collaboration to co-develop and co-commercialise Lynparza, the world's first PARP inhibitor and potential new medicine selumetinib, a MEK inhibitor, for multiple cancer types. Working together, the companies will develop Lynparza and selumetinib in combination with other potential new medicines and as monotherapies. Independently, the companies will develop Lynparza and selumetinib in combination with their respective PD-L1 and PD-1 medicines. About AstraZeneca in Oncology  AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly-growing portfolio of new medicines that has the potential to transform patients' lives and the Company's future. With at least six new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advance Oncology as a key growth driver focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy as illustrated by our investment in Acerta Pharma in haematology.  By harnessing the power of four scientific platforms - Immuno-Oncology, Tumour Drivers and Resistance, DNA Damage Response and Antibody Drug Conjugates - and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.  About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca. Media RelationsKaren Birmingham UK/Global +44 203 749 5634Rob Skelding UK/Global +44 203 749 5821Matt Kent UK/Global +44 203 749 5906Gonzalo Viña UK/Global +44 203 749 5916Jennifer Hursit UK/Global +44 7384 799 726Jacob Lund Sweden +46 8 553 260 20Michele Meixell US +1 302 885 2677 Investor RelationsThomas Kudsk Larsen +44 203 749 5712Henry Wheeler Oncology +44 203 749 5797Christer Gruvris Cardiovascular; Metabolism +44 203 749 5711Nick Stone Respiratory; Renal +44 203 749 5716Josie Afolabi Other +44 203 749 5631Craig Marks Finance; Fixed Income +44 7881 615 764Jennifer Kretzmann Retail Investors +44 203 749 5824US toll-free +1 866 381 7277    Adrian Kemp Company SecretaryAstraZeneca PLC ---------------------------------------------------------------------- i American Cancer Society. Key statistics for pancreatic cancer. Available at: https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html. Accessed October 2018. ii Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website, April 2018. iii Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website, April 2018. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Volvo Group has detected premature degradation of emissions control component

The Volvo Group has detected that an emissions control component used in certain markets with stringent emissions standards is degrading more quickly than expected, reducing its ability to convert nitrogen oxides (NOx) as efficiently as intended, which in turn could cause the engines or vehicles to exceed emissions limits for NOx. The investigation so far indicates that the degradation does not seem to affect all vehicles and engines in the same way and to the same extent. The company is now in the process of informing the appropriate authorities in various markets, and beginning discussions regarding remediation plans. The degradation of the component does not pose a product safety issue, nor does it negatively affect vehicle or engine performance in areas other than emissions control. The degradation is a result of a materials issue that occurs over time. All engines and vehicles equipped with the component meet emissions limits at delivery. The largest volume of potentially affected engines has been sold in North America and Europe. A full analysis of the issue and plans with regulatory authorities are not completed and the company is therefore not yet able to estimate the volume of engines or vehicles that may need to be addressed. Consequently it is not possible to assess the financial impact at this stage; however the cost to redeem the issue could be material. October 16th, 2018 Journalists who would like further information, please contact: Claes Eliasson, head of Media Relations +46 76-553 72 29. This is information that AB Volvo (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 a.m. CEST on October 16, 2018. For more information, please visit volvogroup.com/press   The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs almost 100,000 people, has production facilities in 18 countries and sells its products in more than 190 markets. In 2017 the Volvo Group’s sales amounted to about SEK 335 billion (EUR 35 billion). The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden. Volvo shares are listed on Nasdaq Stockholm.

Navamedic ASA: Releases SippLink™ for MetaVision, one of Europe’s leading electronic patient journal systems.

SippLink enables wireless transfer of data between the Sippi urine measuring system and an external patient data monitoring systems (PDMS). Following successful validation at the University Hospital of Uppsala in Sweden, SippLink for the PDMS MetaVision has now been released to the market. MetaVision is one of the leading PDMS vendors in Europe with clients in Norway, Sweden and all major EU countries. This is the second electronic patient journal system that now is compatible with SippLink. Sippi is the market’s only digital urine measurement system supporting wireless data transfer to these systems. “We are very happy to announce the release of SippLink for MetaVision following successful clinical validation at Uppsala University Hospital. This marks a milestone in our roll-out of Sippi to the increasing number of clinics equipped with PDMS, including all major hospitals and university hospitals. Being able to offer connectivity to Sippi is also a major step for our sales development across Europe, as Sippi is the only system on the market that can close the final gap for a fully digitalized intensive care unit, including digital urine measurement,” says Magnus Emmoth, CEO of Navamedic Medtech. Sippi is a new standard for urine monitoring which enables automated digital measurement. The Sippi® system represents a new and improved way of monitoring urine output, the last manual and non-digitalized viral parameter within the Intensive Care Unit (ICU). For further information, please contact: Tom Rönnlund, CEO, Navamedic ASA, Tel: +46 727 320 321Magnus Emmoth, CEO, Navamedic Medtech AB, Tel: +46 704 12 11 97  About Navamedic ASANavamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group's Medtech business has developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA). www.navamedic.com

Gaming Innovation Group signs first contract with game studio

Gaming Innovation Group Inc. (GiG) has signed an agreement with game studio Jade Rabbit where they will build games directly onto GiG Games’s platform. Jade Rabbit will build games directly onto GiG’s Remote Gaming Server, enabling GiG to release their games on every market which GiG is active in and to every operator GiG integrates to. Stephen Calvert, CPO at Jade Rabbit Studios commented: “We are thrilled to announce this six game agreement, which is a testament to the capabilities and potential of Jade Rabbit. A partner such as GiG provides a fantastic opportunity for us to work with multiple brands across many markets to develop truly innovative slots and we look forward to our first launch in H1 2019.” Mathias Larsson, MD at GiG Games says: “We are very happy to announce this partnership at such an early stage with GiG Games. Jade Rabbit is an amazing game studio with tons of experience from mainly the UK market. This partnership allows GiG Games to release more games on an annual basis.” “It is part of GiG Games’ strategy to work with several premium game studios spread across the world. This is the best way to build truly local games for local markets. At the moment we are in discussions with several studios and it is important for us to pick the best studios to keep our premium quality of games”. The first game from Jade Rabbit will be launched in H1 2019, the contract is for six games in total. A minimum of four games are expected be launched in 2019. ...END… For further information, please contact: Anna-Lena Åström, GIG Head of IR & Corporate Communications, +356 796 998 48, anna.lena@gig.com About Jade Rabbit: Jade Rabbit Gaming was founded in the beginning of 2018 by a small team with 30+ years of experience from the online gaming industry. The team consists of creators, developers and designers all with the aim of creating the best high-end video slots to ever hit the market. The team members are behind some of the most successful games ever in the slots market and have repeatedly created and successfully launched games for desktop and mobile game play. About Gaming Innovation Group (GiG): Gaming Innovation Group Inc. is a technology company providing products and services throughout the entire value chain in the iGaming industry. Founded in 2012, Gaming Innovation Group’s vision is ‘To open up iGaming and make it fair and fun for all’. Through its ecosystem of products and services, it is connecting operators, suppliers and users, to create the best iGaming experiences in the world. Gaming Innovation Group operates out of state-of-the-art offices in St George's Bay, Malta and is listed on the Oslo Stock Exchange under the ticker symbol GIG. For more information about the Company and our services: https://www.gig.com/ https://www.guts.com https://www.betspin.com https://www.rizk.com https://www.thrills.com https://www.kaboo.com https://www.highroller.com  

Capital Crux joins Itiviti’s Global Alliance Programme

Capital Crux provides a wide range of specialized services including cross border business enablement, project management and digital solutions consultancy to top-tier global banks and brokers in China. Through the Itiviti-Capital Crux partnership, the firms will work together on business development activities, focusing on connectivity and post-trade technology projects in the region. “Capital Crux is pleased to join forces with Itiviti, a world-leading trading technology provider, and to introduce their proven solutions to firms in China where we see fit,” commented Sammy Zhou, Managing Partner, Capital Crux. “With our solid industry knowledge and experience, coupled with Itiviti’s complete trading and connectivity offering, we see great synergies and potential for our cooperation.” Philippe Carré, Itiviti’s Global Partnerships Director, commented: “Itiviti is working closely with key Business Introducing Partners (BIP) globally to accelerate our growth. We are very pleased to welcome Capital Crux to this ecosystem and as a key partner in the Asia-Pacific region, confident that many joint clients in mainland China will benefit from our partnership.” Ofir Gefen, President APAC, Itiviti adds: “China continues to be a key focus market for Itiviti and we are excited to see the continued uptake of Itiviti’s solutions in the commodities option market making space, and to build on that by partnering with Capital Crux. We really look forward to working with their team to enhance Itiviti’s presence and offering in China.” Itiviti is exhibiting at the Australia FIX Conference (#9) at Sofitel Sydney Wentworth on October 18 to showcase its complete offering. For further information, please contact:Ofir Gefen, President APAC, Itiviti, Tel: +852 2167 1950, Email: ofir.gefen@itiviti.comPhilippe Carré, Global Partnerships Director, Itiviti, Tel: +44 20 7743 7200Email: philippe.carre@ullink.comAgnes Wong, Marketing Director APAC, Itiviti, Tel: + 852 2167 1986, Email: agnes.wong@itiviti.comSammy Zhou, Managing Partner, Capital Crux, Tel: +852 9732 8395, Email: sammy.zhou@capitalcrux.comJason Zhang, Managing Partner, Capital Crux China, Tel: +86 138 1625 5633, Email: jason.zhang@capitalcrux.com About Capital CruxCapital Crux is a boutique consulting firm founded in 2016 by a team of top tier investment bank professionals. The team is proficient with industry best practices and operating models coupled with extensive China markets experience, and specializes in leveraging its unique position to deliver world-class digital solutions and consultancy services to financial institutions in an increasingly regulated and cost sensitive operating environment. Capital Crux’s strategy and consulting teams bring comprehensive industry experience from tier one banks and has solid expertise on a wide range of subject areas, with a focus on the greater China region. The team has advised a top global bank through their journey to setup the first foreign majority-owned securities joint-venture in China. It is also advising one of the top-tier Chinese brokers on digital transformation to expand its international business.  About ItivitiItiviti is a market-leading global provider of multi-asset trading technology and financial infrastructure solutions for buy-side and sell-side market participants, including NYFIX, one of the industry’s largest FIX-based trading communities. Serving around 2,000 clients worldwide, we provide consistent, reliable access to the most up-to-date and innovative order routing, connectivity and trading solutions available. Top-tier trading firms, banks, brokers, exchanges and institutional investors rely on our technology, solutions and expertise to streamline their daily operations, connect to their desired markets, and trade when and where they want. All while being able to comply with global regulations. With global offices in 18 locations covering all major financial centers the merger of Itiviti and ULLINK in March 2018 created a full-service technology and infrastructure provider, covering all asset classes, geographies and regulatory landscapes. For more information, please visit www.itiviti.com or www.ullink.com. Itiviti is owned by Nordic Capital.    

Stena Bulk confirms scrubber order with Bluesoul

Shanghai Bluesoul Environment Technology, with its base in Shanghai, has had a collaboration agreement with the Stena group for more than a year. Bluesoul is the first Chinese enterprise to be awarded Lloyd’s Register Exhaust Gas Cleaning System Machinery General Design Appraisal as well as DNV GL and ABS AiP.“By installing scrubbers, we will be well equipped to meet the 2020 regulation and are protected from price volatility as well as fuel shortage. In relation to market developments, today’s market predictions  are attractive in theory and currently seems to be so in practice too, despite there being a couple of parameters that remain uncertain. However, there are opportunities already available today to lock in some of the uncertainty, which might be appealing when looking for a more secure investment. We are very happy to be able to confirm this order with Bluesoul, which has performed very well in terms of quality compared with more reputable manufacturers”, says Erik Hånell, President & CEO Stena Bulk.The scrubber to be installed is an Open Loop Hybrid Ready with Water Cleaning, which not only removes the sulfur but also particles from the exhaust.For further information, please contact:Erik HånellPresident & CEOStena Bulk ABMobile: +46 704 855 002erik.hanell@stenabulk.comWith offices in six countries, Stena Bulk is one of the world’s leading tanker shipping companies. The company controls a combined fleet of around 110 vessels. Stena Bulk is part of the Stena Sphere, which has more than 20,000 employees and sales of SEK 60 billion. www.stenabulk.com

Official Program for the 29th annual Stockholm International Film Festival

A third of the films in this year’s program are made by debutants. It is also the festival’s most equal line-up to date, with 39% female directors. The festival will open with the world premiere of Anna Odell’s X&Y with herself and Mikael Persbrandt in the leading roles. — We are incredibly proud of this year's program where we are presenting some of the best films of 2018. We have more female filmmakers in the line-up than ever and we are also focusing on democracy being challenged by populism and fake news, says festival director Git Scheynius. The selection of films that will be presented during the festival in November include titles such as Wildlife by Paul Dano, Capernaum by Nadine Labaki, Cold War by Pawel Pawlikowski, Vox Lux by Brady Corbet, The Kindergarten Teacher by Sara Colangelo, Birds of Passage by Cristina Gallego and Ciro Guerras and Skate Kitchen by Crystal Moselle. This year’s closing film is Yorgos Lanthimos’ The Favourite. The Official Program 2018: http://bit.ly/2yiQhwz  This year’s Spotlight films deal with the theme Democracy in Danger, and the ever-present threat to democracy. They all depict the time we live in today, with fake news, propaganda and populism. Stockholm International Film Festival will present several films on this theme, including Fahrenheit 11/9 by Michael Moore and An Army of Lovers by Ingrid Rydberg.  The recipient of the 2018 Stockholm Visionary Award is the Iranian director and screenwriter Asghar Farhadi, who will visit the festival with his latest film Everybody Knows starring Penélope Cruz and Javier Bardem. Farhadi’s previous films include A Separation (2011) and The Salesman (2016), both awarded with the Oscar for Best Foreign Language Film. Asghar Farhadi will be in Stockholm to accept the Bronze Horse and participate in a Face2Face conversation in conjunction with the screening of Everybody Knows on Friday, November 9th at 6:00 PM at Skandia movie theater in Stockholm. Read more here: http://bit.ly/2J1qVaS  As previously announced, the Canadian director and screenwriter Mary Harron will be honored with this year’s Stockholm Lifetime Achievement Award. Harron will be in Stockholm to accept the Bronze Horse and participate in a Face2Face conversation in conjunction with the screening of her latest film Charlie Says on Saturday, November 10th at 6:00 PM at Skandia movie theater in Stockholm. The recipient of the 2018 Stockholm Achievement Award is the iconic actress Gunnel Lindblom. The award ceremony will take place in conjunction with the screening of Margarethe von Trotta’s documentary Searching for Ingmar Bergman on Sunday, November 11th at 3:00 PM at Skandia movie theater in Stockholm. For a complete list over this year’s visiting directors and when they will be available for interviews, please click here: http://bit.ly/2EoRhoC The nominees for Stockholm Rising Star are: Zahraa Aldoujaili (Amateurs), Yara Aliadotter (Amateurs), Christoffer Nordenrot (The Unthinkable), Fanni Metelius (The Heart), Alba August (Becoming Astrid) and Agnes Lindström Bolmgren (The Cake General). For more information about Stockholm Rising Star, please click here: http://bit.ly/2En8SNz The scholarship 1 Km Film is one of Sweden’s biggest short film competitions that give young filmmakers the opportunity to develop their film dreams. The winner gets the opportunity to make a short film that will be screened at next year’s festival. This year’s nominees are: Ahmed Abdullahi (Martyren), Caroline Ingvarsson (Vi var tre), Cristine Berglund (Att plocka en blomma), Tuna Özer (Kevlar), Åsa Sandzén (Andra stranden), Tia Kouvo (Pensionärerna), Julia Thelin (Brottas), Ernst De Geer (Kulturen), Anette Sidor (Fuck You) and Johan Rosell (Banana Pancake Trail). Tickets to the festival are exclusively released to members today at 10:00 AM at www.stockholmfilmfestival.se. Tickets will also be available for purchase during the program release party tonight from 5:00-8:00 PM at Alma on Nybrogatan 8 in Stockholm. The official festival center at Kulturhuset Stadsteatern opens on Wednesday, October 17th. Purchase your membership cards and tickets here. Don’t forget to apply for press accreditation for this year’s festival:https://vp.eventival.eu/stockholminternationalfilmfestival/2018 Press photosPhotos from the press conference will be available at http://stockholmfilmfestival.se/sv/press this afternoon For more information and interview requests, please contact:Angelika VaskevitchHead of Press, Stockholm International Film FestivalTel: +46 70 278 98 14press@stockholmfilmfestival.se Emma RönnPress Secretary, Stockholm International Film FestivalTel: +46 8 677 50 31 / +46 73 719 53 20pressekreterare@stockholmfilmfestival.se The 29th Stockholm International Film Festival : 7-18 November 2018Stockholm International Film Festival was founded in 1990 and has grown to become one of Europe's leading film festivals. During the festival we present over 150 films from 60 countries. We also arrange exclusive previews throughout the year, open-air screenings during the summer, mobile film screenings for kids and youths as well as Stockholm International Film Festival Junior in April.WE LOVE CINEMA!

Redsense receives first order based on the Consip tender in Italy

Spindial’s winning offer was the first in a large public tender where a DBB-EXA dialysis machine from Nikkiso and the Redsense blood leakage alarm was offered together with a direct connection between the systems. This makes it possible to automatically and immediately stop the blood flow, and thus offer superior patient safety that was a major contributing factor to the result in the procurement. The result in the tender, and the fact that the decision was declared final after a long appealing process, is to be considered a market breakthrough for Redsense. "The concept Spindial offered was new in a public tender context, but it was still declared one of the winners and took second place in the tender’s quality ranking. This says a lot about Spindial’s impressive work as well as the products included in their offer. Redsense is now setting a new standard for patient safety during hemodialysis treatments that has received major attention all over Europe. Based on this, Redsense plays a major role in ongoing public tender processes, and the interest in including a direct connection to Redsense in upcoming dialysis machine models from additional manufacturers has increased significantly,” saysRedsense Medical’s CEO Patrik Byhmer. "It has taken a long time and a lot of hard work to become a winner in this tender, and it is therefore very satisfying to be able to start with the deliveries. We look forward to continue our successful collaboration with Redsense during the delivery process,” says Marcello Grondelli, Spindial’s CEO. The Consip tender in Italy covers over 3 million dialysis treatment over 5 years in total. 

GomSpace Group AB (publ) - Extraordinary general meeting held and decision has also been made regarding earlier publication of the interim report for Q3 2018

The general meeting resolved, in accordance with the proposals presented in the notice to attend the meeting (kept available at the Company’s website www.gomspace.com): (i)            To authorize the board of directors to resolve upon issuance of new shares within the limites of the articles of association. The authorization is valid until the next annual general meeting and deviation from the shareholders’ preferential rights shall be allowed in situations where a directed issue is deemed more appropriate for the Company due to timing, commercial or similar reasons. In the event of deviation from the shareholders’ preferential rights, the starting point for the issue price shall be the prevailing market conditions at the time the shares are issued taking into account marketable discount.   (ii)           That the board of directors shall consist of three (3) ordinary members without deputy members until the end of the next annual general meeting. GomSpace has earlier communicated that the interim report for Q3 2018 will be published on November 30, 2018. The work with the report has progressed faster than expected and to facilitate the intention to carry out a rights issue, the Company will publish the interim report for Q3 2018 on November 6, 2018. For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57              Email: nbu@gomspace.com      About GomSpace Group AB The Company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on www.gomspace.com.                    Miscellaneous This information was submitted for publication, through the agency of the contact person set out above, at 12:00 p.m. CET on October 16, 2018.   

INTERIM REPORT january–September 2018

Quarterly data · Net sales were SEK 6 054 million (5 544), an increase of 9% mainly as a result of increased sales prices and positive currency effects. · EBITDA was SEK 881 million (1 051), a decrease of 16% mainly as a result of increased raw material costs. · Adjusted EBITDA was SEK 893 million (1 080), a decrease of 17%. · The adjusted operating margin was 9% (13%). · Adjusted operating profit was SEK 540 million (717), a decrease of 25%. · Earnings per share amounted to SEK 1.76 (2.48). Key highlights · Solid sales performance in all business areas. · Positive effects from increased sales prices and currency. · Continued headwinds from higher raw material costs. · Strategic investments progressing according to plan. Outlook Q4 · Strong demand within all business areas is expected to continue. · Limited possibilities for further sales price increases. · Sharp increase in wood costs expected to continue. COMMENTS BY CEO  Solid sales performance across all business areas “The strong demand for innovative and sustainable packaging continues, resulting in positive sales performance in all business areas. Revenues in the third quarter increased with 9% compared to the same period last year, fuelled by increased sales prices. However, headwinds from increasing raw material costs and start-up performance, continue to put pressure on our operating results. We are proceeding on schedule towards the start-up of the new KM7 board machine in March-April 2019. Our current focus is to prepare for a stable and successful ramp-up. With the completion of our Next Generation investment programme, we will be in an excellent position to grasp the market opportunities and meet the strong demand for sustainable packaging. A key enabler to unlock our potential is our new organisational structure, consisting of three business divisions with full profitability responsibility, effective as of October 1. Our new structure will increase speed, accountability and customer focus, and pave the way for the continued successful implementation of our strategy.” The resultEBITDA for the quarter amounted to SEK 881 million, a decrease of 16% compared to the same period last year owing mainly to higher costs for pulpwood and chemicals. Fibre costs account for more than one-third of our total operating costs, which is why we are focusing on improving the sourcing balance. Another main priority is production availability; we expect to see increased stability during 2019 and onwards measured by overall equipment efficiency (OEE). The result was also affected by comparatively high prices on the pulp supply to our non-integrated mill in Jakobstad, due to a fixed rebate in the long-term pulp supply agreement. At current pulp prices, this gives a quarterly negative effect of approx. SEK 75 million compared to general market levels.Market outlookStrong demand within all business areas is expected to continue over the next quarters. We will continue to increase sales prices where possible but at a slower pace than in previous quarters. Wood costs are expected to increase further while the wood supply situation has improved significantly. StrategyWe will continue to pursue our strategy for sustainable solutions and profitable growth. To unlock our full potential, we have implemented an agenda of prioritised activities aimed at securing the successful ramp-up of KM7, safeguarding the wood supply, stabilising production, enhancing effectiveness, and accelerating innovation and solutions. Innovation is a key component of our strategy. We aim to improve our new product ratio and introduce new materials with increased efforts throughout the organisation. By establishing a division entirely focused on solutions, we intend to grow current packaging solutions and business models as well as innovating new ones.      For further information, please contact:Susanne Lithander, CFO, +46 8 553 335 00Christopher Casselblad, Investor Relations, +46 8 553 335 08 This information constituted inside information prior to publication. This is information that BillerudKorsnäs AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 13.00 CET on 16 October 2018.

Acando Norway acquires Inventas

Inventas AS (www.inventas.no) is a consulting agency that offers design services within innovation, product design, service design, product development, simulation and production. The company was founded in 1997 and originated from NTNU in Trondheim. Since its establishment, the business has grown organically from having five to over sixty employees in the present.  Inventas consists of designers and product developers with backgrounds from both industrial design and engineering. The company has six regional offices; in Trondheim, Molde, Bergen, Stavanger, Kristiansand and Oslo. A wide-ranging and unique innovation and design environment on the Norwegian market - Inventas fits in very well with Acando’s strategy “Technology driven – Behavior centric”. We are driven by how technology can change society and the way we live our lives, but it's the user's ability and desire to use the technology that creates true value. With the acquisitions recently made, Acando now operates the entire range from award-winning industrial design to programming and heavy analytical skills. This gives us a unique position in the upcoming digitalization of industry and Internet of Things, says Sven Ivar Mørch, CEO, Acando Norway. - More and more physical objects are connected to the Internet, they communicate with each other and process available information. Inventas is the best at designing physical products with built in technology. We wanted a partner with deep knowledge in data processing with cloud-based solutions, AI and digital user interfaces, as our customers want systems that are connected and make use of digital solutions on all levels. We have found a perfect match in Acando. They have extensive expertise in everything from chip programming to the development of large business systems. Together we create the complete offering, says Einar Kolderup Selvig, founder of Inventas. Earlier this year Acando acquired Agree2 and September BI. Through acquisitions and strong organic growth, Acando now has 420 employees in Norway. 

Basware announces EUR 1 billion revenue growth vision

Basware’s vision is to deliver the best global solution for networked purchasing, invoicing and paying. All organisations need to manage their purchasing processes from procurement through to handling invoices and paying them. Currently many organisations only have unsophisticated or partial tools to manage these processes and as a result many are faced with unmanaged spending, inefficient manual and paper-based processes and poor visibility of cashflows. Basware offers a uniquely complete solution for these challenges that is differentiated by the Basware Network, the largest e-invoicing network in the world. This enables customers to manage 100 percent of their spending, make their purchasing processes completely digital, and improve their carbon footprint by reducing paper usage. As every organization in the world can benefit from our solutions, the market opportunity is huge, worth EUR 15 billion per year. Growth in demand for our solutions is underpinned by several megatrends, including digitalization, automation, and artificial intelligence. Basware’s ambition is to be the number one by market share in the networked source-to-pay industry in the large European countries and a leader in the US market. As a result, we today announce that our growth vision is to become an EUR 1 billion revenue company. At the end of the second quarter 2018 Basware announced that it has moved to a growth phase after almost two years of simplifying and improving its operations. We are now focused fully on cloud revenue growth and will make the necessary investments to accelerate this growth. Undisputed market leader Basware has four sources of cloud revenue growth: new customer acquisitions, customer expansions, customer transformations, and partnering. New customer acquisitions: Basware’s key growth markets are the US, UK, Germany and France. These continue to be the areas where we see the greatest opportunity to win new customers, and this is where we will continue to invest the majority of our new sales and marketing spending and where the “hunters” in our sales force will focus. Customer expansions: We have a fantastic existing cloud customer base with approximately 200 key customers for whom the average annual recurring cloud revenue is approximately EUR 200 thousand. We want to support each of our customers across the full spectrum of networked source to pay cloud solutions and in all jurisdictions where they operate. We are the best placed in our industry to do so given the global reach of our network, the largest e-invoicing network in the world. By investing in account management, serving our customers more intimately and more globally, and by improving customer satisfaction, we believe that we can significantly increase the average revenues from our key customers. Customer transformations: We are focused on actively transforming the largest of our on-premise customers to our cloud solutions. When our customers transform to the cloud they benefit from a modern, more useable, constantly updated solution and as a result typically the revenues from each of these customers more than doubles. Partnering: In the past Basware has focused more on direct sales than partner sales with the share of cloud revenues in 2017 from partners being approximately 5 percent. Reaching more end customers via partners is a scalable way to grow both in our existing key markets and in the future in new geographies, and therefore a dedicated partnering function was created as part of the move to a functional organisation structure announced in May 2018. The goal is to increase the percentage of cloud revenues from partners to 20 percent in the long run. Increasing investments into sales and marketing Basware will increase its investments significantly into sales and marketing during the strategy period 2019 to 2022 in order to grow cloud order intake. We are confident that this will be a good investment, because our historical ratio of customer life time value to customer acquisition cost has been 7 times. This means that for every one Euro invested in sales and marketing a return of seven Euros will be generated. In fact, with a gross renewal rate of 95 percent and a net renewal rate of 106 percent, a typical customer lifetime is 19 years. Simplify global trade interactions We have a powerful cloud platform which enables customers to manage all source-to-pay processes. We have the largest open e-Invoicing network in the world. These assets combined put us in a unique position to leverage the rapid technological developments in the industry to bring more value to our customers by simplifying global trade interactions. The role of analytics solutions will be increasingly more important to increase the value of our offering to customers - from getting actionable insights to making strategic business decisions. We will selectively consider partnering and acquisitions to complement our technology portfolio. Customer value beyond expectations We strive to provide an excellent customer experience and maximize customers’ service adoption and benefits so that they want to purchase even more of our solutions. We will make our consulting and customer service organization more scalable. A scalable business model The cloud business model that Basware is transforming to, now accounting for 66 percent of revenues, is very scalable. This means that as revenues grow, the cost of sales does not grow as quickly, improving our gross margin over time. Whilst we will invest more in sales and marketing during the strategy period, underlying profitability will improve as cost of sales declines as a percentage of sales and we exercise discipline in research and development and general and administrative spending. As a general cost philosophy, we will continuously reallocate spending from less productive to more productive areas. Basware’s priority is cloud revenue growth. In addition to the long-term growth vision to become a EUR 1 billion revenue company, Basware today announces a mid-term target to replace any previous targets: Basware will accelerate annual organic cloud growth to more than 20 percent by 2022. There is a huge market opportunity ahead of Basware which requires ambition to capture. That is why we today announce our EUR 1 billion revenue growth vision. We believe that Basware has the building blocks to be the leader in our industry and with these actions are confident that we can further strengthen our global position and drive cloud revenue growth. For further information, please contact:Ben Selby, Head of Investor Relations, Basware Corporation+358 50 305 8077, ben.selby@basware.comDistribution:Nasdaq HelsinkiMain mediainvestors.basware.com/enAbout Basware:Basware  (Nasdaq: BAS1V) is the global leader in providing networked source-to-pay solutions, e-invoicing and value-added services. Basware’s commerce and financing network connects businesses in over 100 countries and territories around the globe. As the largest open business network in the world, Basware provides scale and reach for organizations of all sizes, enabling them to grow their business and unlock value across their operations by simplifying and streamlining financial processes. Small and large companies around the world achieve significant cost savings, more flexible payment terms, greater efficiencies and closer relationships with their suppliers. Find out more at investors.basware.com/en.Follow Basware on Twitter: @Basware , join the discussion on the Basware LinkedIn , Basware Facebook  and Basware Blog .

BASWARE INTERIM REPORT JANUARY 1 – SEPTEMBER 30, 2018 (IFRS)

July-September 2018: · Net sales EUR 33 991 thousand (EUR 35 827 thousand): decrease of 5.1 percent, organic growth at constant currencies 5.2 percent · Organic cloud revenue growth at constant currencies 15.0 percent, amounting to 66.0 percent (56.0 %) of net sales · Adjusted EBITDA EUR -877 thousand (EUR 3 661 thousand) · Adjusted operating profit/loss EUR -3 600 thousand (EUR 1 361 thousand) · Adjusted earnings per share (diluted) EUR -0.21 (0.06) · Operating profit/loss EUR -3 787 thousand (EUR 1 205 thousand) · Earnings per share (diluted) EUR -0.22 (0.05) January-September 2018: · Net sales EUR 104 929 thousand (EUR 109 924 thousand): decrease of 4.5 percent, organic growth at constant currencies 5.8 percent · Organic cloud revenue growth at constant currencies 16.3 percent, amounting to 62.5 percent (53.1 %) of net sales ·  Adjusted EBITDA EUR -3 538 thousand (EUR 2 386 thousand) ·  Adjusted operating profit/loss EUR -11 633 thousand (EUR -4 976 thousand) ·  Adjusted earnings per share (diluted) EUR -1.14 (-0.45) ·  Operating profit/loss EUR 2 379 thousand (EUR -6 648 thousand) ·  Earnings per share (diluted) EUR -0.18 (-0.56) Basware is the global leader in providing networked source-to-pay, e-invoicing and value-added services. Basware’s key strategic priority for the strategy period 2018-2022 is cloud revenue growth. The company continues to strengthen its leading market position in order to grow cloud revenue. For 2018 Basware expects the following on an organic basis at constant currencies: · Cloud revenues to be between EUR 90 and 95 million  · Total costs excluding amortization, depreciation and adjustments to be slightly above 2017 levels Basware has adopted IFRS 15 Revenue from Contracts with Customers as of January 1, 2018 (mandatory application), with full retrospective application. In connection with the IFRS 15 application, the Group has also made certain changes to revenue allocation between Cloud and Non-cloud. Comparatives for 2017 presented in the interim report have been updated to include IFRS 15 restatements and revenue reallocations. From Q1 2018 onwards, Basware has made certain changes in the presentation of its financial information. The company has adopted a functional income statement showing the company’s cost of sales, gross profit and operating expenses by function. In addition, the company has changed the presentation of its geographical information. From Q1 2018 onwards, the company reports the following geographical areas: Americas, Europe, Nordics and APAC. In February 2018 Basware completed the divestment of two businesses. As a result, it is important to consider the organic growth rate when comparing 2018 financials with 2017 financials as the divestments decrease revenues and profitability. Additionally, foreign exchange movements, particularly in US dollars and Sterling, have negatively impacted Basware’s headline revenues during the first three quarters. This has a disproportionate effect on our cloud revenues where US dollars and Sterling comprise a larger share than in total revenues. The interim report is unaudited. GROUP KEY FIGURES +---------------------+------+------+-------+--------+-------+---------+--------+| | 7-9/ | 7-9/ |Change,| 1-9/| 1-9/|Change,  | 1-12/|+---------------------+------+------+-------+--------+-------+---------+--------+|EUR thousand  | 2018 | 2017 | %| 2018| 2017| % | 2017|+---------------------+------+------+-------+--------+-------+---------+--------+|Net sales  | 33| 35| -5.1|104 929 |109 924| -4.5 |149 167 || | 991 | 827 | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Cloud revenue | 22| 20| 11.9| 65 566 | 58 720| 11.7| 80 332|| | 440 | 052 | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Cloud order intake* |4 483 |3 475 | 29.0 | 15 531 |12 995 | 19.5 | 17 943 || | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+| | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|EBITDA  | -1|3 505 | | 10 474 | 714 | | 599 || | 064 | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Adjusted EBITDA | -877 |3 661 | | -3 538 | 2 386 | | 3 294 || | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Operating | -3|1 205 | | 2 379 |-6 648 | | -9 509 ||profit/loss  | 787 | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Adjusted operating | -3|1 361 | |-11 633 | -4 976| -133.8 | -6 814 ||profit/loss  | 600 | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+| | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Profit/loss before | -4| 688 | | 756 |-9 013 | |-12 276 ||tax  | 274 | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Profit/loss for the | -3| 694| | -2 558 |-8 093 | 68.4 |-11 524 ||period  | 229 | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+| | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Cash and cash | 46| 25| 82.9| 46 235 | 25 275| 82.9 | 20 683 ||equivalents | 235 | 275 | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+| | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Earnings per share  | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Diluted, EUR  |-0.22 | 0.05 | | -0.18 | -0.56 | 68.7 | -0.80 || | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+|Adjusted earnings per|-0.21 | 0.06 | | -1.14 | -0.45 | -155.7 | -0.61 ||share, diluted, EUR  | | | | | | | |+---------------------+------+------+-------+--------+-------+---------+--------+ *From Q2 2018 onwards cloud order intake is the key order intake figure reported BUSINESS OPERATIONSBasware is the global leader in networked purchase-to-pay solutions, including e-invoicing and financing services. Basware’s commerce network connects businesses in over 100 countries and territories around the globe. As the largest open business network in the world, Basware provides scale and reach for organizations of all sizes, enabling them to grow their business and unlock value across their operations by simplifying and streamlining financial processes. Small and large companies around the world achieve significant cost savings, more flexible payment terms, greater efficiencies and closer relationships with their suppliers. CEO Vesa Tykkyläinen:Our vision at Basware is to deliver the best global solution for networked purchasing, invoicing and paying. There is a huge potential market for our services, worth EUR 15 billion annually. We are the best placed to capitalise on this opportunity thanks to our network, which is the largest electronic invoicing network in the world. As a result of this strong combination of opportunity and capability, our growth vision is to become an EUR 1 billion revenue company. Every day we move closer to becoming a pure cloud company and our cloud revenues now stand at 66 percent of total. This quarter our cloud order intake growth rate accelerated to 29 percent, driven by customer expansions and transformations, new customer acquisitions and partner sales. Customers wins this quarter include National Oilwell Varco, the Government of South Australia, Hoyts and Balenciaga. In July we announced the outsourcing of our scanning services to Xerox. The deal closed at the beginning of October and 387 employees will transfer to Xerox from Basware. The partnership draws on the strengths of both parties, enabling Basware to focus on electronic invoicing whilst our customers will benefit from the best in paper handling from Xerox. It also simplifies our operations at Basware, which enables us to focus more on our core objective of cloud revenue growth. Additionally, this quarter Klaus Andersen joined us as Chief Technology Officer, completing the key leadership announced in May this year as Basware moved to a functional organisation. Basware’s industry leading solutions can seamlessly connect to more than 250 different ERP systems. This quarter we continued to release new functionality including Smart Search, which is differentiated by our smart data model, and enables procurement departments to ensure that end users are directed towards the most appropriate purchasing options. As both CEO and a shareholder of Basware, I am very excited by the progress that we continue to make during this quarter. Our key employees also share my excitement and also invested their own money into Basware this quarter as part of a share matching plan. Together the leadership of Basware is highly confident in our ability to capitalise on the huge market opportunity ahead of us. NET SALES Basware’s net sales year-to-date amounted to EUR 104 929 thousand (EUR 109 924 thousand), a decrease of 4.5 percent. This equated to 5.8 percent organic growth at constant currencies. The difference is related to the sale of Banking and Financial Performance Solutions as well as foreign exchange movements, especially US dollar and Sterling. Basware’s net sales for the third quarter amounted to EUR 33 991 thousand (EUR 35 827 thousand), a decrease of 5.1 percent. This equated to 5.2 percent organic growth at constant currencies. Cloud revenues grew well during the third quarter. Cloud revenues in the third quarter were EUR 22 440 thousand (EUR 20 052 thousand), up by 11.9 percent, and accounted for 66.0 percent (56.0 %) of net sales. This equated to 15.0 percent organic growth at constant currencies. Using 2017 exchange rates to calculate 2018 revenues, Cloud revenues in the third quarter would have been EUR 22 541 thousand. In the third quarter SaaS revenues grew 14.3 percent and transaction services revenues 11.7 percent compared to the third quarter of 2017. The SaaS growth rate equated to 21.0 percent and transaction growth rate to 12.4 percent organic growth at constant currencies. In non-cloud revenues, maintenance and licence revenues declined in line with expectations as we transition customers to the cloud. Non-cloud revenues were significantly impacted by the divestments made in the first quarter. The maintenance revenues declined 8.9 percent and licences 36.7 percent on an organic basis at constant currencies. Consulting revenues declined 8.6 percent on an organic basis at constant currencies. Basware has adopted IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. In connection with the IFRS 15 application, the Group has also made certain changes in revenue allocation between Cloud and Non-cloud. The net impact of IFRS 15 restatements and the changes in revenue allocation between Cloud and Non-cloud for 2017 comparatives is EUR -74 thousand for the full year and EUR 383 thousand for Q3 2017 on Group level, with Cloud revenue increasing by EUR 1 163 thousand for full year 2017 and EUR 700 thousand for Q3 2017 and Non-cloud revenue decreasing by EUR 1 236 thousand for full year 2017 and EUR 317 thousand for Q3 2017. +-------------+-------+-------+--------+-------+-------+--------+--------+|Net sales by | 7-9/ | 7-9/ |Change, | 1-9/ | 1-9/ |Change, | 1-12/ ||revenue type | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|EUR thousand | 2018 | 2017 | % | 2018 | 2017 | % | 2017 |+-------------+-------+-------+--------+-------+-------+--------+--------+|Cloud Revenue| | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|SaaS  | 10 177| 8 903| 14.3| 29 416| 25 276| 16.4| 34 808 |+-------------+-------+-------+--------+-------+-------+--------+--------+|Transaction | 11 029| 9 875| 11.7| 32 405| 28 919| 12.1| 39 689 ||services  | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Other cloud | 1 233| 1 274| -3.2| 3 744| 4 525| -17.3| 5 835 ||revenue  | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Cloud Revenue|22 440 |20 052 | 11.9 | 65 566| 58 720| 11.7| 80 332 ||total | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Non-Cloud | | | | | | | ||Revenue  | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Maintenance | 6 150 | 8 965 | -31.4 | 20 212| 28 170| -28.3| 37 026 |+-------------+-------+-------+--------+-------+-------+--------+--------+|License sales| 401 | 790 | -49.3 | 1 589| 2 810| -43.4| 4 192 |+-------------+-------+-------+--------+-------+-------+--------+--------+|Consulting | 4 966 | 6 063 | -18.1 | 17 504| 20 299| -13.8| 27 746 ||services | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Other non | 34 | -42 | | 59| -74| | -129 ||-cloud | | | | | | | ||revenue | | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Non-Cloud |11 551 |15 776 | -26.8 | 39 364| 51 204| -23.1| 68 836 ||Revenue total| | | | | | | |+-------------+-------+-------+--------+-------+-------+--------+--------+|Group Total | 33 991| 35 827| -5.1|104 929|109 924| -4.5|149 167 |+-------------+-------+-------+--------+-------+-------+--------+--------+ CLOUD ORDER INTAKE Basware’s total cloud annual recurring revenue (ARR) gross order intake in the third quarter amounted to EUR 4.5 million, up from EUR 3.5 million in the third quarter of 2017, an increase of 29.0 percent. This equated to 35.0 percent growth on an organic constant currency basis. There will be a time lag before order intake is visible in net sales. Typically, around one quarter of new ARR order intake converts into revenues in the year that it is won, with roughly fifty to sixty percent converting to revenues in the second year and the remainder thereafter. Further information on the definition of annual recurring revenue gross order intake is included in the section on Definition of Alternative Performance Measures. +-------------------+-----+-----+---------+------+------+---------+------+|Annual recurring |7-9/ |7-9/ |Change,  | 1-9/ | 1-9/ |Change,  |1-12/ ||revenue gross order| | | | | | | ||intake | | | | | | | |+-------------------+-----+-----+---------+------+------+---------+------+|EUR thousand  |2018 |2017 | % | 2018 | 2017 | % | 2017 |+-------------------+-----+-----+---------+------+------+---------+------+|Cloud |4 483|3 475| 29.0|15 531|12 995| 19.5|17 943|+-------------------+-----+-----+---------+------+------+---------+------+|Purchase-to-Pay |3 130|1 988| 57.5| 9 321| 8 303| 12.3|11 246||subscriptions | | | | | | | |+-------------------+-----+-----+---------+------+------+---------+------+ FINANCIAL PERFORMANCE Basware’s adjusted EBITDA was EUR -877 thousand (EUR 3 661 thousand) in the third quarter. The adjustments to EBITDA totalled EUR 187 thousand (EUR 156 thousand) in the quarter. Basware’s operating profit/loss for the quarter amounted to EUR -3 787 thousand (EUR 1 205 thousand). Basware’s adjusted EBITDA was EUR -3 538 thousand (EUR 2 386 thousand) year-to-date. The operating profit/loss for the first three quarters amounted to EUR 2 379 thousand (EUR -6 648 thousand). Basware’s profitability year-to-date and particularly in the third quarter of 2018 has been impacted by the disposals that closed in the first quarter, increased spending on sales and marketing and increased share-based compensation, all of which are in line with Basware’s strategy. The disposed businesses were contributing roughly EUR 8 million of EBITDA in 2017. In line with the strategy we have spent an additional EUR 3 million on sales and marketing in the third quarter of 2018 compared to the third quarter of 2017. As we further align our employees with shareholders, the costs related to share-based compensation increased by roughly EUR 1 million compared to the comparison period. The company’s cost of sales was EUR 16 101 thousand (EUR 16 966 thousand) and total operating expenses including depreciation and amortization EUR 21 361 thousand (EUR 17 400 thousand) in the third quarter. Out of total operating expenses, sales and marketing expenses were EUR 10 759 thousand (EUR 7 809 thousand), research and development expenses EUR 6 599 thousand (EUR 6 539 thousand) and general and administration expenses EUR 4 003 thousand (EUR 3 052 thousand). Other operating income and expenses were EUR -316 thousand (EUR -257 thousand). Research and development expenses in the income statement totalled EUR 6 599 thousand (EUR 6 539 thousand). Of this, EUR 1 535 thousand related to depreciation (EUR 1 126 thousand). Research and development expenses capitalized during the quarter amounted to EUR 1 751 thousand (EUR 2 192 thousand). Basware’s research and development investments totalled EUR 6 815 thousand (EUR 7 606 thousand), or 20.0 percent (21.2 %) of net sales during the quarter. The company’s net finance expenses were EUR -487 thousand (EUR -401 thousand) for the quarter.Basware’s profit/loss before tax was EUR -4 274 thousand (EUR 688 thousand) and profit/loss for the quarter EUR -3 299 thousand (EUR 694 thousand). Taxes for the quarter impacted the profit/loss by EUR 1 045 thousand (EUR 7 thousand). Diluted earnings per share were EUR -0.22 (EUR 0.05) for the quarter. FINANCING AND INVESTMENTS Cash flows from operating activities were EUR -2 676 thousand in the third quarter (EUR -4 840 thousand) and year-to-date EUR -3 421 thousand (EUR -2 206 thousand). Basware’s operating cash flows are seasonal as a relatively large part of payments for annual maintenance are made in the first quarter. Basware’s cash and cash equivalents including short-term deposits totalled EUR 46 235 thousand (EUR 25 275 thousand) at the end of the quarter. In addition to cash and cash equivalents, Basware has an undrawn revolving credit facility of EUR 10 million, bringing total available liquidity at the end of the quarter to EUR 56 235 thousand (EUR 35 275 thousand). In the third quarter of 2018, the company participated in a new fixed rate bond with a loan share totalling EUR 10 million. The bond’s maturity is five years. Basware’s total assets on the balance sheet at the end of the quarter were EUR 219 252 thousand (EUR 220 439 thousand). Net cash flows from investments were EUR -1 489 thousand (EUR -2 453 thousand) in the quarter. The equity ratio was 52.3 percent (53.4 %) and gearing 9.6 percent (20.4 %). The company’s interest-bearing liabilities totalled EUR 57 202 thousand (EUR 49 282 thousand), of which current liabilities accounted for EUR 17 089 thousand (EUR 1 996 thousand). The return on investment was -9.2 percent (2.8 %) and return on equity -11.2 percent (2.3 %) in the quarter. PERSONNEL Basware’s personnel expenses were EUR 22 045 thousand (EUR 21 370 thousand) in the quarter. Basware employed 1 727 (1 826) people on average during the quarter and 1 736 (1 827) at the end of the quarter. Following the partnership with Xerox announced in the third quarter, 387 employees will transfer from Basware to Xerox in the fourth quarter. Geographical division of personnel: +---------------------+------+------+-------+-----+-----+---------+------+|Personnel   |7-9/  |7-9/  |Change,|1-9/ |1-9/ |Change,  |1-12/ |+---------------------+------+------+-------+-----+-----+---------+------+|Employed, on average | 2018 | 2017 | % |2018 |2017 | % | 2017|+---------------------+------+------+-------+-----+-----+---------+------+|Americas  | 138 | 130 | 6.2| 137| 131| 4.8 | 131|+---------------------+------+------+-------+-----+-----+---------+------+|Europe   | 457 | 463 | -1.2| 461| 479| -3.8 | 475|+---------------------+------+------+-------+-----+-----+---------+------+|Nordics  | 473 | 555 | -14.7| 497| 562| -11.6 | 558|+---------------------+------+------+-------+-----+-----+---------+------+|APAC  | 658| 678| -2.9| 673| 668| 0.8| 673|+---------------------+------+------+-------+-----+-----+---------+------+|Group total  |1 727 |1 826 | -5.4|1 768|1 840| -3.9 | 1 838|+---------------------+------+------+-------+-----+-----+---------+------+ In accordance with the new organisational structure announced on June 1, 2018, at the end of the quarter 12.4 percent of the personnel worked in sales and marketing, 48.6 percent in R&D and production and products, 31.0 percent in customer services and 8.0 percent in administration. The average age of employees is 35.4 (35.2) years. Women account for 28.0 percent (27.5 %) of employees, men for 72.0 percent (72.5 %). OTHER EVENTS OF THE PERIOD Composition of the Audit Committee  David Bateman, member of the Board of Directors of Basware Corporation, joined the Board’s Audit Committee as of July 1, 2018. All other members of the Audit Committee remain unchanged. Changes in Basware’s Executive Team Klaus Andersen was appointed as Chief Technology Officer (CTO) and as a member of the Executive Team at Basware. Andersen joined Basware in September and reports to the CEO. Basware launches new Matching Share Plan for key employeesThe Board of Directors of Basware Corporation resolved in its meeting on July 17, 2018 to establish a new Matching Share Plan 2018-2020 for the Group’s key employees. The aim of the plan is to further align the objectives of shareholders and key employees, to retain key employees at the company, and to offer them competitive reward plans based on acquiring and holding the company’s shares.The potential rewards from the plan will be paid partly in Basware shares and partly in cash. The cash proportion is intended to cover taxes and tax-related costs arising from the reward to the employee.The prerequisite for receiving reward on the basis of the Matching Share Plan is that the plan member acquires Basware shares. The plan member will, as a reward, receive matching shares for each share subject to the share ownership prerequisite after a matching period of three (3) years. Receipt of matching shares is contingent on the continuation of employment or service and on the plan member holding the acquired shares upon reward payment.The rewards to be paid in aggregate to plan members on the basis of the Matching Share Plan correspond to the value of a maximum total of 77,714 Basware Corporation shares, including also the proportion to be paid in cash. The plan as a whole entails an aggregate share ownership interest of approximately 116,571 shares for the plan members, via personal share acquisitions and the right to future share ownership through the Matching Share Plan. EVENTS AFTER THE PERIOD Basware announces EUR 1 billion revenue growth vision Basware’s vision is to deliver the best global solution for networked purchasing, invoicing and paying. All organisations need to manage their purchasing processes from procurement through to handling invoices and paying them. Currently many organisations only have unsophisticated or partial tools to manage these processes and as a result many are faced with unmanaged spending, inefficient manual and paper-based processes and poor visibility of cashflows. Basware offers a uniquely complete solution for these challenges that is differentiated by the Basware Network, the largest e-invoicing network in the world. This enables customers to manage 100 percent of their spending, make their purchasing processes completely digital, and improve their carbon footprint by reducing paper usage. As every organization in the world can benefit from our solutions, the market opportunity is huge, worth EUR 15 billion per year. Growth in demand for our solutions is underpinned by several megatrends, including digitalization, automation, and artificial intelligence. Basware’s ambition is to be the number one by market share in the networked source-to-pay industry in the large European countries and a leader in the US market. As a result, we today announce that our growth vision is to become an EUR 1 billion revenue company. At the end of the second quarter 2018 Basware announced that it has moved to a growth phase after almost two years of simplifying and improving its operations. We are now focused fully on cloud revenue growth and will make the necessary investments to accelerate this growth. Undisputed market leader Basware has four sources of cloud revenue growth: new customer acquisitions, customer expansions, customer transformations, and partnering. New customer acquisitions: Basware’s key growth markets are the US, UK, Germany and France. These continue to be the areas where we see the greatest opportunity to win new customers, and this is where we will continue to invest the majority of our new sales and marketing spending and where the “hunters” in our sales force will focus. Customer expansions: We have a fantastic existing cloud customer base with approximately 200 key customers for whom the average annual recurring cloud revenue is approximately EUR 200 thousand. We want to support each of our customers across the full spectrum of networked source to pay cloud solutions and in all jurisdictions where they operate. We are the best placed in our industry to do so given the global reach of our network, the largest e-invoicing network in the world. By investing in account management, serving our customers more intimately and more globally, and by improving customer satisfaction, we believe that we can significantly increase the average revenues from our key customers. Customer transformations: We are focused on actively transforming the largest of our on-premise customers to our cloud solutions. When our customers transform to the cloud they benefit from a modern, more useable, constantly updated solution and as a result typically the revenues from each of these customers more than doubles. Partnering: In the past Basware has focused more on direct sales than partner sales with the share of cloud revenues in 2017 from partners being approximately 5 percent. Reaching more end customers via partners is a scalable way to grow both in our existing key markets and in the future in new geographies, and therefore a dedicated partnering function was created as part of the move to a functional organisation structure announced in May 2018. The goal is to increase the percentage of cloud revenues from partners to 20 percent in the long run. Increasing investments into sales and marketing Basware will increase its investments significantly into sales and marketing during the strategy period 2019 to 2022 in order to grow cloud order intake. We are confident that this will be a good investment, because our historical ratio of customer life time value to customer acquisition cost has been 7 times. This means that for every one Euro invested in sales and marketing a return of seven Euros will be generated. In fact, with a gross renewal rate of 95 percent and a net renewal rate of 106 percent, a typical customer lifetime is 19 years. Simplify global trade interactions We have a powerful cloud platform which enables customers to manage all source-to-pay processes. We have the largest open e-Invoicing network in the world. These assets combined put us in a unique position to leverage the rapid technological developments in the industry to bring more value to our customers by simplifying global trade interactions. The role of analytics solutions will be increasingly more important to increase the value of our offering to customers - from getting actionable insights to making strategic business decisions. We will selectively consider partnering and acquisitions to complement our technology portfolio. Customer value beyond expectations We strive to provide an excellent customer experience and maximize customers’ service adoption and benefits so that they want to purchase even more of our solutions. We will make our consulting and customer service organization more scalable. A scalable business model The cloud business model that Basware is transforming to, now accounting for 66 percent of revenues, is very scalable. This means that as revenues grow, the cost of sales does not grow as quickly, improving our gross margin over time. Whilst we will invest more in sales and marketing during the strategy period, underlying profitability will improve as cost of sales declines as a percentage of sales and we exercise discipline in research and development and general and administrative spending. As a general cost philosophy, we will continuously reallocate spending from less productive to more productive areas. Basware’s priority is cloud revenue growth. In addition to the long-term growth vision to become a EUR 1 billion revenue company, Basware today announces a mid-term target to replace any previous targets: Basware will accelerate annual organic cloud growth to more than 20 percent by 2022. There is a huge market opportunity ahead of Basware which requires ambition to capture. That is why we today announce our EUR 1 billion revenue growth vision. We believe that Basware has the building blocks to be the leader in our industry and with these actions are confident that we can further strengthen our global position and drive cloud revenue growth. Definitions related to cloud metrics included in EUR 1 billion vision statement: Cloud gross churn rate is defined as the total amount of cloud revenues lost during the period, divided by the total cloud revenues at the beginning of the period. Cloud net churn rate is defined as the total amount of cloud revenues lost during the period minus the new cloud ARR won from add-on sales to existing customers during the period, divided by the total cloud revenues at the beginning of the period. Cloud gross renewal rate is defined as 100 percent minus the cloud gross churn rate. Cloud net renewal rate is defined as 100 percent minus the cloud net churn rate. Customer lifetime is defined as 1 divided by the cloud gross churn rate. Lifetime value of the order intake won during the period is calculated by multiplying Cloud ARR order intake during the period by the cloud gross margin and dividing by the cloud gross churn rate. The customer acquisition cost is defined as the total expenditure on sales and marketing for the 12 months prior to the period (to account for the lead time between new sales and marketing expenditure converting to order intake). RISKS AND UNCERTAINTY FACTORS     Basware has a growth strategy with high net sales growth expectations for the cloud business. Executing the strategy requires significant investments in sales and marketing and related resources as well as continued investments in product development. At the same time, the industry transformation from an on-premise license-based business model to a SaaS model will accelerate the decline of certain Basware revenue streams, including license sales and maintenance. The transformation will also make consulting revenues more volatile. Until the transformation is complete, this will act as a drag on Group net sales growth. Additionally, even higher than expected pace in the license to SaaS transformation would have a negative impact on expected net sales in the short term. In addition to SaaS, Basware expects high growth rates in its network-based transaction services which will, besides successful sales effort, also require an efficient supplier onboarding process. Sales from Value Added Services, including Financing Services, are dependent on Basware’s ability to bring innovative and attractive products to the market according to its planned timetable and move customers quickly to a phase where they are using the services extensively enough to provide meaningful revenue to Basware. The fact that more than 50 percent of the company’s sales are expected to come from non-euro countries exposes the Group’s net sales growth to foreign exchange rate movements. In case there is a significant movement of GBP, USD, NOK, SEK or AUD against the euro, reported net sales may be affected. In addition, a proportion of Basware’s costs are denominated in INR and RON. Execution of the growth strategy and going through constant change puts new demands on the organization as well as its management and leadership capabilities. The company’s ability to attract, retain and develop the right type of talent to deliver on its strategy is critical as well as management focus and ability to drive change. Basware considers acquisitions as part of its strategy. Acquisitions entail risks, such as failure in integrating acquisitions or in ensuring that the planned financial benefits and synergies of the acquisitions materialize. The cloud transformation process requires cash investment. The company’s ability to secure financing for this transformation may affect its ability to deliver on the strategy. Basware’s biggest operational risks relate to service disruption as a result of for example data centre failures, various data security threats and non-compliance risks related to Basware’s solutions and services, the company’s activities or its employees’ behaviour. Operational risks are actively managed by continuous improvement in risk monitoring and protection practices as well as internal training of Basware’s personnel. Basware operates in a market where technological and business model innovation play a key role. While Basware is recognized as a leader within its segments by independent analysts, it is critical that Basware continues to innovate and develop its offering. FUTURE OUTLOOKOperating environment and market outlook All organisations need to manage their purchasing processes from procurement through to handling invoices and paying them. Currently many organisations only have unsophisticated or partial tools to manage these processes and as a result many are faced with unmanaged spending, inefficient manual and paper-based processes and poor visibility of cashflows. Basware offers a uniquely complete solution for these challenges that is differentiated by the Basware Network, the largest e-invoicing network in the world, and enables customers to manage 100 percent of their spending and make their purchasing processes completely paperless. Basware expects the demand for networked purchase-to-pay services to continue to grow. The total potential market for networked purchase-to-pay services is estimated to be worth EUR 15 billion in annual revenues. Outlook for 2018 Basware is the global leader in providing networked source-to-pay, e-invoicing and value-added services. Basware’s key strategic priority for the strategy period 2018-2022 is cloud revenue growth. The company continues to strengthen its leading market position in order to grow cloud revenue. Themes affecting cloud revenues in 2018: · SaaS revenues anticipated to continue to grow strongly on an organic basis · Transaction services revenues growth anticipated to accelerate as growth initiatives take effect · Other cloud revenues continue to be impacted by UK public sector revenues · Cloud revenues have a higher proportion of US dollar and Sterling and so are disproportionately affected by foreign exchange movements Themes affecting non-cloud revenues in 2018: · Maintenance and licence revenues will continue to decline as Basware transitions existing customers to cloud services · Consulting revenues are also affected by the cloud transition and more standardised implementations · Non-cloud revenues are disproportionately affected by the divestments completed in February 2018 For 2018 Basware expects the following on an organic basis at constant currencies: · Cloud revenues to be between EUR 90 and 95 million  · Total costs excluding amortization, depreciation and adjustments to be slightly above 2017 levels Constant currencies means that the effects of any changes in currencies are eliminated by calculating the figures for the period using 2017 exchange rates. Organic means that the figures are adjusted to remove the effects of any acquisitions or disposals within the past 12 months. Espoo, Finland, Tuesday, October 16, 2018 BASWARE CORPORATIONBoard of Directors Vesa Tykkyläinen, CEO, Basware Corporation For more information, please contact:Niclas Rosenlew, CFO, Basware CorporationTel. +358 50 480 2160, niclas.rosenlew@basware.comDistribution:Nasdaq HelsinkiKey mediainvestors.basware.com/en SUMMARY OF FINANCIAL STATEMENTS AND NOTES TO THE FINANCIAL STATEMENTS JANUARY 1 – SEPTEMBER 30, 2018    CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME +--------------------+------+------+-------+------+------+-------+-----+|EUR thousand  |7-9/20|7-9/20|Change,|1-9/20|1-9/20|Change,|1-12/|| |18  |17  |% |18 |17 |%  |2017 |+--------------------+------+------+-------+------+------+-------+-----+|NET SALES  | 33| 35| -5.1 | 104| 109| -4.5 | 149|| | 991| 827 | | 929 | 924 | | 167|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Cost of sales | -16| -16| -5.1 | -52| -56| -7.4 | -75|| | 101 | 966 | | 595 | 804 | | 891|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|GROSS PROFIT | 17| 18| -5.2 | 52| 53| -1.5 | 73|| | 890 | 862 | | 335 | 120 | | 276|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Sales and marketing | -10| -7| 37.8 | -31| -26| 17.2 | -36|| | 759 | 809 | | 072 | 508| | 455|+--------------------+------+------+-------+------+------+-------+-----+|Research and | -6| -6| 0.9 | -20| -22| -7.5 | -29||development | 599 | 539 | | 374 | 026| | 629|+--------------------+------+------+-------+------+------+-------+-----+|General and | -4| -3| 31.2 | -12| -9| 26.3 | -14||administration | 003 | 052 | | 185 | 645 | | 110|+--------------------+------+------+-------+------+------+-------+-----+|Total operating | -21| -17| 22.8 | -63| -58| 9.4 | -80||expenses | 361 | 400 | | 631 | 179| | 194|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Other operating | -316 | -257 | 22.7 | 13| -1| | -2||income and expenses | | | | 675 | 589 | | 593|+--------------------+------+------+-------+------+------+-------+-----+|OPERATING | -3|1 205 | |2 379 | -6| | -9||PROFIT/LOSS | 787 | | | | 648 | | 509|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Finance income and | -487 | -401 | 21.5 | -1| -1| 7.3 | -1||expenses | | | | 470 | 370 | | 719|+--------------------+------+------+-------+------+------+-------+-----+|Share of profit/loss| 0 | -117 |-100.0 | -153 | -995 | -84.6 | -1||of a joint venture | | | | | | | 048|+--------------------+------+------+-------+------+------+-------+-----+|PROFIT/LOSS BEFORE | -4| 688 | | 756 | -9| | -12||TAX | 274 | | | | 013 | | 276|+--------------------+------+------+-------+------+------+-------+-----+|Income tax |1 045 | 7 | | -3| 920 | | 752|| | | | | 314 | | | |+--------------------+------+------+-------+------+------+-------+-----+|PROFIT/LOSS FOR THE | -3| 694 | | -2| -8| 68.4 | -11||PERIOD | 229 | | | 558 | 093 | | 524|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Other comprehensive | | | | | | | ||income | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Other comprehensive | | | | | | | ||income that will not| | | | | | | ||be reclassified to | | | | | | | ||profit or loss | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Remeasurement of | 0 | -25 | | 18 | -87 | | 155||employee benefits | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Other comprehensive | | | | | | | ||income that may be | | | | | | | ||reclassified | | | | | | | ||subsequently to | | | | | | | ||profit or | | | | | | | ||loss | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Exchange differences| 350 | -1| |1 502 | -5| | -6||on translating | | 118 | | | 395 | | 743||foreign operations | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Income tax relating | -11 | 69 | | -60 | 255 | | 290||to components of | | | | | | | ||other comprehensive | | | | | | | ||income | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Cash flow hedges | -112 | 0 | | -76 | 0| | 0|+--------------------+------+------+-------+------+------+-------+-----+|Other comprehensive | 227 | -1| |1 384 | -5| | -6||income for the year | | 074 | | | 277 | | 299||net of tax | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|TOTAL COMPREHENSIVE | -3| -380 |-691.0 | -1| -13| 91.2 | -17||INCOME | 002 | | | 175 | 320 | | 823|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Profit/loss | | | | | | | ||attributable to:  | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Equity holders of | -3| 694 | | -2| -8| 68.4 | -11||the parent company | 229 | | | 558 | 093 | | 524|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Total comprehensive | | | | | | | ||income attributable | | | | | | | ||to: | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Equity holders of | -3| -380 |-691.0 | -1| -13| 91.2 | -17||the parent company | 002 | | | 175 | 320 | | 823|+--------------------+------+------+-------+------+------+-------+-----+| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|Earnings per share | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|undiluted, EUR |-0.22 | 0.05 | |-0.18 |-0.56 | 68.6 |-0.80|| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+|diluted, EUR |-0.22 | 0.05 | |-0.18 |-0.56 | 68.7 |-0.80|| | | | | | | | |+--------------------+------+------+-------+------+------+-------+-----+  CONSOLIDATED STATEMENT OF FINANCIAL POSITION +-------------------+---------------+---------------+----------+-------------+|EUR thousand  |Sept. 30, 2018 |Sept. 30, 2017 |Change, % |Dec. 31, 2017|+-------------------+---------------+---------------+----------+-------------+|ASSETS  | | | | |+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|Non-current assets | | | | |+-------------------+---------------+---------------+----------+-------------+|Intangible assets  | 45 299 | 48 980 | -7.5 | 49 039|+-------------------+---------------+---------------+----------+-------------+|Goodwill  | 79 129 | 92 826 | -14.8 | 91 961|+-------------------+---------------+---------------+----------+-------------+|Tangible assets  | 923 | 1 480 | -37.6 | 1 291|+-------------------+---------------+---------------+----------+-------------+|Share of investment| 0 | 207 | | 153||in a joint venture | | | | |+-------------------+---------------+---------------+----------+-------------+|Non-current | 38 | 38 | | 38 ||financial assets  | | | | |+-------------------+---------------+---------------+----------+-------------+|Trade and other | 3 530 | 3 109 | 13.6 | 3 617||receivables  | | | | |+-------------------+---------------+---------------+----------+-------------+|Contract assets | 1 404 | 2 651 | -47.0 | 2 450|+-------------------+---------------+---------------+----------+-------------+|Deferred tax | 7 821 | 10 982 | -28.8 | 10 362||assets  | | | | |+-------------------+---------------+---------------+----------+-------------+|Non-current assets | 138 144 | 160 271 | -13.8 | 158 910|+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|Current assets  | | | | |+-------------------+---------------+---------------+----------+-------------+|Trade receivables  | 24 617 | 23 839 | 3.3 | 24 534|+-------------------+---------------+---------------+----------+-------------+|Other receivables  | 6 820 | 6 901 | -1.2 | 6 880|+-------------------+---------------+---------------+----------+-------------+|Contract assets | 3 076 | 3 536 | -13.0 | 3 446|+-------------------+---------------+---------------+----------+-------------+|Income tax | 361 | 616 | -41.4 | 358||receivables  | | | | |+-------------------+---------------+---------------+----------+-------------+|Cash and cash | 46 235 | 25 275 | 82.9 | 20 683||equivalents  | | | | |+-------------------+---------------+---------------+----------+-------------+|Current assets  | 81 108 | 60 167 | 35.5 | 55 900|+-------------------+---------------+---------------+----------+-------------+| |   |   | | |+-------------------+---------------+---------------+----------+-------------+|ASSETS  | 219 252 | 220 439 | -0.5 | 214 811|+-------------------+---------------+---------------+----------+-------------+  CONSOLIDATED STATEMENT OF FINANCIAL POSITION +-------------------+---------------+---------------+----------+-------------+|EUR thousand |Sept. 30, 2018 |Sept. 30, 2017 |Change, % |Dec. 31, 2017|+-------------------+---------------+---------------+----------+-------------+|EQUITY AND | | | | ||LIABILITIES  | | | | |+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|Shareholders' | | | | ||equity  | | | | |+-------------------+---------------+---------------+----------+-------------+|Share capital  | 3 528 | 3 528 | | 3 528 |+-------------------+---------------+---------------+----------+-------------+|Share premium | 1 187 | 1 187 | | 1 187 ||account  | | | | |+-------------------+---------------+---------------+----------+-------------+|Treasury shares  | -638 | -841 | -24.2 | -841|+-------------------+---------------+---------------+----------+-------------+|Invested | 110 928 | 111 132 | -0.2 | 111 132||unrestricted equity| | | | ||fund   | | | | |+-------------------+---------------+---------------+----------+-------------+|Other reserves | 516 | 540 | -4.4 | 592|+-------------------+---------------+---------------+----------+-------------+|Translation | -9 781 | -9 917 | -1.4 | -11 229||differences  | | | | |+-------------------+---------------+---------------+----------+-------------+|Retained earnings  | 8 868 | 12 014 | -26.2 | 8 920|+-------------------+---------------+---------------+----------+-------------+|Shareholders' | 114 609 | 117 643 | -2.6 | 113 289||equity  | | | | |+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|Non-current | | | | ||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Deferred tax | 4 734 | 5 647 | -16.2 | 4 569||liability  | | | | |+-------------------+---------------+---------------+----------+-------------+|Interest-bearing | 40 113 | 47 286 | -15.2 | 47 286||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Other non-current | 127 | 1 319 | -90.4 | 1 693||financial | | | | ||liabilities | | | | |+-------------------+---------------+---------------+----------+-------------+|Contract | 2 996 | 3 005 | -0.3 | 2 374||liabilities | | | | |+-------------------+---------------+---------------+----------+-------------+|Liabilities from | 361 | 616 | -41.4 | 434||employee benefits  | | | | |+-------------------+---------------+---------------+----------+-------------+|Non-current | 48 331 | 57 874 | -16.5| 56 357||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|Current | | | | ||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Interest-bearing | 17 089 | 1 996 | 756.2 | 1 996||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Trade payables and | 23 276 | 24 635 | -5.5 | 31 409||other liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Contract | 15 575 | 16 918 | -7.9 | 10 656||liabilities | | | | |+-------------------+---------------+---------------+----------+-------------+|Income tax | 109 | 132 | -17.3 | 177||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+|Current provisions | 264 | 1 241 | -78.7 | 928|+-------------------+---------------+---------------+----------+-------------+|Current | 56 313 | 44 922 | 25.4| 45 165||liabilities  | | | | |+-------------------+---------------+---------------+----------+-------------+| | | | | |+-------------------+---------------+---------------+----------+-------------+|EQUITY AND | 219 252 | 220 439 | -0.5| 214 811 ||LIABILITIES  | | | | |+-------------------+---------------+---------------+----------+-------------+  CONSOLIDATED STATEMENT OF CHANGES IN EQUITY   +-------------+-------+--------+--------+-----------+---------+------------+---------+------+|EUR thousand |Share |Share |Treasury|Inv. un |Other |Translation |Retained |Total || |capital|premium |shares  |-restricted|reserves |differences |earnings | || | |account | | | | | | || | | | | | | | | || | | | |equity  | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528 | 1 187 | -841 | 111 131 | 592 | -11 229 | 8 920 | 113||EQUITY | | | | | | | | 289 ||Jan. 1, 2018 | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Effect of | | | | | | | -128 | -128 ||IFRS 9 | | | | | | | | ||restatement –| | | | | | | | ||bad debt | | | | | | | | ||provision | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Effect of | | | | | | | 1 043 |1 043 ||IFRS 2 | | | | | | | | ||amendment | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528 | 1 187| -841| 111 131| 592 | -11 229 | 9 835| 114||EQUITY | | | | | | | | 204 ||Jan. 1, 2018 | | | | | | | | ||(restated)  | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Comprehensive| | | | | | 1 442  | -2 564 | -1||income | | | | | | | | 123 |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Share based | | | 204| -204| | | 1 580 |1 580 ||payments  | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Defined | | | | | | 6| 18| 24||benefit plan | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Cash flow | | | | | -76| | | -76||hedges | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528| 1 187| -638| 110 928| 516| -9 781| 8 868| 114||EQUITY | | | | | | | | 609||Sept. 30, | | | | | | | | ||2018  | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+| | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+| | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+| | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|EUR thousand |Share |Share |Treasury|Inv. un |Other |Translation |Retained |Total || |capital|premium |shares  |-restricted|reserves |differences |earnings | || |  |account | | | | | | || | | | | | | | | || | | | |equity  | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528 | 1 187 | -1 043 | 111 333 | 540 | -4 863 | 22 182| 132||EQUITY | | | | | | | | 864||Jan. 1, 2017 | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Effect of | | | | | | 86| -2 495|-2 409||IFRS 15 | | | | | | | | ||restatement | | | | | | | | ||to revenue | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528 | 1 187| -1 043| 111 333| 540| -4 776 | 19 687| 130||EQUITY | | | | | | | | 455||Jan. 1, 2017 | | | | | | | | ||(restated) | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Effect of | | | | | | | 7| 7||IFRS 15 | | | | | | | | ||restatement | | | | | | | | ||to revenue | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Comprehensive| | | | | | -5 140| -8 100| -13||income  | | | | | | | | 240|+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Share based | | | 202 | -202 | | | 507| 507||payments  | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|Defined | | | | | | | -87| -87||benefit plan | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+|SHAREHOLDERS’| 3 528| 1 187| -841| 111 132| 540| -9 917| 12 014| 117||EQUITY | | | | | | | | 643||Sept. 30, | | | | | | | | ||2017 | | | | | | | | ||(restated)  | | | | | | | | |+-------------+-------+--------+--------+-----------+---------+------------+---------+------+ CONSOLIDATED STATEMENT OF CASH FLOWS  +-----------------------------+--------+--------+--------+--------+---------+|EUR thousand |7-9/2018|7-9/2017|1-9/2018|1-9/2017|1-12/2017|+-----------------------------+--------+--------+--------+--------+---------+|Cash flows from operating | | | | | ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Profit/loss for the period  | -3 229| 694| -2 558| -8 093| -11 524 |+-----------------------------+--------+--------+--------+--------+---------+|Adjustments for profit:  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Depreciation and amortisation| 2 723| 2 300| 8 095| 7 361| 10 108 |+-----------------------------+--------+--------+--------+--------+---------+|Share of profit/loss of a | 0| 117| 153| 995| 1 048 ||joint venture | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Gain (-) / loss (+) on | 0| 0| -16 276| 0| 0 ||disposals of assets | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Unrealised foreign exchange | 176| 158| 141| 773| 764 ||gains and losses | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Financial income and expenses| 354| 207| 1 276| 621| 1 002 |+-----------------------------+--------+--------+--------+--------+---------+|Tax on income from operations| -1 045| -7| 3 314| -920| -752 |+-----------------------------+--------+--------+--------+--------+---------+|Other adjustments | 542| -60| 1 271| 412| 642 |+-----------------------------+--------+--------+--------+--------+---------+|Total adjustments | 2 750| 2 715| -2 026| 9 243| 12 812 |+-----------------------------+--------+--------+--------+--------+---------+|Changes in working capital:  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Increase (-) / decrease (+) | 4 651| -2 030| 1 860| -2 351| -3 123||in trade and other | | | | | ||receivables | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Increase (+) / decrease (-) | -5 490| -4 805| 1 932| 4 958| 4 766||in trade and other payables | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Increase (+) / decrease (-) | -618| -979| -683| -3 831| -4 141||in provisions | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Total changes in working | -1 457| -7 813| 3 108| -1 224| -2 499||capital | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Financial items in operating | -505| -163| -1 378| -579| -958 ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Income taxes paid (-) / | -235| -273| -567| -1 553| -1 832 ||received (+)  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash flows from operating | -2 676| -4 840| -3 421| -2 206| -4 001 ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash flows used in investing | | | | | ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Purchase of tangible and | -2 174| -2 453| -8 689| -9 714| -12 485 ||intangible assets  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Net proceeds from sale of | 686| 0| 29 641| 0| 0 ||tangible and intangible | | | | | ||assets* | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash flows from investing | -1 489| -2 453| 20 952| -9 714| -12 485 ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash flows from financing | | | | | ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Repayment of current | -998| -20 998| -1 996| -27 998| -27 998 ||borrowings | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Proceeds from non-current | 9 923| 30 000| 9 923| 30 000| 30 000 ||borrowings  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash flows from financing | 8 925| 9 002| 7 927| 2 002| 2 002 ||activities  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Net change in cash and cash | 4 760| 1 708| 25 458| -9 918| -14 484 ||equivalents  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+| | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash and cash equivalents at | 41 413| 23 610| 20 683| 35 755| 35 755 ||the beginning of period  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Net foreign exchange | 63| -43| 94| -562| -588 ||difference  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+|Cash and cash equivalents at | 46 235| 25 275| 46 235| 25 275| 20 683 ||the end of period  | | | | | |+-----------------------------+--------+--------+--------+--------+---------+ *Includes proceeds and disbursements directly attributable to the divestments made in Q1 2018 ACCOUNTING PRINCIPLES This interim report has been prepared in accordance with IAS 34. The same accounting principles have been followed as in the annual financial statements except for the adoption of new standards and amendments effective as of January 1, 2018.  Preparation of financial statements in accordance with IFRS requires Basware’s management to make estimates and assumptions that have an effect on the amount of assets and liabilities on the balance sheet at the closing date as well as the amounts of income and expenses for the financial period. In addition, the management must exercise its judgment regarding the application of accounting policies. Since the estimates and assumptions are based on the views at the date of the financial statements, they include risks and uncertainties. The actual results may differ from the estimates and assumptions. The amounts presented in the income statement and balance sheet are Group figures. The amounts presented in the release are rounded, so the sum of individual figures may differ from the sum reported. Percentage changes for net figures are shown on an absolute basis. New and amended IFRS standards Basware has adopted IFRS 15 Revenue from Contracts with Customers as of January 1, 2018 (mandatory application), with full retrospective application. Revenue for different revenue types are recognized over time except for licenses which is recognized at a point in time. As the new standard affects only a minority of the Group’s customer contracts, the impact of the standard on the Group’s 2017 restated total revenue is not material, being EUR -74 thousand in total. However, as a result of the application of the standard, part of Cloud revenue will be recognized later and part of Non-cloud revenue earlier compared to the previous revenue recognition standard. Due to this, 2017 restated IFRS 15 Cloud revenue is EUR 1 667 thousand lower and Non-cloud revenue EUR 1 596 thousand higher compared to the reported revenue. In connection with the IFRS 15 application, the Group has made certain changes in the revenue allocation between Cloud and Non-cloud. Revenues related to dedicated customer services as part of SaaS subscriptions will now be allocated as Cloud revenues. This reallocation does not impact total Group revenue. However, for 2017 a total of EUR 2 830 thousand of revenues reported as part of Non-cloud is now recorded as Cloud revenue. The total net impact of IFRS 15 restatements and the changes in revenue allocation between Cloud and Non-cloud for full year 2017 is EUR -74 thousand on Group level, with Cloud revenue increasing EUR 1 163 thousand and Non-cloud revenue decreasing EUR 1 236 thousand. As a result, the share of Cloud revenue of the Group’s total 2017 revenue has increased slightly. Net sales by revenue type after IFRS 15 restatements and changes in revenue allocation +--------------------------+-------+-------+-------+------+|Net sales by revenue type | 1-3/| 4-6/| 7-9/|10-12/|+--------------------------+-------+-------+-------+------+|EUR thousand  | 2017| 2017| 2017| 2017|+--------------------------+-------+-------+-------+------+|Cloud Revenue | | | | |+--------------------------+-------+-------+-------+------+|SaaS | 8 002| 8 372| 8 903| 9 532|+--------------------------+-------+-------+-------+------+|Transaction services  | 9 471| 9 573| 9 875|10 770|+--------------------------+-------+-------+-------+------+|Other cloud revenue  | 1 444| 1 807| 1 274| 1 310|+--------------------------+-------+-------+-------+------+|Cloud Revenue total |18 917 |19 752 |20 052 |21 612|+--------------------------+-------+-------+-------+------+|Non-Cloud Revenue  | | | | |+--------------------------+-------+-------+-------+------+|Maintenance | 9 849 | 9 357 | 8 965 | 8 856|+--------------------------+-------+-------+-------+------+|License sales | 900 | 1 120 | 790 | 1 383|+--------------------------+-------+-------+-------+------+|Consulting services | 7 071 | 7 165 | 6 063 | 7 447|+--------------------------+-------+-------+-------+------+|Other non-cloud revenue | 73 | -105 | -42 | -54|+--------------------------+-------+-------+-------+------+|Non-Cloud Revenue total |17 893 |17 536 |15 776 |17 631|+--------------------------+-------+-------+-------+------+|Group Total | 36 810| 37 287| 35 827|39 243|+--------------------------+-------+-------+-------+------+ IFRS 15 restatements increased the Group’s non-current assets on December 31, 2017 by EUR 2 082 thousand, current assets by EUR 1 181 thousand, non-current liabilities by EUR 2 374 thousand, current liabilities by EUR 3 525 thousand, and decreased equity by EUR 2 636 thousand. IFRS 15 restatements had no material impact on basic or diluted EPS, and no impact on cash flows. IFRS 15 restatements and the changes in revenue allocation between Cloud and Non-cloud also affect the subscription annual recurring revenue gross order intake reported in 2017. The restated numbers are outlined below also adjusting for the effect of the divested businesses. The annual recurring revenue gross order intake related to the divested businesses was EUR 1.3 million in 2017. Purchase-to-pay subscription annual recurring revenue gross order intake after IFRS 15 restatements and changes in revenue allocation, and adjusting for divestments:  +-------------------+-----+-----+-----+-------+-----+-----+-----+|Annual recurring | 7-9/| 4-6/|1-3/ |10-12/ |7-9/ | 4-6/| 1-3/||revenue gross order| | | | | | | ||intake  | | | | | | | |+-------------------+-----+-----+-----+-------+-----+-----+-----+|EUR thousand  | 2018| 2018|2018 | 2017 |2017 | 2017| 2017|+-------------------+-----+-----+-----+-------+-----+-----+-----+|Purchase-to-Pay |3 130|3 449|2 742| 2 943|1 988|3 809|2 506||subscriptions   | | | | | | | |+-------------------+-----+-----+-----+-------+-----+-----+-----+ Basware has adopted IFRS 9 Financial Instruments (effective date January 1, 2018), which replaces the previous IAS 39 Financial Instruments: Recognition and Measurement. The main impact of IFRS 9 concerns the timing of recording expected credit losses. IFRS 9 has not been applied retrospectively. The Group has adopted the amendment to IFRS 2 Share-based Payment (effective date January 1, 2018). The amendment concerns incentive schemes with “net settlement” features to cover withholding tax obligations and where the employer has an obligation to withhold tax from the received benefit of the share-based payment in the country in question. From 2018 onwards, a compensation cost pursuant to IFRS 2 will be recognized for such payments, based on the entire scheme being an equity-settled payment. DEFINITION OF ALTERNATIVE PERFORMANCE MEASURES Basware presents the following financial measures to supplement its consolidated financial statements which are prepared in accordance with IFRS. These measures are designed to measure growth and provide insight into the company’s underlying operational performance. The Group has applied the guidance from the European Securities and Markets Authority (ESMA) on Alternative Performance Measures which is applicable as of July 3, 2016, and defined alternative performance measures as follows: Cloud revenue includes net sales from SaaS and other subscription types, transaction services and financing services excluding alliance fees. Non-cloud revenue includes net sales from licences, maintenance and consulting, as well as alliance fees. Organic revenue growth is calculated by comparing net sales between comparison periods in constant currencies excluding alliance fees as well as net sales from acquisitions or disposals that have taken place in the past 12 months. Net sales in constant currencies is calculated by eliminating the impact of exchange rate fluctuations by calculating the net sales for the current period by using the comparable period’s exchange rates. Gross investments are total investments made to non-current assets including acquisitions and capitalized research and development costs. Other capitalized expenditure consists of investments in property, plant & equipment and intangible assets excluding acquisitions and capitalized research and development costs. EBITDA is calculated as operating profit/loss plus depreciation and amortization. Adjusted EBITDA is calculated from EBITDA excluding any adjustments related to alliance fees, acquisitions and disposals, restructuring and efficiency measures, impairment losses and litigation fees and settlements. Adjusted operating profit/loss (Adjusted EBIT) is calculated from operating profit/loss excluding any adjustments related to alliance fees, acquisitions and disposals, restructuring and efficiency measures, impairment losses and litigation fees and settlements. Adjusted earnings per share (Adjusted EPS) is calculated by excluding from the profit/loss any adjustments related to alliance fees, acquisitions and disposals, restructuring and efficiency measures, impairment losses and litigation fees and settlements. Annual recurring revenue gross order intake is calculated by summing the total order intake in the period expressed as an annual contract value. For cloud order intake this includes all SaaS and Network recurring revenues including transaction revenues. For the subscription order intake this includes SaaS and other purchase-to-pay subscription types and excludes transaction revenue. Gross order intake covers new cloud customers, add-ons and renewal uplifts but excludes churn. There will be a time lag before this order intake is visible in net sales. Historical quarterly order intake for cloud and purchase-to-pay subscriptions is shown below: +-------------------+-----+-----+-----+-------+-----+-----+-----+|Annual recurring | 7-9/| 4-6/|1-3/ |10-12/ |7-9/ |4-6/ |1-3/ ||revenue gross order| | | | | | | ||intake | | | | | | | |+-------------------+-----+-----+-----+-------+-----+-----+-----+|EUR thousand | 2018| 2018|2018 | 2017 |2017 | 2017| 2017|+-------------------+-----+-----+-----+-------+-----+-----+-----+|Cloud |4 483|6 392|4 657| 4 948|3 475|5 496|4 024|+-------------------+-----+-----+-----+-------+-----+-----+-----+|Purchase-to-Pay |3 130|3 449|2 742| 2 943|1 988|3 809|2 506||subscriptions | | | | | | | |+-------------------+-----+-----+-----+-------+-----+-----+-----+ Adjusted operating profit/loss and adjusted EBITDA +--------------------------+-----+------+-------+------+------+---------+------+| |7-9/ | 7-9/ |Change,| 1-9/ | 1-9/ |Change,  |1-12/ || | | |  | | | | |+--------------------------+-----+------+-------+------+------+---------+------+|EUR thousand     |2018 | 2017 | % | 2018 | 2017 | % | 2017 |+--------------------------+-----+------+-------+------+------+---------+------+|Operating profit/loss | -3| 1 205| | 2 379|-6 648| |-9 509|| | 787| | | | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Adjustments: | | | | | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Acquisition, disposal and |-553 | | | -17| -133| | -133||restructuring income (-) | | | | 758 | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Acquisition, disposal and | 625 | 108| 478.7 |2 707 | 246| | 416||restructuring expenses (+)| | | | | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Efficiency related | 115 | -65 | |1 039 |1 445 | -28.1| 2 023||expenses | | | | | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Settlements | 0 | 114| | 0 | 114| | 389|+--------------------------+-----+------+-------+------+------+---------+------+|Total adjustments | 187 | 156| 19.9| -14| 1 672| | 2 695|| | | | | 012 | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Adjusted operating | -3|1 361 | | -11|-4 976| -133.8|-6 814||profit/loss  | 600 | | | 633 | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Depreciation and | -2| -2| 18.4 | -8|-7 361| 10.0|10 108||amortization | 723 | 300| | 095 | | | |+--------------------------+-----+------+-------+------+------+---------+------+|Adjusted EBITDA |-877 | 3 661| | -3| 2 386| | 3 294|| | | | | 538 | | | |+--------------------------+-----+------+-------+------+------+---------+------+ DIVESTMENTS Basware signed an agreement on February 2, 2018 to sell its Financial Performance Solutions and Banking businesses to Verdane Capital. The divestments were completed on February 28, 2018 and starting from March 1, 2018 Basware Group has not consolidated these businesses in its consolidated financial statements. In 2017, the combined net sales of Financial Performance Solutions and Banking businesses were approximately EUR 15 million and combined direct costs approximately EUR 7 million. The combined sale price of the two businesses was EUR 35.0 million, and after purchase price adjustments related mainly to net working capital, the net cash proceeds from the divestments are estimated to be EUR 30.1 million. In addition, EUR 14.0 million of consolidated goodwill has been allocated to the divested businesses, and EUR 4.8 million of fixed assets, mainly capitalized research and development expenses, was written down. In total, the Group recognized a gain on sale of assets amounting to EUR 16.3 million in the first quarter as a result of the divestments. Tax impact of the divestments will be covered by deferred tax assets recognized for accumulated tax losses. SEGMENT REPORTING Basware reports one operating segment. The reported segment is comprised of the entire Group, and the segment figures are consistent with the Group figures. INFORMATION ON PRODUCTS AND SERVICES Basware reports revenues by type. Cloud revenue includes SaaS, Transaction services (consisting of e-invoicing, scan and capture services, printing services and network start-up fees) and Other cloud revenue. Non-cloud revenue includes Maintenance, License sales, Consulting services (consisting of professional services and customer services management) and Other non-cloud revenue. +-------------+-------+-------+---------+--------+--------+---------+-------+|Net sales by | 7-9/ | 7-9/ |Change,  | 1-9/ | 1-9/ |Change,  | 1-12/ ||revenue type | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|EUR thousand | 2018 | 2017 | % | 2018 | 2017 | % | 2017 |+-------------+-------+-------+---------+--------+--------+---------+-------+|Cloud Revenue| | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|SaaS |10 177 | 8 903 | 14.3 | 29 416 | 25 276 | 16.4 |34 808 |+-------------+-------+-------+---------+--------+--------+---------+-------+|Transaction |11 029 | 9 875 | 11.7 | 32 405 | 28 919 | 12.1 |39 689 ||services  | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Other cloud | 1 233 | 1 274 | -3.2 | 3 744 | 4 525 | -17.3 | 5 835 ||revenue  | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Cloud Revenue|22 440 |20 052 | 11.9 | 65 566 | 58 720 | 11.7 |80 332 ||total | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Non-Cloud | | | | | | | ||Revenue  | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Maintenance | 6 150 | 8 965 | -31.4 | 20 212 | 28 170 | -28.3 |37 026 |+-------------+-------+-------+---------+--------+--------+---------+-------+|License sales| 401 | 790 | -49.3 | 1 589 | 2 810 | -43.4 | 4 192 |+-------------+-------+-------+---------+--------+--------+---------+-------+|Consulting | 4 966 | 6 063 | -18.1 | 17 504 | 20 299 | -13.8 |27 746 ||services | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Other non | 34 | -42 | | 59 | -74 | | -129 ||-cloud | | | | | | | ||revenue | | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Non-Cloud |11 551 |15 776 | -26.8 | 39 364 | 51 204 | -23.1 |68 836 ||Revenue total| | | | | | | |+-------------+-------+-------+---------+--------+--------+---------+-------+|Group Total |33 991 |35 827 | -5.1 |104 929 |109 924 | -4.5 |149 167|+-------------+-------+-------+---------+--------+--------+---------+-------+ GEOGRAPHICAL INFORMATION From Q1 2018, the company has changed the presentation of its geographical information. Basware reports geographical areas Americas, Europe, Nordics and APAC. Americas includes business operations in North and South America. Europe includes operations in Europe and Russia, excluding the Nordic countries (Denmark, Finland, Norway and Sweden), which are reported separately. APAC includes operations in Asia and the Pacific region. +----------------+------+-------+---------+-------+--------+---------+-------+|Net sales by the| 7-9/ | 7-9/ |Change,  | 1-9/ | 1-9/ |Change,  | 1-12/ ||location of | | | | | | | ||customer  | | | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+|EUR thousand  | 2018 | 2017 | % | 2018 | 2017 | % | 2017 |+----------------+------+-------+---------+-------+--------+---------+-------+|Americas  |6 954 | 5 945| 17.0 | 19 661| 18 307 | 7.4| 24 403|| | | | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+|Europe   | 11|11 529 | 1.3 | 35 268| 33 361 | 5.7| 45 401|| | 673 | | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+|Nordics  | 13|16 410 | -17.6| 44 771| 52 608 | -14.9| 71 818|| | 526| | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+|APAC  |1 838 | 1 944 | -5.5 | 5 228| 5 648 | -7.4| 7 545|| | | | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+|Group total  | 33| 35 827| -5.1 |104 929|109 924 | -4.5|149 167|| | 991 | | | | | | |+----------------+------+-------+---------+-------+--------+---------+-------+ +---------------------+-----+------+---------+-----+-----+-------+------+|Personnel   |7-9/ | 7-9/ |Change,  | 1-9/| 1-9/|Change,|1-12/ |+---------------------+-----+------+---------+-----+-----+-------+------+|Employed, on average |2018 | 2017 | % | 2018| 2017| % | 2017|+---------------------+-----+------+---------+-----+-----+-------+------+|Americas  | 138 | 130 | 6.2 | 137| 131 | 4.8 | 131|+---------------------+-----+------+---------+-----+-----+-------+------+|Europe   | 457 | 463 | -1.2 | 461| 479| -3.8 | 475|+---------------------+-----+------+---------+-----+-----+-------+------+|Nordics  | 473 | 555 | -14.7 | 497| 562| -11.6 | 558|+---------------------+-----+------+---------+-----+-----+-------+------+|APAC  | 658| 678| -2.9 | 673| 668| 0.8 | 673|+---------------------+-----+------+---------+-----+-----+-------+------+|Group total  |1 727|1 826 | -5.4 |1 768|1 840| -3.9% | 1 838|+---------------------+-----+------+---------+-----+-----+-------+------+ FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES +-----------------------------+------+-----+------+------+----------+----------+| |Sept. |Sept. |Dec. 31, 2017 || |30, |30, | || |2018  |2017  | |+-----------------------------+------+-----+------+------+----------+----------+|EUR thousand  |Book |Fair |Book |Fair |Book value|Fair value|| |value |value|value |value | | |+-----------------------------+------+-----+------+------+----------+----------+|Financial assets  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Non-current: | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Non-current financial assets | 38 | 38| 38 | 38 | 38| 38|+-----------------------------+------+-----+------+------+----------+----------+|Non-current trade and other | 911 | 911|1 498 |1 498 | 1 400| 1 400||receivables | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Current: | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Current trade receivables | 24| 24| 23| 23| 24 534| 24 534|| | 617 | 617| 839 | 839 | | |+-----------------------------+------+-----+------+------+----------+----------+|Current other receivables | 165| 165| 146 | 146 | 182| 182|+-----------------------------+------+-----+------+------+----------+----------+|Cash and cash equivalents | 46| 46| 25| 25| 20 683| 20 683|| | 235 | 235| 275 | 275 | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Financial liabilities  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Non-current: | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Financial liabilities valued | | | | | | ||at amortized acquisition | | | | | | ||cost:  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Loans from financial | 40| 40| 47| 47| 47 286| 47 286||institutions, interest | 113 | 113 | 286 | 286 | | ||-bearing  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+| | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Current:  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Loans from financial | 17| 17|1 996 |1 996 | 1 996| 1 996||institutions, interest | 096 | 096| | | | ||-bearing  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+|Trade payables and other |9 952 |9 952|8 262 |8 262 | 12 532| 12 532||liabilities  | | | | | | |+-----------------------------+------+-----+------+------+----------+----------+ Financial liabilities arising from derivative financial instruments of EUR 76 thousand are classified as level 2 and unquoted equity shares of EUR 38 thousand as level 3 in the fair value measurement hierarchy. COMMITMENTS AND CONTINGENT LIABILITIES +-----------------------------+--------------+--------------+-------------+|EUR thousand  |Sept. 30, 2018|Sept. 30, 2017|Dec. 31, 2017|+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Own guarantees  | | | |+-----------------------------+--------------+--------------+-------------+|Business mortgages of own | 0| 1 200| 1 200||debts | | | |+-----------------------------+--------------+--------------+-------------+|Guarantees  | 605| 218| 202|+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Commitments on behalf of | | | ||subsidiaries and group | | | ||companies  | | | |+-----------------------------+--------------+--------------+-------------+|Guarantees | 327| 100| 100|+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Other own guarantees  | | | |+-----------------------------+--------------+--------------+-------------+|Lease liabilities  | | | |+-----------------------------+--------------+--------------+-------------+|Current lease liabilities  | 930| 864| 850|+-----------------------------+--------------+--------------+-------------+|Lease liabilities maturing in| 909| 698| 847||1–5 years  | | | |+-----------------------------+--------------+--------------+-------------+|Total  | 1 839| 1 562| 1 697|+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Other rental liabilities  | | | |+-----------------------------+--------------+--------------+-------------+|Current rental liabilities  | 6 554 | 5 753 | 6 424|+-----------------------------+--------------+--------------+-------------+|Rental liabilities maturing | 8 749 | 10 880 | 11 368||in 1–5 years  | | | |+-----------------------------+--------------+--------------+-------------+|Rental liabilities maturing | 33 | 230 | 180||later  | | | |+-----------------------------+--------------+--------------+-------------+|Total  | 15 336| 16 863| 17 973|+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Other own contingent | 17 174| 18 425| 19 670||liabilities, total  | | | |+-----------------------------+--------------+--------------+-------------+| | | | |+-----------------------------+--------------+--------------+-------------+|Total commitments and | 18 106| 19 943| 21 172||contingent liabilities  | | | |+-----------------------------+--------------+--------------+-------------+ RELATED PARTY TRANSACTIONS Loans from related parties +--------------------------+---------------+--------------+-------------+|EUR thousand  |Sept. 30, 2018 |Sept. 30, 2017|Dec. 31, 2017|+--------------------------+---------------+--------------+-------------+|Arrowgrass Master Fund LTD| 10 000 | 0 | 10 000|+--------------------------+---------------+--------------+-------------+ Loans from related parties includes the share of Arrowgrass Master Fund LTD of the Group’s term loan financing signed in September 2017 and totaling EUR 30 million. The other lenders are Nordea Bank AB, OP Corporate Bank Plc and Ilmarinen Mutual Pension Insurance Company. Loans from related parties have been provided at commercial interest rates.  GROUP QUARTERLY INCOME STATEMENT +------------------+-----+-----+--------+----------+--------+--------+--------+|EUR thousand  |7-9/2|4-6/2|1-3/2018|10-12/2017|7-9/2017|4-6/2017|1-3/2017|| |018 |018 | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|NET SALES  | 33| 34| 35 969| 39 243 | 35 827 | 37 287 | 36 810 || | 991 | 969| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Cost of sales  | -16| -18|-17 913 | -19 087 |-16 966 |-19 363 |-20 476 || | 101 | 580| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|GROSS PROFIT/LOSS | 17| 16| 18 056 | 20 156 | 18 862 | 17 924 | 16 334 || | 890 | 389| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Sales and | -10| -10| -9 879 | -9 947| -7 809| -9 304| -9 395||Marketing  | 759| 434| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Research and | -6| -6| -6 811 | -7 603| -6 539| -7 657| -7 830||Development  | 599| 964| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|General and | -4| -4| -3 868 | -4 465| -3 052| -3 335| -3 257||Administration  | 003| 315| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Total operating | -21| -21|-20 558 | -22 015| -17 400| -20 296| -20 483||expenses  | 361| 712| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Other operating | -316| -1| 14 997 | -1 003| -257| -397| -934||income and | | 006| | | | | ||expenses  | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|OPERATING | -3| -6| 12 495 | -2 862| 1 205| -2 769| -5 084||PROFIT/LOSS  | 787| 329| | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|% of net sales  | | | 34.7 %| | 3.4 %| | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Finance income and| -487|-382 | -600| -349 | -401 | -457 | -512 ||expenses  | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Share of results | 0| 0 | -153| -53 | -117 | -396 | -482 ||of a joint | | | | | | | ||venture  | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Profit/loss before| -4| -6| 11 741| -3 264 | 688 | -3 623 | -6 077 ||tax  | 274| 712 | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|% of net sales  | | | 32.6 %| | 1.9 % | | |+------------------+-----+-----+--------+----------+--------+--------+--------+| | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|Income taxes  |1 045| 966 | -5 325| -168 | 7 | 207 | 706 || | | | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|PROFIT/LOSS FOR | -3| -5| 6 416| -3 431 | 694 | -3 416 | -5 371 ||THE PERIOD  | 229| 746 | | | | | |+------------------+-----+-----+--------+----------+--------+--------+--------+|% of net sales  | | | 17.8 %| | 1.9 % | | |+------------------+-----+-----+--------+----------+--------+--------+--------+ GROUP KEY INDICATORS  +----------------------------------------------+---------+---------+----------+|EUR thousand |1-9/2018 |1-9/2017 |1-12/2017 |+----------------------------------------------+---------+---------+----------+|Net sales  | 104 929 | 109 924 | 149 167 |+----------------------------------------------+---------+---------+----------+|Growth of net sales, %  | -4.5 % | 1.4 %* | 0.4 %* |+----------------------------------------------+---------+---------+----------+|Organic revenue growth | 5.8 %| 2.2 %*| 1.5 %*|+----------------------------------------------+---------+---------+----------+|EBITDA  | 10 474| 714 | 599 |+----------------------------------------------+---------+---------+----------+|% of net sales | 10.0 %| 0.6 % | 0.4 % |+----------------------------------------------+---------+---------+----------+|Adjusted EBITDA | -3 538| 2 386| 3 294|+----------------------------------------------+---------+---------+----------+|% of net sales  | | 2.2 %| 2.2 % |+----------------------------------------------+---------+---------+----------+|Operating profit/loss  | 2 379| -6 648 | -9 509 |+----------------------------------------------+---------+---------+----------+|% of net sales | 2.3 % | | |+----------------------------------------------+---------+---------+----------+|Adjusted operating profit/loss | -11 633| -4 976| -6 814 |+----------------------------------------------+---------+---------+----------+|% of net sales | | | |+----------------------------------------------+---------+---------+----------+|Profit/loss before tax  | 756 | -9 013 | -12 276 |+----------------------------------------------+---------+---------+----------+|% of net sales  | 0,7 % | | |+----------------------------------------------+---------+---------+----------+|Profit/loss for the period  | -2 558 | -8 093 | -11 524 |+----------------------------------------------+---------+---------+----------+|% of net sales  | | | |+----------------------------------------------+---------+---------+----------+| | | | |+----------------------------------------------+---------+---------+----------+|Return on equity, %  | -3.0 % | -8.6 % | -9.4 % |+----------------------------------------------+---------+---------+----------+|Return on investment, %  | 1.8 % | -5.4 % | -5.8 % |+----------------------------------------------+---------+---------+----------+|Interest-bearing liabilities  | 57 202 | 49 282 | 49 282 |+----------------------------------------------+---------+---------+----------+|Cash and cash equivalents  | 46 235 | 25 275 | 20 683 |+----------------------------------------------+---------+---------+----------+|Gearing, %  | 9.6 % | 20.4 % | 25.2 % |+----------------------------------------------+---------+---------+----------+|Equity ratio, %  | 52.3 % | 53.4 % | 52.7 % |+----------------------------------------------+---------+---------+----------+|Total assets  | 219 252 | 220 439 | 214 811 |+----------------------------------------------+---------+---------+----------+| | | | |+----------------------------------------------+---------+---------+----------+|Gross investments  | 8 656| 9 670 | 12 498 |+----------------------------------------------+---------+---------+----------+|% of net sales  | 8.2 % | 8.8 % | 8.4 % |+----------------------------------------------+---------+---------+----------+| | | | |+----------------------------------------------+---------+---------+----------+|R&D investments, expensed**  | 15 882| 18 285| 24 372|+----------------------------------------------+---------+---------+----------+|R&D costs, capitalised   | 6 643| 7 558| 9 879|+----------------------------------------------+---------+---------+----------+|R&D investments, total  | 22 526 | 25 844 | 34 251 |+----------------------------------------------+---------+---------+----------+|% of net sales  | 21.5 % | 23.5 % | 23.0 % |+----------------------------------------------+---------+---------+----------+| | | | |+----------------------------------------------+---------+---------+----------+|Depreciation and amortization | 8 095| 7 361| 10 108|+----------------------------------------------+---------+---------+----------+|Other capitalised expenditure  | 1 983| 2 113| 2 620|+----------------------------------------------+---------+---------+----------+| | | | |+----------------------------------------------+---------+---------+----------+|Personnel expenses  | 72 053 | 73 204 | 99 083 |+----------------------------------------------+---------+---------+----------+|Personnel on average during the period  | 1 768 | 1 840 | 1 838 |+----------------------------------------------+---------+---------+----------+|Personnel at end of period  | 1 736 | 1 827 | 1 829 |+----------------------------------------------+---------+---------+----------+|Change in personnel from comparison period, % | -5.0 % | -2.9 % | -3.2 % |+----------------------------------------------+---------+---------+----------+ * Based on IFRS15 restated revenue including reallocations for 2017 and reported revenue for 2016 ** R&D expenses excluding depreciation +----------------------+------------+------------+-----------+|Group Share | 1-9/2018| 1-9/2017 | 1-12/2017||Indicators  | | | |+----------------------+------------+------------+-----------+|Earnings per share, | -0.18| -0.56 | -0.80 ||undiluted (EUR) | | | |+----------------------+------------+------------+-----------+|Earnings per share, | -0.18 | -0.56| -0.80 ||diluted (EUR) | | | |+----------------------+------------+------------+-----------+|Adjusted earnings per | -1.15| -0.45| -0.61 ||share, undiluted (EUR)| | | |+----------------------+------------+------------+-----------+|Adjusted earnings per | -1.14| -0.45| -0.61 ||share, diluted (EUR) | | | |+----------------------+------------+------------+-----------+|Equity per share (EUR)| 7.94| 8.19 | 7.89 |+----------------------+------------+------------+-----------+|Price per earnings | 200.88| -70.96 | -59.18 ||(P/E) | | | |+----------------------+------------+------------+-----------+|Share price | | | ||performance (EUR) | | | |+----------------------+------------+------------+-----------+|- lowest price | 30.20 | 31.96 | 31.96|+----------------------+------------+------------+-----------+|- highest price | 47.60| 42.47 | 47.50|+----------------------+------------+------------+-----------+|- average price | 40.88| 39.68 | 38.84|+----------------------+------------+------------+-----------+|- closing price | 35.60| 40.00 | 47.50|+----------------------+------------+------------+-----------+|Market capitalization |513 828 898 |574 388 120 |682 085 892||at end of period* | | | ||(EUR) | | | |+----------------------+------------+------------+-----------+|Share issue adjusted | | | ||number of | | | |+----------------------+------------+------------+-----------+|traded shares | 1 545 773 | 1 299 650 | 1 681 791|+----------------------+------------+------------+-----------+|% of average number of| 10.7 % | 8.6 % | 11.7 % ||shares | | | |+----------------------+------------+------------+-----------+|Number of shares* | | | |+----------------------+------------+------------+-----------+|- at end of the period| 14 433 396 | 14 359 703 | 14 359 703|+----------------------+------------+------------+-----------+|- average during the | 14 436 935 | 14 356 548 | 14 357 343||period | | | |+----------------------+------------+------------+-----------+|- average during the | 14 436 935 | 14 395 519 | 14 406 674||period, diluted | | | |+----------------------+------------+------------+-----------+ * Excluding treasury shares SHARE AND SHAREHOLDERS Basware Corporation’s share capital totalled EUR 3 528 369 (3 528 369) at the end of the quarter and the number of shares was 14 433 396 (14 359 703). Basware Corporation holds 31 460 (42 233) of its own shares, corresponding to approximately 0.2 percent (0.3 %) of the total number of shares. Basware had 11 467 (11 992) shareholders at the end of the quarter, including 11 nominee-registers (9). Nominee-registered holdings accounted for 51.8 percent (44.7 %) of the total number of shares. The company’s Annual General Meeting of March 15, 2018 authorized the Board of Directors to decide on the repurchase of the company’s own shares and on share issue as well as on the issuance of options and other special rights entitling to shares.Additional information on shareholdings of major shareholders is available on the company’s investor website at investors.basware.com/en.

myFC develops technology that secures the company’s recurring revenues from fuel, and protects users and manufacturers from counterfeit fuel cards

myFC today announces it has a patent pending that protects the fuel chemistry of its PowerCard. Specifically, the patent covers the technology allowing the device to immediately recognize if a power card is in fact a myFC original PowerCard, safe for the intended use, and ensuring the device does not accept any uncertified or counterfeit versions. Sales of fuel cards is a significant potential source of recurring revenue for myFC and therefore an integral part of the company’s business model. Previously communicated calculations by myFC state that under the assumption that that users would use one to two fuel cards a month, the company’s potential annual revenues for the sale of fuel cards could be five to ten times higher than the revenues for the fuel cell. This technology is also significant for the users. A prerequisite for myFC’s offering is that fuel cards are readily and conveniently available, and that consumers can trust the quality of the fuel. Smartphone manufacturers integrating myFC’s technology into their devices likewise need to be certain their products aren’t compromised by counterfeit or non-certified fuel cards. “This is a significant breakthrough for myFC, which I am happy to finally be able to share. This innovation ensures that no counterfeit cards will be accepted by our system. That means consumers can trust the cards they use are certified and safe, manufacturers can be confident the warranties of their products won’t be compromised, and we at myFC are assured our potential recurrent revenue from PowerCards is protected,” says Björn Westerholm, CEO of myFC. “Developing the system that protects our own, patented fuel is highly complex in itself. But I also want to underline that we have managed to do it very cost-effectively with high scalability and usability, ensuring that it is ultimately commercially viable to include it in thousands of power cards,” adds Westerholm. This information is information that myFC is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 07:55 CET on 17 October 2018.

MAG Interactive AB (publ) presents interim report Sep 2017 – Aug 2018

COMMENT FROM DANIEL HASSELBERG, CEO Revenue growth thanks to new games “Revenues in the reporting period June-August increased compared to the previous quarter thanks to our two new games Paint Hit and Word Domination. During the reporting period we saw an average of 15 million active players on a monthly basis, which is up significantly compared to the previous quarter and more than double the amount compared to the same period previous year. The contribution from games increased 20% compared to previous year. During the reporting period, we were able to significantly increase our investments in marketing compared to the previous quarter thanks to our new games, which in the short term puts pressure on the profit margin. As we are applying our ROI focused and data driven performance marketing models we expect good returns on these investments over time. The main focus for MAG is to create games with strong long term player commitment. Our multiplayer games Ruzzle, Quiz Duel and Word Domination are all great examples of games that are able to create robust underlying profitability over a long period of time. While the recent quarters have shown declining revenues from our single player games due to difficulties in maintaining marketing volumes, it is positive to see that our multiplayer portfolio has continued to develop favorably. Multiplayer and strong social game design are the keys to success for MAG both historically and in the future." SUMMARY OF THE PERIOD JUNE UNTIL AUGUST 2018 ·  The Group's Net sales for the period were 53,740 KSEK (57,916 KSEK), a decrease of 7% compared to the same period previous year. Net sales adjusted for currency effects is 51,305 KSEK ·  The Group's Net sales for the period corresponds to an increase of 5% compared to the previous reporting period, March-May ·  The Group's game contribution for the period was 22,849 KSEK (19,001 KSEK), an increase of 20% compared to the same period the previous year ·  Daily and monthly active users (DAU and MAU) were 2.8 million and 15.3 million respectively during the quarter, an increase of 73% and an increase of 107% compared with the same period last year ·  The Group's EBITDA for the period was -796 tkr (4,420 tkr) SIGNIFICANT EVENTS SINCE THE END OF THE REPORTING PERIOD · No significant events after the end of the reporting period Full interim report is available at http://www.maginteractive.com/investor-relations/. Further reporting dates  Annual General Meeting            18 December 2018                                 Interim report September-November 23 January 20192018/2019Interim report September-February 10 April 20192018/2019Interim report September-May 26 June 20192018/2019Interim report September-August 23 October 20192018/2019   TWITCH CAST The 17th of October at 10:00, CEO Daniel Hasselberg and CFO Magnus Wiklander will hold a Twitch video cast call to present the interim report. Link to the Twitch feed www.twitch.com/maginteractive. More information is available at www.maginteractive.se/investor-relations. This announcement contains inside information pursuant to Article 7 of the EUMarket Abuse Regulation relating to MAG Interactive AB (publ). The informationwas submitted for publication through the agency of the contact persons setout below, on October 17th, 2018 at 08.00 CET.For additional information,please contact: Daniel Hasselberg / VD / +46 (0)8 644 35 40 /daniel@maginteractive.com Magnus Wiklander / CFO / +46 (0)8 644 35 40 /magnus.wiklander@maginteractive.com About MAG InteractiveMAG Interactive is a leading developer and publisher of casual mobile gamesfor a global audience. MAG Interactive reaches over 10 million active playersevery month and the game portfolio consists of ten successful games with over250 million downloads, including successful titles Ruzzle, Word Domination andWordBrain, all of which have reached #1 spots on the App Store and GooglePlay. With offices located in Stockholm and Brighton, MAG Interactive’s gamesare distributed through virtual app stores allowing for global reach withminimum effort. MAG Interactive is listed on Nasdaq First North Premier withticker MAGI. Avanza Bank AB is acting as MAG Interactive's Certified Adviser.For more information visit www.maginteractive.com.                  

Mycronic receives order for advanced maskwriter

Mycronic has received an order for a Prexision-800 from a customer in Asia. The system is configured with limited functionality and is scheduled for delivery in the second quarter of 2019. The order, which was booked in the fourth quarter, is valued at between USD 30-35 million and also includes certain upgrades to the customer’s existing system. Mycronic’s Business Area Pattern Generators provides mask writers for manufacturing photomasks in several fields of application. These mainly consist of display manufacturing (TV, smartphones and tablets) and applications in the multi-purpose market, a broad segment that includes applications such as electronic packaging, microelectromechanical systems (MEMS) and touchscreen functions. A fully optioned Prexision-800 can – while maintaining productivity – produce patterns that are almost 25 percent more compact than previously possible. This ensures efficient production of the most advanced and critical photomasks for displays, such as 4K smartphones and advanced AMOLED displays. “It is gratifying to secure another order for a system based on the Prexision-800 platform. The customer can upgrade the functionality at a later date to a Prexision-800 system that fully meet the industry’s high standards for manufacturing of new, innovative display applications while maintaining productivity,” says Charlott Samuelsson, Sr VP Business Area Pattern Generators, Mycronic. For further information, please contact: Charlott SamuelssonSr VP Business Area Pattern GeneratorsTel: +46 709 844 282, e-mail: charlott.samuelsson@mycronic.com Tobias BülowDirector IR & Corporate CommunicationsTel: +46 734 018 216, e-mail: tobias.bulow@mycronic.com The information in this press release was published on October 17, 2018, at 08:00 am CET. About MycronicMycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic’s headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in France, Japan, China, the Netherlands, Singapore, the United Kingdom, South Korea, Germany and the USA. Mycronic (MYCR) is listed on Nasdaq Stockholm. www.mycronic.com

Hansa Medical Receives FDA Fast Track Designation for Imlifidase for Transplantation

Imlifidase (IdeS) is an enzyme in late-stage clinical development that specifically cleaves IgG antibodies, thereby inhibiting the IgG-mediated immune response. Hansa Medical is initially developing imlifidase as a proprietary treatment to enable kidney transplantation in sensitized patients previously unable to undergo transplant surgery due to the presence of donor-specific antibodies (DSAs). In addition, imlifidase is being evaluated in a Phase 2 study in anti-GBM antibody disease, a rare and acute autoimmune disorder, and imlifidase has potential applications in other solid organ transplants and in a variety of additional acute autoimmune indications. “This Fast Track Designation is validation of imlifidase’s potential to address the significant unmet medical need for highly sensitized patients, a patient population for which transplantation is extremely difficult or impossible,” said Søren Tulstrup, President and Chief Executive Officer of Hansa. “Our two recently reported Phase 2 studies demonstrate imlifidase’s ability to enable kidney transplantation for these patients, who otherwise face high mortality rates associated with long-term dialysis. We continue to actively engage with the regulatory agencies and anticipate submitting a Biologic License Application (BLA), as well as a Marketing Authorisation Application (MAA), in either the fourth quarter of this year or the first quarter of 2019.” The imlifidase Fast Track Designation is supported by efficacy data reported from four successfully completed Phase 2 studies that demonstrate imlifidase’s ability to rapidly and significantly reduce Donor Specific Antibodies (DSAs), thereby enabling kidney transplantation. The FDA's Fast Track program is designed to facilitate the development and expedite the review of new drugs to treat serious or life-threatening conditions that demonstrate the potential to address an unmet medical need. Fast Track designation provides a company more frequent communication with the FDA regarding the investigational drug’s development plan and also provides eligibility for priority review if certain criteria are met. This is information that Hansa Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below at 08:00am CEST on October 17, 2018.

Castellum’s Interim Report January-September 2018: A record strong quarter – 13% growth in income from property management

“For Castellum, this resulted in a new record quarter - income from property management rose 13%. The strong earnings after the third quarter mean that I am now even more convinced that in 2018, Castellum will be able to meet its overall target: an increase in income from property management (and thus the dividend) of 10%,” says CEO Henrik Saxborn. “New profitable development opportunities arise through continued high demand for modern, sustainable office spaces. Over the last few years, Castellum has taken a leading role in the expansion of Nyhamnen in central Malmö by constructing a new Swedish National Courts Administration and a new Nordic head office for E.ON. The investment totals SEK 2.3 billion and is one of the largest in the company’s history. This further reinforces Castellum’s position as a community-builder in the Öresund region,” concludes Saxborn.    Enclosure: Interim Report January-September 2018 This information is information that Castellum is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 8:00 a.m. CET on October 17, 2018. For additional information, please contact:Henrik Saxborn, CEO, Phone +46-31 60 74 50Ulrika Danielsson, CFO, Phone +46-706 47 12 61www.castellum.com Castellum is one of the largest listed real estate companies in Sweden. Property values amount to SEK 87.5 billion and holdings comprise office, warehousing/logistics and public sector properties, covering a total leasable area of 4.4 million square metres. The real estate portfolio is owned and managed under the Castellum brand through a decentralized organization with strong and clear local presence in 20 cities in Sweden and also in Copenhagen and Helsinki.   In 2018, Castellum received two awards for sustainability efforts; designated Number One in the world by GRESB for the offices-and-logistics sector, as well as the Level Gold award for sustainability reporting from the EPRA (European Public Real Estate Association). In addition, Castellum is the only Nordic real-estate and construction company elected to the Dow Jones Sustainability Index (DJSI), joining a select group of companies in the world who perform best on sustainability issues.   The Castellum share is listed on Nasdaq Stockholm Large Cap. Castellum AB (publ), Box 2269, SE-403 14 Gothenburg | Corp Id no SE 556475-5550 | Phone +46 31 60 74 00

Nordic Nanovector ASA: Change of Date for Q3 2018 Results Presentation and Webcast

Oslo, Norway, 17 October 2018 Nordic Nanovector ASA (OSE: NANO) announces it will present its results for the third quarter 2018 on Tuesday, 6 November 2018 (previously scheduled for Tuesday, 21 November), and will host a results presentation and webcast on the same day (details will be announced nearer the time). During this presentation, the Company will present updated clinical results from the LYMRIT 37-01 trial with Betalutin® in relapsed/refractory indolent non-Hodgkin’s lymphoma patients. These results will be published on 1 November in an abstract* that will be presented in a poster at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition (1-4 December 2018). As a consequence of the change in date of the third quarter 2018 results presentation, the Company will enter its two-week ‘quiet period’ starting on the 23 October 2018. In addition, the Company has decided it will not continue hosting separate presentations of the results in Norwegian. *ASH abstract Title: LYMRIT 37-01: A phase I/II study of 177Lu-lilotomab satetraxetan (Betalutin®) antibody-radionuclide-conjugate (ARC) for the treatment of relapsed non-Hodgkin’s lymphoma (NHL) - Analysis with 6-month follow-up Authors: A. Kolstad, et al. The abstract will be published on 1 November 2018 at 09:00am Eastern time at http://www.hematology.org/Annual-Meeting/ For further information, please contact: IR enquiries Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44 7561 431 762 Email: ir@nordicnanovector.com International Media Enquiries Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44 207 638 9571 Email: nordicnanovector@citigatedewerogerson.com About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. Further information can be found at www.nordicnanovector.com

Nordic Nanovector – Financial Calendar

Oslo, Norway, 17 October 2018 FINANCIAL YEAR 2018 Quarterly Report - Q3   06.11.2018 (changed from 21.11.2018) Quarterly Report - Q4   27.02.2019 FINANCIAL YEAR 2019 Annual General meeting 25.04.2019 Quarterly Report - Q1   23.05.2019 Half-yearly Report        22.08.2019 Quarterly Report - Q3   21.11.2019 The dates are subject to change. The time and location of the presentations will be announced in due time. This information is published pursuant to the requirements set out in the Continuing obligations. For further information, please contact: IR enquiries Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44 7561 431 762 Email: ir@nordicnanovector.com International Media Enquiries Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44 207 638 9571 Email: nordicnanovector@citigatedewerogerson.com About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. Further information can be found at www.nordicnanovector.com

Medivir scales back research costs to focus on clinical development

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects. As part of this plan, Medivir will notify the Public Employment Office of potential employee redundancies impacting approximately 60 positions, mainly within pre-clinical research and administration. Medivir will also call for consultations with the trade unions regarding the possible consequences for the employees. The plan is to reduce Medivir’s annual running cost base, excluding the clinical project costs, by approximately two thirds. Medivir is also exploring strategic alternatives for the research stage projects and organization. “The focus on the clinical portfolio, together with the associated cost reduction within pre-clinical research, are necessary steps for us to continue to develop the value of our clinical stage projects in an optimal way,” said Dr. Uli Hacksell, acting chief executive officer at Medivir. Medivir's clinical pipeline consists of four projects; remetinostat for cutaneous T-cell lymphoma (phase II), birinapant in combination with Keytruda® for solid tumors (phase I), MIV-818, a nucleotide prodrug for liver cancer that recently entered into a phase I clinical trial, and MIV-711, an osteoarthritis candidate drug with fresh and promising data from the recent phase IIa extension study. Tomorrow, Thursday October 18, at 2.00 pm (CET) Medivir will host a conference call for investors, analysts and the media where Uli Hacksell presents and comments the recent days’ development and the way forward for the company. Phone numbers for participants from:Sweden + 46 8 566 426 64Europe + 44 20 3008 9802US + 1 855 753 2237 The conference call will also be streamed via a link on the website: www.medivir.comThe presentation will be available on Medivir’s website after completion of the conference. For further information, please contact:For media information:Cord Communications, Lars Wahlström, phone: +46 734 340771. lars.wahlstrom@cordcom.se Uli Hacksell, acting CEO, Medivir AB, phone: +46 (0)8 546 831 00. Medivir AB is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CET on October 17, 2018. About MedivirMedivir is a pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitors and nucleotide/nucleoside science and we are dedicated to innovative pharmaceuticals that meet great unmet medical needs. Medivir's clinical pipeline consists of remetinostat for cutaneous T-cell lymphoma, currently in phase II, birinapant in combination with Keytruda® for solid tumors, currently in phase I, MIV-818, a nucleotide prodrug drug for liver cancer that recently entered into a phase I clinical trial, and MIV-711, a potentially disease-modifying osteoarthritis candidate drug with fresh and promising data from the recent phase IIa extension study. Medivir is listed on the Nasdaq Stockholm Mid Cap List (ticker: MVIR). www.medivir.com.

Senzime reports from the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco, USA

For more than 68 years, the ASA Annual Meeting has been the most comprehensive anesthesia-related educational event in the world, bringing together top influential and notable professionals in anesthesiology, pain medicine and critical care medicine. Numerous presenters discussed patient safety initiatives and necessary steps to reduce adverse events in the perioperative period. Hundreds of technical, scientific and educational exhibits displaying and demonstrating the latest products, services and industry research. During the exhibition Senzime had the opportunity to address a worldwide audience of Key opinion leaders and demonstrate the TetraGraph, as well as formally launch the TetraGraph Viewer. This software allows the user to easily export patient data. “The anesthesia discussions today is all about having the patient in focus. The ability to digitally present data and analyze trends is a key component,” says Lena Söderström, CEO of Senzime. Senzimes distributors from Australia & New Zealand and South Korea also attended the event to meet with local customers visiting the conference. For further information, please contact:  Lena Söderström, CEO Tel: +46-708 16 39 12. Email: lena.soderstrom@senzime.com TO THE EDITORS   About Senzime   Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime. www.senzime.com   

CLS signs agreement with IGT for development and commercialization of product for MR generated temperature monitoring

Clinical Laserthermia Systems AB (publ) and Image Guided Therapy SA (IGT)  have signed an agreement, in line with the ”term sheet” previously communicated. The purpose of the agreement is to develop and commercialize a software product offering doctors MR-generated, optimal conditions for viewing, measuring and controlling tissue temperatures during treatment with laser ablation and CLS’ immune stimulating imILT® procedure. The objective is to make the product compatible with MR systems from all leading vendors. With this new product offering CLS will strengthen its position in establishing the TRANBERG® product portfolio for image guided laser ablation and imILT® treatments within the market for interventional MR procedures. -  Our main goal is to offer the doctors, choosing to use the products of CLS, an improved workflow where they in the best way possible can monitor the treatment procedure. With this new software we will offer the hospital a more complete solution, said Lars-Erik Eriksson, CEO at CLS. In brief, the collaboration means that IGT will provide the core technology for the development of the new product, while CLS will bring the know-how of thermal therapies and the regulatory process that is required for EC approval in Europe and FDA clearance in the U.S. The new product will will be registered in CLS’ quality assurance system. CLS and IGT each covers its own costs within the project, said Lars-Erik Eriksson.  - We are aiming at having the new software product approved and ready to launch during the second half of 2019. Already today we have hospitals waiting to test the product, said Dan Mogren, CCO at CLS. The commercial part of the agreement includes joint sales and marketing of the product and with an exclusive right for CLS to sell the software together with our products for soft tissue ablation and imILT® treatments, said Dan Mogren. IGT is a French medtech company that, utilising research work from the university in Bordeaux, has developed products in the field of MR guided, minimally invasive cancer treatments. IGT has also been involved with two main developments: MR guidance for RF ablation procedures and MR guided focused ultrasound ablation devices (MRgFUS). More about Image Guided Therapy   About the CLS TRANBERG®|Thermal Therapy System CLS developed the system for image guided high precision soft tissue thermal therapy and ablation procedures. The system can be configured for MR or CT/US guided procedures using tissue temperature feedback for precise therapy and ablation control. The system includes a desk-top mobile laser unit, new innovative non-cooled laser applicators, external tissue temperature probe sensors and procedure specific accessories. CLS utilizes unique, non-cooled, diffusing laser fiber technology to optimize heat distribution in tissue while eliminating the need for external cooling. The system also includes features designed to improve workflow and reduce procedure times. This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. 

Nomination Committee for Securitas’ Annual General Meeting 2019

The following representatives of Securitas AB’s shareholders will be members of the Nomination Committee for the Annual General Meeting 2019: - Carl Douglas, Investment AB Latour, [Chairman of the Nomination Committee]- Mikael Ekdahl, Melker Schörling AB- Maria Nordqvist, Lannebo Fonder- Johan Sidenmark, AMF Försäkring och Fonder- Jan Andersson, Swedbank Robur Fonder The Chairman of the Board, Marie Ehrling, shall convene the Nomination Committee to its first meeting and shall also be co-opted to the Nomination Committee. The Nomination Committee shall prepare proposals for the Annual General Meeting in 2019 regarding the election of Chairman of the General Meeting, members of the Board of Directors, Chairman of the Board, Vice Chairman of the Board, auditor, fees for the members of the Board including division between the Chairman, the Vice Chairman, and the other Board members, as well as fees for committee work, fees to the company’s auditor and, if necessary, changes of the instructions for the Nomination Committee. The Annual General Meeting will be held on May 6, 2019 at 4 p.m. CET, at Courtyard Marriott Hotel in Stockholm, Sweden. Shareholders who wish to submit proposals to the Nomination Committee should send an email to valberedningen@securitas.com. This press release is also available at: www.securitas.com Information: Micaela Sjökvist, Head of IR and Acting SVP Corporate Communications and Public Affairs, Securitas AB, mobile +46 76 116 7443 or email micaela.sjokvist@securitas.com

Archer commences Equinor Drilling Services Fixed Platforms contract

Stavanger, Norway (October 17, 2018) On October 1st 2018 Archer successfully transitioned over four new and nine existing operations to the “Drilling Services Fixed Platforms” contract with Equinor previously awarded on 3rd April this year. Archer now provides integrated drilling, engineering, rentals and well services on 13 of the 20 Equinor production drilling and quarters (PDQ) platforms on the Norwegian Continental Shelf. “Following contract award in April, both our onshore and offshore teams have worked relentlessly to ensure a safe and effective start up and transition on all platforms. We have cross trained Archer and service contractor personnel, whilst also increasing our workforce by over 400 personnel. I would like to take this opportunity to express my gratitude to the team for their professionalism and commitment”, says Joachim Bengtsson - Archer’s Operations Manager for Equinor. The new contract work scope, coupled with the four additional platforms (Grane, Gullfaks A,B,C), has increased the Archer employee family significantly, and we now have over 1,000 personnel dedicated to delivering operational excellence and ensuring maximum value through reducing total well cost for Equinor. Archer will continue to grow our organization over the coming months as we integrate and deliver additional services. The contract ensures Archer’s continued operations for Equinor in the Norwegian continental shelf until at least October 1, 2022, with a value of more than NOK 6 billion based on the current drilling schedule. There are further contractual options which can secure operations until 2028. “This contract represents a new chapter in the delivery of platform drilling services to Equinor, whereby the drilling contractor, service contractors and Equinor will collaborate as one team, and jointly deploy resources and skills to optimize well deliveries. Our main objectives are improved efficiency, reduced POB and cost per well, reduced carbon foot print and reduced risk exposure for personnel with no harm to people as our first priority. We will accomplish this through close collaboration, continuous improvement through effective recording and sharing of lessons learned, and a win-win performance culture. We firmly believe this is and will be the future operational model in Norway” continues Mr. Bengtsson. For additional information please contact: Joachim Bengtsson, Operations Manager for EquinorM: +47 41291929joachim.bengtsson@archerwell.com #wearearcher #oneteam

Arjo to divest low-spec medical beds business

Arjo, a market-leading supplier of medical devices and solutions, today signed an agreement to divest Acare – the group’s low-spec medical beds business – to China-based CBL Group. The divestment is a key part of the group’s action plan to improve profitability in the medical beds product category. Arjo acquired the Chinese company Acare Medical Science Ltd. in 2012 to expand its presence in emerging markets. Arjo has now decided to focus on the premium segment for medical beds where the company already has strong market positions and where the profitability is significantly better. “The divestment of Acare is part of the action plan that we have prepared to improve the group’s gross margin in the medical beds category. Our strength is found outside the value segment and that is also the area on which we will focus to maintain and further strengthen our leading positions in the market,” says Joacim Lindoff, President and CEO of Arjo. CBL Group has its head office situated in Guangzhou, China, and has about 1,200 employees. Acare is deemed to have better conditions for developing with CBL, which already has an extensive offering in the low and mid-price segment and thus will be able to add the know-how and the synergies required for continuing to develop the operations. The divestment encompasses a production and sales unit in Zhuhai, China, that has 186 employees and generated sales of about SEK 80 M in 2017. The divestment is expected to be completed at the end of 2018. The divestment has no considerable effect on cash flow or results 2018 but is expected to have a positive annual effect of approximately SEK 25 M on operating profit from 2019. About Acare Acare Medical was founded in 1999 and acquired by Getinge Group in 2012. Product development and production of simple low-price beds take place at Acare’s facility in Zhuhai, China, and sales amounted to about SEK 80 M in 2017. Acare Medical’s products are sold through Arjo’s in-house sales organisation and via distributors. The primary markets are China and India. Acare Medical has 186 employees. For further information, please contact: Kornelia Rasmussen, EVP Marketing Communications & Public RelationsTel: +46 (0)10 335 4810E-mail: kornelia.rasmussen@arjo.com This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 14:15 CET on October 17, 2018. About Arjo  At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2017, Arjo sales amounted to approximately SEK 7.7 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Extended notice: Noreco acquires Shell’s Danish upstream assets

Norwegian Energy Company ASA's (“Noreco” or the “Company”) wholly owned subsidiary, Altinex AS (“Altinex”) has entered into an agreement to acquire Royal Dutch Shell Plc’s (“Shell”) upstream assets in Denmark (the “Acquisition”). Through the transaction, Noreco becomes the second largest oil and gas producer in Denmark and a considerable E&P company. Establishing Noreco as a considerable independent E&P company This acquisition will establish Noreco as an E&P company on the Danish Continental Shelf (“DCS”), and position it as the second largest oil and gas producer in the country. Noreco will post completion have a 36.8% non-operated interest in the Danish Underground Consortium (“DUC”) with assets that comprise 15 fields in four producing hubs; Halfdan, Tyra, Gorm and Dan. DUC is a joint venture between Total (31.2%), Shell (36.8%), Chevron (12.0%) and Nordsøfonden (20.0%) cooperating to recover oil from the Sole Concession holder’s area of the Danish North Sea. Total recently announced the acquisition of Chevron’s (12.0%) interest, which remains subject to approval of partners and relevant authorities. The Sole Concession covers 1,635.7 km² of the DCS. DUC is operated by Total which has extensive offshore experience in the region and worldwide. The transaction The transaction will be structured as a sale to Altinex of all shares in Shell Olie- Og Gasudvinding Danmark B.V. (“SOGU”), which in turn owns a 36.8% interest in DUC and a 100% interest in Shell Olie- Og Gasudvinding Denmark Pipelines ApS (“SOGUP”), which will own a proportionate interest in the F3 gas pipeline. Included in the transaction are proven and probable (2P) reserves of 209 million barrels of oil equivalent (mmboe) based on an independent CPR assessment as per year-end 2017, of which 65% are liquids. Further, Noreco estimates significant reserves and production growth coming from existing resources (discoveries, EOR initiatives & new projects). Shell’s share of production from DUC in 2017 was 67 thousand barrels of oil equivalent per day (mboepd). Noreco expects to maintain strong production in the years to come. The DUC portfolio has attractive economics, with 2017 opex of USD 13 per boe. As the Tyra hub is being redeveloped, the portfolio will be revitalised and offer improved economics accompanied by prolonged field life. Liquids production volumes are protected through a guarantee lasting from signing of the Acquisition through 2020. Local SOGU staff mostly dedicated to the DUC will pass to Noreco along with the business with their existing contracts of employment intact and full continuity of service. In total ca. 8 employees will follow from Shell, which will bring additional competences to the Noreco organisation. Following the transaction, Noreco will have 15 employees, and does not plan to make any organisational reductions. The SOGU organisation is based in Copenhagen, and Mr. Lee James Hodder serves as managing director. The Board of Directors of SOGU currently consists of Mr. Lee James Hodder and Mr. Michael Lund Jensen. Completion of the transaction is subject to: receipt of all mandatory consents, approvals and clearances from governmental authorities, including the Danish Energy Agency; that no party relevant to the joint operating agreements invokes option rights to purchase Shell’s SOGU interest; and other conditions customary for a transaction of this nature. Subject to fulfilment of applicable conditions, completion is targeted for H1 2019. Noreco will, to the extent required by section 3.5 of the Oslo Stock Exchange Continuing Obligations, prepare an information memorandum with further information on the Acquisition and Noreco’s operations following completion of the Acquisition. Transaction consideration and financing The consideration of the transaction is USD 1.9 billion with effective date as of 1 January 2017, with pro contra adjustment currently estimated by Noreco to USD 0.7 billion. The transaction will be financed through a new seven year Reserve Based Lending bank facility provided by BMO Capital Markets, Deutsche Bank and Natixis of up to USD 900 million with a sub-limit of USD 100 million for letters of credit, by the issuance of a convertible bond of up to USD 160 million (the “Convertible Bond”), issuing new ordinary shares (the “Shares”) through a USD 352 million private placement (the “Private Placement”) and USD 40 million through a subsequent offering (the “Subsequent Offering”). USD 30 million of the Subsequent Offering has been underwritten (further details follow below). In order to fund part of the initial payment to Shell, Noreco will enter into a short-term funding agreement of USD 35 million (the “Deposit Loan”). The deposit loan including accrued interest will upon closing of the Transaction be rolled into the Convertible Bond at par, increasing the size of the Convertible Bond to up to USD 160 million. The Convertible Bond, Private Placement, and Deposit Loan will be directed towards and subscribed by Noreco’s largest shareholders CQS (UK) LLP (“CQS”), Kite Lake Capital Management (UK) LLP (“Kite Lake”), Taconic Capital Advisors UK LLP (Taconic), and by funds managed or advised by York Capital Management Europe (UK) Advisors LLP (“York”) (together, the “Investors”). The subscription price per Share in the Private Placement is set to USD 22.62 (NOK 185) per Share, and will result in the issuance 15.6 million Shares. The Convertible Bond will have a tenor of eight years. The convertible element will have a duration of five years and have a strike price of 29.73% above the share price in the private placement. This gives a conversion price of USD 29.34 (NOK 240) per Share, subject to customary adjustment mechanisms. Interest will be payment-in-kind with additional bonds at 8.0% with the possibility for Noreco to choose to pay cash interest of 6.0%. Following expiry of the conversion period, the bond will carry an interest of 0.0%. The Convertible Bond will be non-callable during the first 30 months. It will thereafter be callable at par if the mean volume weighted average price of the shares over a period of 20 consecutive dealing days exceed 130.0% of the then current conversion price, to the extent not converted by the holders thereof. The Convertible Bond will be mandatory redeemable upon the expiry of the conversion period. The Deposit Loan will carry a fixed interest of 12.0% annually, and will be rolled into the Convertible Bond upon completion of the Transaction no later than 15 October 2019. The Deposit loan is secured by an initial deposit payment to Shell amounting to USD 40 million. If completion of the Transaction does not occur, the Loan shall be rolled into the current NOR10 bond issue at par and be repaid together with accrued interest in cash on 31 March 2020. Noreco intends in connection with completion of the Acquisition to call NOR10 at the applicable call price (101.5% of par). The Convertible Bond, the Private Placement and the Subsequent Offering are subject to approval from the Company’s shareholders. An extraordinary general meeting of shareholders in Noreco will be called on or about 17 October 2018 (the “EGM”). Subject to completion of the Private Placement, a Subsequent Offering of around 1.8 million shares, amounting to up to USD 40 million will be made towards existing shareholders as of 16 October 2018, as registered in the VPS on 18 October 2018, who were not allocated Shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action. Such shareholders will be granted transferable preferential rights to subscribe for, and, upon subscription, be allocated new Shares. The preferential rights will be listed and tradeable on Oslo Børs. Over-subscription will be allowed. The Company's Shares will accordingly trade ex. right to participate in the Subsequent Offering as of 17 October 2018. The subscription price per Share in such Subsequent Offering will be the same as the subscription price in the Private Placement. USD 30 million of the Subsequent Offering will be underwritten by CQS, Kite Lake and Taconic (each an "Underwriter" and, together, the "Underwriters"). Each of the Underwriters have, severally, and not jointly, undertaken to subscribe for the new Shares not subscribed for during the subscription period of the Subsequent Offering. The underwriting obligation of each Underwriter does not include a guarantee for the payment by any subscriber or any other Underwriter of their subscription amount in the Subsequent Offering. The Underwriters will receive a guarantee commission of 2.0% of their guaranteed amount, subject to completion of the subsequent Offering or, as the case may be, certain other events. In connection with the transaction, Noreco will implement a new share incentive program for its key management as well as Board of Directors. Current options in the money (100,000) will be settled with cash at NOK 240 per share amounting to a total of NOK 19.8 million, while options out of the money will be cancelled (subject to option-holders’ approval). The new program consists of 1,510,000 new options. Existing management and board of directors will be allotted 715,000 options which will have a strike price of NOK 240 per share and a vesting period of three years as well as 170,000 options with a strike price determined by the VWAP 30 days after completion of the Transaction. The remaining 625,000 options will be intended for new employees and will have a strike price based on board policies. The EGM will be called on or about 17 October 2018 where the Company’s board will propose that the shareholders approve the Private Placement, the Convertible Bond, the Subsequent Offering, as well as the new share incentive program and associated authorisation to issue new Shares. The board will in addition ask for a new authorisation to issue up to 10.0% new Shares in one or several share issues. The board has obtained voting undertakings from shareholders representing 56% of the outstanding shares of Noreco, who have undertaken to vote in favour of the proposals. Completion of the proposed resolutions will be subject to completion of the Acquisition. Listing of the Shares issued in the Private Placement on Oslo Børs, and execution of the contemplated Subsequent Offering, will require a prospectus pursuant to chapter 7 of the Norwegian Securities Trading Act. It is expected that such prospectus will be published on or about the time of completion of the Acquisition, and that the Subsequent Offering will commence shortly thereafter. ABG Sundal Collier ASA, Arctic Securities AS, BMO Capital Markets Ltd. and Jefferies are engaged as financial advisors to the Company, ABG Sundal Collier ASA and Arctic Securities AS act as joint lead managers for the Private Placement, Convertible Bond, the Deposit Loan, and the Subsequent Offering. BAHR, CMS and Lundgrens act as legal advisors to the Company, PwC acts as tax advisor and Rystad Energy acts as strategic and commercial advisor. Key financials The below table outlines key financials and other selected key metrics for SOGU for the financial periods ended 31 December per respective period. Key financials for period ended 31 December 2014 2015 2016 2017USDm Audited Audited Audited Audited Sales....................................... 2,353 1,241 849 1,149EBITDAX....................................... 1,691 791 421 821Exploration -32 -18 -2 -1expenses.......................................Depreciation & -853 -1,151 -1,088 -1,009amortisation.......................................EBIT....................................... 805 -377 -669 -189Net profit....................................... 17 -272 -148 -188 Total assets 4,860 4,064 3,076 2,246Shareholder's -161 -208 466 230equity.......................................Total 5,021 4,272 2,610 2,016liabilities....................................... Production 79 71 64 67(mboepd)*.......................................* Production sourced from Danish Energy Agency Company presentation Noreco will host a company presentation in Oslo 18 October 2018 at 10:00 CET. Venue: Arctic Securities AS, Haakon Viis Gt 5, 0161 Oslo Noreco will host a company presentation in Stavanger 18 October 15:00 CET: Venue: Norsk Oljemuseum, Kjeringholmen 1 A, 4006 Stavanger Contacts: Riulf Rustad, Chair of the Board +47 900 87 703 ir@noreco.com  About SOGU’s assets Halfdan Halfdan is the largest producing field in Denmark and the most important DUC asset in terms of value and resources. The field came into production in 1999 and consists of two main groups of platforms, Halfdan A and Halfdan B in addition to an unmanned wellhead platform, Halfdan CA (North East). Produced oil is transported in pipeline to shore via Gorm while the gas is transported to the Tyra hub. Gas can also be imported (for injection) and exported to Dan. Injection water is supplied from Dan. SOGU’s share of remaining reserves is estimated to 61 MMstb oil and 163 Bscf gas as of 31.12.2017 based on independent reserves report. Halfdan produced 24 mboepd in 2017 (net to SOGU). Dan hub Dan was the first field in production in Denmark in 1972. Close to 28% of total Danish oil production has been extracted from Dan. The field remains a significant asset within the DUC portfolio. The Dan field has been developed in several phases and now consists of a total of 12 platforms. The oil production from Dan is transported to Gorm while the gas is transported to Tyra East. The Dan hub has two satellite fields, Kraka and Regnar, of which Kraka is currently producing. SOGU’s share of remaining reserves related to the Dan hub is estimated to 28 MMstb oil as of 31.12.2017 based on independent reserves report. The Dan hub produced 10 mboepd in 2017 (net to SOGU). Tyra hub The Tyra field commenced production in 1984. The field installations comprise three platform complexes, Tyra West, Tyra East and Tyra South East. Tyra is the centre for Denmark’s national energy infrastructure, processing ~90% of the nation’s gas production. The oil and condensate production from the Tyra field and its satellite fields are transported to shore via Gorm. Total, as operator is undertaking the full redevelopment of Tyra as Denmark’s major gas hub, and in the process extending the life of the Danish North Sea. The redevelopment of Tyra ensures continued production from Denmark’s largest gas field and will protect important Danish North Sea infrastructure. The Tyra redevelopment was sanctioned in 2017 and is expected to bring the hub on-stream in 2022. As part of the agreement, Noreco will assume all of Shell’s existing commitments and obligations, including the Tyra redevelopment. The Tyra hub also includes the satellite fields Valdemar, Roar, Svend (Svend is shut in), Harald and Lulita (Noreco holds a 10% working interest in producing field Lulita prior to the transaction). SOGU’s share of remaining reserves related to the Tyra hub is estimated to 35 MMstb oil and 263 Bscf gas as of 31.12.2017 based on independent reserves report. The Tyra hub produced 27 mboepd in 2017 (net to SOGU). Gorm hub Gorm production started in 1981, making it the second Danish field in production. Gorm provides processing and utilities support tosatellite fields Skjold, Rolf and Dagmar (Dagmar is shut in)in addition to being the export centre for most of the liquids produced on the Danish Continental Shelf. The oil from Gorm and the rest of the DUC portfolio is transported onhore to the Frederica refinery via pipeline. Gas from Gorm is sent to the Tyra hubfor export. SOGU’s share of remaining reserves related to the Gorm hub is estimated to 11 MMstb oil as of 31.12.2017 based on independent reserves report. The Gorm hub produced 6 mboepd in 2017 (net to SOGU). About Noreco Noreco is a publicly owned company with focus on the oil, gas and offshore industry. The company's shares are listed on the Oslo Stock Exchange (ticker NOR). For further information, please visit: www.noreco.com.This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act and section 3.4 of the Oslo Stock Exchange’s Continuing Obligations. IMPORTANT INFORMATION This release does not constitute an offer, invitation or solicitation of an offer to buy, subscribe or sell any shares in the Company. The distribution of this release in certain jurisdictions is restricted by law. This release is not for distribution or release, directly or indirectly, in or into any jurisdiction in which the distribution or release would be unlawful. Matters discussed in this release may contain certain forward-looking statements relating to the business, financial performance and results of the Company and/or the industry in which it operates, Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words “believes”, expects”, “predicts”, “intends”, “projects”, “plans”, “estimates”, “aims”, “foresees”, “anticipates”, “targets”, and similar expressions. Any forward-looking statements contained in this release, including assumptions, opinions and views of the Company or cited from third party sources are solely opinions and forecasts which are subject to risks, uncertainties and other factors that may cause actual events to differ materially from any anticipated development. Neither the Company nor any of its subsidiary undertakings or any such person’s affiliates, officers or employees provides any assurance that the assumptions underlying such forward-looking statements are free from errors, nor does any of them accept any responsibility for the future accuracy of the opinions expressed in this release or the actual occurrence of the forecasted developments. The Company assume no obligation to update any forward-looking statements or to confirm these forward-looking statements to our actual results.

Cherry acquires remaining shares in Game Lounge

Cherry currently owns 95 percent of Game Lounge, which in turn owns 100 percent of Game Lounge Ltd. Cherry has today signed an agreement to acquire the remaining 5 percent of Game Lounge. The purchase consideration consists of three parts and can amount to a maximum SEK 260 million. The first part of the purchase consideration is fixed and amounts to SEK 100 million to be paid in cash when Cherry gains control of the shares. The second part of the purchase considerations amounts to SEK 60 million and is conditional on Game Lounge’s consolidated EBITDA for the period 1 January 2019 to 30 June 2019 exceeding SEK 90 million. In the event that the target of SEK 90 million is not reached as per 30 June 2019, the measurement period will be extended until 30 September 2019, at which time, Game Lounge’s consolidated EBITDA shall amount to at least SEK 150 million. The third part of the purchase consideration amounts to SEK 100 million and requires Game Lounge’s consolidated EBITDA to exceed SEK 300 million for any consecutive four calendar quarter period between 1 July 2019 and 31 December 2021, or between 1 October 2019 and 31 December 2021 in the event that the measurement period for the second part of the purchase consideration is extended in accordance with the above. Cherry is entitled to pay all or part of the second and third parts of the purchase consideration in Class B shares in Cherry. The sellers are employees of Game Lounge. Against this background, the acquisition constitutes a so-called related-party transaction and must therefore be approved by a general meeting in Cherry. Cherry’s Board of Directors will prepare a written account of the acquisition and obtain an independent valuation statement (fairness opinion) regarding Game Lounge. The operations in Game Lounge have developed well and Cherry’s Board of Directors makes the assessment that the company will continue to enjoy favourable market conditions into the future and that it is therefore desirable to increase Cherry’s holding to 100 percent. The sellers will remain in their senior positions, are shareholders in Cherry and also participate in incentive program within the Cherry Group. Accordingly, the Board of Directors assesses that the terms of the acquisition, including the purchase consideration, are in line with the market and will therefore recommend that Cherry’s Annual General Meeting approve the acquisition in accordance with the principal terms above. For further information, please contact: Gunnar Lind, Acting President and CEO, gunnar.lind@cherry.seChristine Rankin, CFO, Tel.: +46 765 399 492, christine.rankin@cherry.seAnders Antonsson, IR & Communications: +46 709 994 970, anders.antonsson@cherry.se This information is such that Cherry AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication under the auspices of the contacts detailed above on 17 October 2018, at 3:50 p.m. CET. CHERRY IN BRIEF Cherry is an innovative and fast-growing gaming company with operations in gaming, media and entertainment.The company was founded in 1963 and today, Cherry operates through five diversified business areas: Online Gaming, Game Development, Online Marketing, Gaming Technology, and Restaurant Casino. The Group’s objective is to grow organically in combination with strategic acquisitions of fast-growing companies. Cherry employs some 1,400 people and has about 9,250 shareholders. The company’s class B share is listed on the Nasdaq Stockholm exchange, Mid Cap segment. More information is available at www.cherry.se.

Nederman acquires Luwa Air Engineering AG, a global market leader in fibre and textile air engineering

Luwa, founded in 1935, is a global market leader in textile air engineering and a quality and performance leader with a global brand in the fibre and textile industry. The Luwa Group’s activities include the design and engineering of single components and whole systems as well as manufacturing, assembly, installation and after sales services. Manufacturing and assembly facilities are situated in India and China and the group has a significant global installed base that is the source of Luwa’s deep understanding of the technical demands as well as the local requirements of customers.  The acquisition price amounts to CHF 28.5 million under a locked box mechanism, based on consolidated equity capital as of December 31, 2017.   The acquisition is funded by a combination of cash and existing bank facilities. The acquisition price will be paid in two instalments, the first instalment today on completion, and the second instalment of CHF 5.7 million two calendar years after completion. The Luwa Group, with approximately 350 employees, had a turnover in 2017 of CHF 66 million. Luwa will be part of the Nederman Mikropul organisation. The Luwa brand and team will continue to operate as before, and their high quality solutions will add to the Nederman Group’s capabilities in the strategically important global fibre and textile market. “Luwa is an excellent complimentary fit for the Nederman Group. Combining Luwa’s strong market presence, particularly in the Asia Pacific region, and their proven world leading technical capabilities and strong brand name and installed base within the strategically important fibre and textile markets, with Nederman’s global organisation and presence will make the Nederman Group a more complete partner for our customers,” says President and CEO, Sven Kristensson.   On behalf of the sellers and owners for the past 11 years, Gruenwald Equity Group, Dr Raimund Koenig, founder and managing partner says: “The perfect fit of Luwa with Nederman again shows the success of the long term strategic and operational investment approach of Gruenwald Equity in developing businesses.”  For further information,please contact:Sven Kristensson, CEO          Matthew Cusick, CFO                              Telephone: +46 42 18 87 00    Telephone +46 42 18 87 00 e-mail: e-mail: matthew.cusick@nederman.com sven.kristensson@nederman.com      This information is information that Nederman Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 04:30 p.m. CET on October 17, 2018.        Facts about NedermanThe Nederman Group is a world-leading supplier and developer of products and solutions within the environmental technology sector. We filter, clean and recycle in demanding industrial environments. Clean air is a cornerstone for sustainable production and Nederman’s products and solutions improve production efficiency, reduce environmental impact and protect employees from harmful dust, smoke and fumes. The Nederman Group is listed on Nasdaq Stockholm. The Group has 1800 employees and presence in more than 50 countries. Learn more at nedermangroup.com  Nederman Holding AB (publ), P.O. Box 602, SE-251 06 Helsingborg, Sweden. Corporate registration number: 556576-4205

QuickCool AB (publ): QuickCool calls for the Extraordinary General Meeting and Rights Issue

The Board proposes that the EGM: -               Decides to reduce the share capital of the Company with 4.224.789,60 kronor, without reducing the number of shares. Thereby, the share capital of the Company will be reduced to 12.674.368,80 kronor and the quota value of the share to 0,6 kronor. The reason for the proposal is to align the quota value to the terms and conditions of the financing agreement that was entered with European High Growth Opportunities Securitization Fund through its advisor Alpha Blue Ocean (for more information, please refer to the press release of 21 June 2018). -               Decides on a rights issue of 6.2 MSEK, comprising Units that if fully subscribed brings circa 6,2 MSEK before issuance costs. Summary: · The one who is a registered shareholder on 23 November 2018 in QuickCool has preferential rights to Units in this Rights Issue, where every existing share entitles to one (1) Unit Right (UR) and ten (10) URs entitle to subscribe to one (1) Unit at a subscription rate of 3,00 SEK per Unit. · One Unit comprises three (3) shares and one (1) warrant TO2.   · The subscription period starts on 27 November and ends on 11 December 2018. · The rights issue is guaranteed through guarantee commitments to about 50% of the rights issue, amounting to circa 3 MSEK. · The rights issue will primarily be used to improve the financial flexibility in conjunction with the production of the 0-series and the third party testing.   · The terms and conditions of the rights issue are aligned with the terms and conditions that were agreed with European High Growth Opportunities Securitization Fund.   Indicative Timeplan   +---------------+-----------------------------------------------------------+|15 November |Extraordinary General Meeting to decide on rights issue ||2018 | |+---------------+-----------------------------------------------------------+|21 November |Last day for trading of QuickCool share, including the ||2018 |preferential right to participate in the Rights Issue |+---------------+-----------------------------------------------------------+|22 November |First day for trading of QuickCool share, excluding the ||2018 |preferential right to participate in the Rights Issue |+---------------+-----------------------------------------------------------+|23 November |Day for recording the ones who are entitled to the ||2018 |preferential right to participate in the Rights Issue |+---------------+-----------------------------------------------------------+|About 23 |Memorandum is published ||November 2018 | |+---------------+-----------------------------------------------------------+|27 November – |Subscription period ||11 December | ||2018 | |+---------------+-----------------------------------------------------------+|27 November – 7|Trading period of URs on Spotlight Stock Market ||December 2018 | |+---------------+-----------------------------------------------------------+|27 November |Trading period of BTAs until the rights issue is registered||2018 (onwards) |with the Swedish Companies Registration Office |+---------------+-----------------------------------------------------------+|About 13 |Publication of final outcome in the Rights Issue ||December 2018 | |+---------------+-----------------------------------------------------------+ The Board of Directors’ proposal will be presented and decided upon at the Extraordinary General Meeting on 15 November 2018. The EGM is called for in a separate press release today. Lund, 17 October 2018QuickCool AB (publ)Board of Directors Fredrik RadencrantzCEO QuickCool AB Ideon Science ParkBeta 6, Scheelevägen 17 - SE-223 70 Lund - SwedenE-mail: fredrik.radencrantz@quickcool.se Web: www.quickcool.seMobile +46 (0)73 834 1188 This information is such that QuickCool AB is required to make public in accordance with the EU’s market abuse regulation (MAR) and the Swedish Securities Market Act. The information was made publicly available by the Company’s contact person on 17 October, 2018. Quickcool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the Quickcool SYSTEM. Quickcool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool.se

Atea reports financial results for Q3 2018

Financial highlights are as follows: ·  Revenue: NOK 7.1 billion (NOK 6.7 billion) ·  Gross profit: NOK 1.7 billion (NOK 1.6 billion) ·  EBITDA before share based compensation: NOK 249 million (NOK 272 million) ·  EBIT: NOK 132 million (NOK 176 million) Outside of Denmark, Atea reported revenue growth of 15.7% in Q3 and EBIT growth of 24.2% from last year. In Denmark, Atea reported lower revenue and a EBIT loss of DKK 39 million (NOK 50 million) in Q3, as a court conviction in June continued to negatively impact the business throughout the quarter. Furthermore, Atea incurred operating losses of NOK 8 million in a newly launched start-up venture called AppXite, which was in line with management’s expectations. Adjusted for the cost of a legal penalty in Denmark and the operating losses in the AppXite business venture, Group EBIT was NOK 144 million in Q3 2018. Approval of the self-cleaning program was delayed compared with management’s assumptions during the Q2 report and the company had higher-than-expected share based compensation costs due to a very strong appreciation in the Atea share price during Q3. “I am very pleased with Atea’s continued strong growth in revenue and operating profit in all geographies outside of Denmark,” commented Atea CEO Steinar Sønsteby. “In Denmark, we look forward to returning to normal operations and turning around the business following the acceptance of our self-cleaning program in September.” The interim report and presentation are available at https://www.atea.com/investors/financial-reports/The press conference is available via webcast at https://www.atea.com/investors/financial-reports/2018/webcast-q3-18/   The Stock Exchange Announcement is available at https://www.atea.com/about-atea/news/  For further information, please contact: Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930 55 655 Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188 About Atea Atea is the leading supplier of IT infrastructure and system integration in the Nordic and Baltic regions with 7,200 employees. Atea is present in 87 cities in Norway, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia. Atea delivers IT products from leading vendors and assists its customers with specialist competencies within IT infrastructure services. Atea had revenue of approximately NOK 32 billion in 2017 and is listed on Oslo Stock Exchange https://www.atea.com 

Tele2 AB: Interim Report Third Quarter 2018

CEO comment by Allison Kirkby“The final quarter before the closing of the merger with Com Hem was once again a quarter of solid business trends, allowing us to make another upgrade of our full-year guidance. Mobile end-user service revenue growth was 5 percent and adjusted EBITDA growth was 9 percent, like-for-like. Our investment markets continue to outperform while Sweden remained resilient, returning to mid-single digit EBITDA growth as the drag from Roam Like at Home is now behind us. Operating cash flow for continuing operations grew by 14 percent on a rolling 12-months basis.” Highlights · Revenue growth of 4 percent like-for-like, to SEK 6,538 million · Mobile end-user service revenue growth of 5 percent and adjusted EBITDA growth of 9 percent, like-for-like · Rolling 12 months operating cash flow growth of 14 percent · Sweden returns to growth of 1 percent in mobile end-user service revenue, driven by B2B, and adjusted EBITDA growth of 6 percent · Continued momentum in our investment markets with like-for-like growth in mobile end-user service revenue of 22 percent in Kazakhstan and 12 percent in Croatia  · Extraordinary General Meeting and European Commission approved Com Hem merger, with expected closing on November 5 · Earnings per share, after dilution, was SEK 1.28 · 2018 financial guidance upgraded with adjusted EBITDA between SEK 7.0 and 7.2 billion (previously between SEK 6.8 and 7.1 billion) Presentation of the third quarter 2018Tele2 will host a presentation with the possibility to join through a conference call, for the global financial community at 10:00 am CEST (09:00 am BST, 04:00 am EDT) on Thursday, October 18, 2018. The presentation will be held in English and will also be available as a webcast on Tele2’s website: www.tele2.com   Dial-in informationTo ensure that you are connected to the conference call, please dial in a few minutes before the start of the conference call to register your attendance. Ask for ‘Tele2’.Dial-in numbers:SE: +46 (0)8 5033 6574UK: +44 (0)330 336 9105US: +1 929-477-0324For more information, please contact:Joel Ibson, Head of Public Relations, Tele2 AB, Phone: +46 766 26 44 00Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07:00 CEST on October 18, 2018._________________________________________________________________________ TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across eight countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on Nasdaq Stockholm since 1996. In 2017, Tele2 generated revenue of SEK 25 billion and reported an adjusted EBITDA of SEK 6.4 billion. For definitions of measures, please see the last pages of the Annual Report 2017. Follow @Tele2group on Twitter for the latest updates.

Ericsson reports third quarter results 2018

Third quarter highlights   · Sales as reported increased YoY by 9% and sales adjusted for comparable units and currency increased by 1%. · Segment Networks showed a sales growth adjusted for comparable units and currency of 5% YoY with strong sales growth in North America as well as in Europe and Latin America. · Gross margin was 36.5% (26.9%). Gross margin excluding restructuring charges improved to 36.9% (28.5%), driven mainly by cost reductions, the continued ramp-up of Ericsson Radio System (ERS) and good progress in reviewing Managed Services contracts. · Operating margin was 6.0% (-7.4%). Operating margin excluding restructuring charges was 7.0% (-1.7%). · Networks operating margin excluding restructuring charges was 16.1% (11.9%) driven by cost reductions and ERS ramp-up, partly offset by increased investments in R&D. · Digital Services operating margin excluding restructuring charges was -15.9% (-29.9%) supported by a gross margin excluding restructuring charges of 36.9% (32.0%). Sequentially, gross margin declined from 42.6% mainly due to increased provisions related to transformation projects. · Managed Services operating margin excluding restructuring charges improved to 6.8% (-9.5%) as a result of cost reductions and customer contract reviews. · Cash flow from operating activities was SEK 2.0 (0.0) b. and free cash flow excluding M&A was SEK 0.7 (-0.8) b. Net cash increased YoY to SEK 32.0 (24.1) b. +----------------------------+------+------+------+------+------+-------+-------+|SEK b. |Q3 |Q3 |YoY |Q2 |QoQ |9 month|9 month|| |2018 |2017 |change|2018 |change|s |s 2017 || | | | | | |2018 | |+----------------------------+------+------+------+------+------+-------+-------+|Net sales |53.8 |49.4 |9% |49.8 |8% |147.0 |147.5 |+----------------------------+------+------+------+------+------+-------+-------+|Sales growth adj. for |-  |-  |1%  |-  |7%  |-  |-  ||comparable units and | | | | | | | ||currency  | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+|Gross margin |36.5% |26.9% |- |34.8% |- |35.2% |24.0% |+----------------------------+------+------+------+------+------+-------+-------+|Operating income (loss) |3.2 |-3.7 |- |0.2 |- |3.1 |-15.5 |+----------------------------+------+------+------+------+------+-------+-------+|Operating margin |6.0% |-7.4% |- |0.3% |- |2.1% |-10.5% |+----------------------------+------+------+------+------+------+-------+-------+|Net income (loss) |2.7 |-3.5 |- |-1.8 |- |0.2 |-13.9 |+----------------------------+------+------+------+------+------+-------+-------+|EPS diluted, SEK |0.83 |-1.09 |- |-0.58 |- |0.01 |-4.31 |+----------------------------+------+------+------+------+------+-------+-------+|EPS (non-IFRS), SEK [1] |1.03 |-0.29 |- |-0.09 |- |1.04 |-2.15 |+----------------------------+------+------+------+------+------+-------+-------+|Cash flow from operating |2.0 |0.0 |- |1.4 |41% |5.1 |-1.6 ||activities | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+|Free cash flow excluding M&A|0.7 |-0.8 |- |-0.2 |- |1.3 |-5.4 ||[2] | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+|Net cash, end of period |32.0 |24.1 |33% |33.1 |-3% |32.0 |24.1 |+----------------------------+------+------+------+------+------+-------+-------+|Gross margin excluding |36.9% |28.5% |-  |36.7% |-  |36.5%  |26.2%  ||restructuring charges  | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+|Operating income (loss) |3.8  |-0.8  |-  |2.0  |85%  |6.7  |-9.4  ||excluding restructuring | | | | | | | ||charges  | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+|Operating margin excluding |7.0%  |-1.7% |-  |4.1%  |-  |4.6%  |-6.4%  ||restructuring charges  | | | | | | | |+----------------------------+------+------+------+------+------+-------+-------+ [1] EPS diluted, excl. amortizations and write-downs of acquired intangible assets, and excluding restructuring charges. Potential ordinary shares are not considered when their conversion to ordinary shares would increase earnings per share. [2] Free cash flow excluding M&A: See Alternative Performance Measures (APM) at the end of the report. Non-IFRS financial measures are reconciled to the most directly reconcilable line items in the financial statements at the end of this report. Comments from Börje Ekholm, President and CEO of Ericsson (NASDAQ:ERIC) "We continue to execute on our focused strategy, tracking well towards our 2020 targets. We see improvements across our businesses resulting in a gross margin[1] of 36.9% (28.5%) and an operating margin[1] of 7.0% (-1.7%). Organic [2] sales growth was 1% for the Group, despite headwind from exited non-strategic contracts. We continue to invest in our competitive 5G-ready portfolio to enable our customers to efficiently migrate to 5G. Operators around the world plan for launching 5G services, led by North America. The strong customer interest in 5G generates a gradual increase in costs for field trials. We expect the costs to remain on high levels, at least for the coming 12-18 months, and they are included in our 2020 profitability target of at least 10%. Networks gross margin[1] improved to 41.5% (34.8%) with an organic[2] sales growth of 5%. The strong sales were mainly driven by a continued high activity level primarily in North America. Due to the strong sequential sales increase in the third quarter we expect lower effects from seasonality than normal in the fourth quarter in Networks. Digital Services gross margin[1] improved to 36.9% (32.0%) YoY, but declined QoQ. We see clear results of our cost-out activities and good progress in large parts of the business. At the same time, provisions related to large digital transformation projects increased in the quarter, explaining the sequential drop in gross margin. We are not satisfied with the development in these digital transformation projects and are thus increasing our efforts to turn them around. In Managed Services, gross margin[1] improved to 12.9% (-4.0%) supported by efficiency gains and customer contract reviews. We have finalized 40 of the targeted 42 contracts, with an annualized profit improvement of SEK 0.9 b. We are increasing our investments in R&D to reshape the offering based on automation and artificial intelligence. We see strong customer interest in the coming solutions, but sales are so far limited as we are in early stages. In segment Emerging Business and Other, sales grew by 22% driven by growth in the iconectiv business. We continue to invest in strategic future growth areas such as Internet of Things (IoT) and saw increasing momentum with one important customer win with our connectivity platform solutions in the quarter. As parts of the portfolio in Emerging Business are in an early phase, sales are so far limited. We will remain disciplined in our investments in Emerging Business by tracking each venture against delivery milestones. Even though the cost reduction program, announced in July 2017, has been completed, we continue our efforts to drive efficiency and cost reductions to further increase competitiveness. Our estimate for restructuring charges of SEK 5-7 b. for the full year remains. Free cash flow excluding M&A improved to SEK 0.7 (-0.8) b. and our cash position remains strong. Our work to further strengthen the balance sheet continues. As previously disclosed, we have been voluntarily cooperating since 2013 with an investigation by the SEC and, since 2015, with an investigation by the DOJ into Ericsson’s compliance with the U.S. FCPA. While we cannot comment in detail we can provide the following update on the process. We have identified facts that are relevant to the investigations and these facts have been shared with the authorities. We continue to cooperate with the SEC and the DOJ and are engaged in discussions with them to find a resolution. While the length of these discussions cannot be determined, based on the facts that we have shared with the authorities, we believe that the resolution of these matters will likely result in monetary and other measures, the magnitude of which cannot be estimated currently but may be material. We continue our efforts to improve on our compliance program. See further details in “Other information”. There is strong momentum in the global 5G market with lead markets moving forward. The global radio access market is recovering from several years of negative growth and our investments in R&D have positioned us well to benefit from this development. More work remains, however, to get all parts of the business to a satisfactory performance level. We remain confident in reaching our long-term target of at least 12% operating margin beyond 2020.” Börje Ekholm President and CEO [1] Excluding restructuring charges [2] Organic sales growth: Sales adjusted for comparable units and currency Planning assumptions going forward Market related                                                                                                                                 · The Radio Access Network (RAN) equipment market is estimated to decline by -2% for full-year 2018 with 2% CAGR for 2017-2022. (Source: Dell’Oro) Currency exposure                                            · Rule of thumb: A weakening by 10% of USD to SEK would have a negative impact of approximately -5% on net sales and approximately -1 percentage point on operating margin (based on 2017 full-year currency exposure). Ericsson related 2018; Sales · Sales growth in 2017 between Q3 and Q4 was 17%. · Due to strong sequential sales increase in the third quarter, lower effects from seasonality than normal are expected in the fourth quarter in Networks. Ericsson related 2018; Operating expenses · Gradually increased cost for field trials. · Operating expenses typically increase between Q3 and Q4 due to seasonality. · To further strengthen technology leadership, R&D expenses will increase primarily in Networks in Q4. · The divestment of Media Solutions is expected to be closed around year-end 2018 with estimated additional expenses of SEK -0.2 b. in Q4. Ericsson related 2018; Other · Restructuring charges for full-year 2018 are estimated to be SEK 5-7 b. · Actual and estimated net impact from amortization and capitalization of development expenses and from recognition and deferral of hardware costs: +--------+-------+--------+-------+--------------+----------------+--------+|SEK b. |Q3 2018|Q4 2018 |Q4 2017|FY 2017 Actual|FY 2018 Estimate|FY 2019 || |Actual |Estimate|Actual | | |Estimate|+--------+-------+--------+-------+--------------+----------------+--------+|Cost of |-0.2 |-0.1 |-0.8 |-2.6 |-0.7 | ||sales | | | | | | |+--------+-------+--------+-------+--------------+----------------+--------+|R&D |-0.5 |-0.5 |-0.6 |-0.3 |-1.7 | ||expenses| | | | | | |+--------+-------+--------+-------+--------------+----------------+--------+|Total |-0.7 |-0.6 |-1.4 |-2.9 |-2.4 |-1 to -2||impact | | | | | | |+--------+-------+--------+-------+--------------+----------------+--------+ NOTES TO EDITORS You find the complete report with tables in the attached PDF or by following this link https://www.ericsson.com/assets/local/investors/documents/financial-reports-and-filings/interim-reports-archive/2018/9month18-en.pdf or on www.ericsson.com/investors The company will hold a press briefing, which will also be available through a live webcast, starting at 09.00 CEST on October 18, 2018 at Ericsson Studio, Grönlandsgatan 8, Kista, Sweden.  A conference call for analysts, investors and media will begin at 14.00 (CEST). Live webcast of the briefing and conference call details, as well as supporting slides, will be available at www.ericsson.com/press and www.ericsson.com/investors  FOR FURTHER INFORMATION, PLEASE CONTACT Contact person Peter Nyquist, Head of Investor RelationsPhone: +46 10 714 64 99E-mail: peter.nyquist@ericsson.com  Additional contacts Helena Norrman, Senior Vice President, Marketing and CommunicationsPhone: +46 10 719 34 72E-mail: media.relations@ericsson.com Investors Åsa Konnbjer, Director, Investor RelationsPhone: +46 10 713 39 28E-mail: asa.konnbjer@ericsson.com Stefan Jelvin, Director, Investor RelationsPhone: +46 10 714 20 39E-mail: stefan.jelvin@ericsson.com  Rikard Tunedal, Director, Investor RelationsPhone: +46 10 714 54 00E-mail: rikard.tunedal@ericsson.com Media Ola Rembe, Vice President, Head of External CommunicationsPhone: +46 10 719 97 27E-mail: media.relations@ericsson.com  Corporate CommunicationsPhone: +46 10 719 69 92E-mail: media.relations@ericsson.com This information is information that Telefonaktiebolaget LM Ericsson is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CEST on October 18, 2018.  

Ahlsell awarded work-site logistics contract for the construction of Karlatornet in Gothenburg

Ahlsell has been awarded the work-site logistics contract for the construction of Karlatornet, the tallest building ever built in the Nordic region. Karlatornet, which is to be built in the new Karlastaden district in Gothenburg, will have 73 floors and be 245 meters high. The tower is expected to be ready for its first residents in 2021 and the new district is planned to be completed a few years later. The contract covers the full logistic solution for the project, and Ahlsell will have some 40 employees involved in the logistics throughout the project time. For Ahlsell, the project will be running at full speed from 2020 onwards, with a ramping up period throughout 2019. The customer is Serneke Bygg AB and for them, it was critical to find a business partner with competence and innovative thinking about complex logistics flows. "It’s a high construction on a very small area. Already at an early stage, we at Serneke identified the logistical challenges in the project. The logistics concept we planned for has now, with help from Ahlsell, been refined further. With their experience of complex flows and commitment to work-site logistics, it was natural to select them as partners in the project.", says Conny Segerdahl, Site manager, Karlatornet, Serneke Bygg AB. Ahlsell has a thorough experience of efficient and sustainable logistics solutions, why efficient work-site logistics has been on the agenda for a long time. For the last three years, the company has worked with an increased focus to define and market the solution. "There are studies showing that installers only work efficiently with installation 30-40% of the time. The rest of the time is spent on waiting, searching for or retrieving material. In current times of resource shortage and requirements for cost-effectiveness, there is a huge upside for customers to get the right products, to the right place at the right time.", says Fredrik Bergegård, Sales Director at Ahlsell Sverige. The service “efficient work-site logistics” only represents a small part of the Group revenues today, but the potential is significant. "We are convinced that efficient work-site logistics is the future way to build, as there are so many benefits. The customer reduces its total cost of the project while reducing the risk of project delays. It also results in a sustainable construction as fewer trucks with a higher filling degree reduces greenhouse gas emissions. Another advantage is that the workplace accidents are reduced too, as construction material is not laying around on the construction site before being used." Fredrik continues. The partners have agreed not to disclose the scope of the contract. For Ahlsell, the profitability level of the agreement is in line with the Group's. For further information please contact:    Karin Larsson, Head of Investor Relations and external communications+46 8 685 59 24, Karin.Larsson@ahlsell.se Ahlsell is the Nordic region’s leading distributor of installation products, tools and supplies for installers, construction companies, facility managers, industrial and power companies and the public sector. The unique customer offer covers more than one million individual products and solutions. The Group has a turnover of just over SEK 29 billion and is listed on Nasdaq Stockholm. About 97% of revenue is generated in the three main markets of Sweden, Norway and Finland. With about 5,800 employees, more than 230 branches and three central warehouses, we constantly fulfil our customer promise: Ahlsell makes it easier to be professional! Press ReleaseStockholm, October 18, 2018

Citycon Oyj’s Interim Report for 1 January – 30 September 2018: Solid operating performance continued and administrative expenses declined significantly.

- Occupancy remained at a high level of 96.1%.- Successful opening of newest asset Mölndal Galleria in Gothenburg Sweden.- Divestments conducted in 2017 and in 2018 as well as weaker currencies impacted net rental income and EPRA Earnings as expected.- Cost savings initiatives progressed well and administrative expenses decreased significantly by 14% year-on-year.- Fair value change of investment properties was EUR -54.2 million mainly driven by secondary assets in Finland and Norway.- Loan-to-value (LTV) increased to 48.2% as a result of fair value changes and higher outstanding debt mainly due to the acquisition of the remaining 50% share in Mölndal Galleria.- Guidance related to Direct operating profit, EPRA Earnings and EPRA Earnings per share specified JULY—SEPTEMBER 2018- Net rental income was EUR 53.6 million (Q3/2017: 58.6). Divestments decreased net rental income by EUR 5.1 million and weaker currencies by EUR 1.3 million.- EPRA Earnings was EUR 36.8 million (39.3) due to lower net rental income following disposals. Lower administrative and direct net financial expenses partly offset this reduction. EPRA Earnings per share (basic) was EUR 0.041 (0.044), negative impact from weaker currencies was EUR 0.001.- IFRS-based earnings per share was EUR -0.01 (0.01) as a result of increase in net financial expenses due to indirect one-off costs of EUR 21.5 million mainly related to the bond tender as well as impacts from divestments and currencies. Bond buy-back will reduce financing costs going forward. JANUARY—SEPTEMBER 2018- Net rental income was EUR 161.2 million (Q1-Q3/2017: 174.6). (Re)development projects and acquisition of Straedet in Denmark increased NRI by EUR 6.2 million, while property divestments decreased net rental income by EUR 14.4 million and weaker SEK and NOK by EUR 4.2 million.- EPRA Earnings was EUR 109.3 million (118.5) due to lower net rental income. Lower administrative expenses as well as direct net financial expenses partly offset this reduction. EPRA Earnings per share (basic) was EUR 0.123 (0.133), negative impact from weaker currencies was EUR 0.004.- IFRS-based earnings per share was EUR 0.01 (0.07) as a result of net fair value losses on investment properties, increase in net financial expenses and impacts from property divestments as well as currencies. KEY FIGURES +-----------+----+-------+-------+-----+-------+-------+------+----------+-------+| | |Q3/2018|Q3/2017|%1)  |Q1-Q3 |Q1-Q3 |%1) |Comparable|2017 || | | | | |/2018 |/2017 | |change | || | | | | | | | |% 3) | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|Net rental |MEUR|53.6 |58.6 |-8.6%|161.2 |174.6 |-7.7% |-5.4% |228.5 ||income | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|Direct |MEUR|47.8 |51.7 |-7.5%|143.6 |154.7 |-7.2% |-4.8% |200.5 ||operating | | | | | | | | | ||profit 2) | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|Earnings |EUR |-0.01 |0.01 |- |0.01 |0.07 |-82.7%|-81.8% |0.10 ||per | | | | | | | | | ||share | | | | | | | | | ||(basic) | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|Fair value |MEUR|4,183.4|4,184.2|0.0% |4,183.4|4,184.2|0.0% |- |4,183.4||of | | | | | | | | | ||investment | | | | | | | | | ||properties | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|Loan to |% |48.2 |47.5 |1.5% |48.2 |47.5 |1.5% |- |46.7 ||Value (LTV)| | | | | | | | | ||2) | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|EPRA based | | | | | | | | | ||key | | | | | | | | | ||figures 2) | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|EPRA |MEUR|36.8 |39.3 |-6.4%|109.3 |118.5 |-7.8% |-6.3% |152.3 ||Earnings | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|EPRA |EUR |0.041 |0.044 |-6.4%|0.123 |0.133 |-7.8% |-6.3% |0.171 ||Earnings | | | | | | | | | ||per | | | | | | | | | ||share | | | | | | | | | ||(basic) | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+|EPRA NAV |EUR |2.66 |2.78 |-4.3%|2.66 |2.78 |-4.3% |- |2.71 ||per share | | | | | | | | | |+-----------+----+-------+-------+-----+-------+-------+------+----------+-------+ 1) Change from previous year. Change-% is calculated from exact figures.2) Citycon presents alternative performance measures according to the European Securities and Markets Authority (ESMA) new guidelines.More information is presented in Basis of Preparation and Accounting Policies in the notes to the accounts.3) Change from previous year (comparable exchange rates). Change-% is calculated from exact figures. CEO MARCEL KOKKEEL:“Our strategic focus is to concentrate on multi-functional shopping centres in growing urban areas. During the third quarter, we continued to execute on our strategy and successfully opened our newest shopping centre Mölndal Galleria in greater Gothenburg in Sweden. The new centre consist of 26,000 square meters of retail, groceries, food and beverage as well as services with excellent connections to public transportation at the heart of the growing city of Mölndal. Mölndal Galleria is a true testimony to Citycon’s strategy to recycle and deploy capital to high quality irreplaceable assets in growing urban areas. We have been very pleased with how Mölndal Galleria has been received by the local community and we are confident that it will be the social and commercial hub of the surrounding community.In January-September 2018 our business developed in line with our expectations. Our operating performance remained solid, but our EPRA earnings declined to EUR 0.123 as a result of disposals and negative currency impact. However, thanks to our strict cost management measures, administrative expenses declined significantly. During the reporting period, net rental income amounted to EUR 161 million and the pro-forma like-for-like net rental income, which includes Iso Omena and Buskerud shopping centres for the April-September period, grew by 0.8%.During the third quarter, we successfully completed the re-financing of a bond expiring in 2020. In August, we issued a EUR 300 million Eurobond to institutional investors and used most of the proceeds to buy back part of a EUR 500 million bond expiring in 2020. As a result, we de-risked the re-financing of a large bond expiring in 2020, whilst the average cost of debt improved to 2.36% and the average loan maturity now clearly exceeds our target of over 5 years.In the retail industry a noticeable divergence between the best and other assets is clearly visible. We continue to see this polarization also in our asset portfolio. The performance in our prime shopping centres in major urban areas remained good during January-September 2018, while the development in secondary shopping centres, particularly in Finland, was softer. As a result, the fair value changes of our investment properties were EUR -54.2 million during January-September 2018 driven by Finland and Norway. Due to negative fair value changes and higher debt, our loan-to-value metric increased to 48.2% at the end of September. Lowering the loan-to-value remains a key priority for management. We aim to divest EUR 200-400 million of assets in the coming few years and use the proceeds to strengthen our balance sheet.With three quarters of the year now behind us and after the announced divestments, we have specified our guidance range. We now expect our EPRA EPS to be in the range of EUR 0.1575-0.1675 for the full year 2018.“ OUTLOOK 2018 SPECIFIED +-------------------------------+-----+---------------+-------------+| | | |Previously |+-------------------------------+-----+---------------+-------------+|EPRA Earnings per share (basic)|EUR |0.1575 – 0.1675|0.155 – 0.170|+-------------------------------+-----+---------------+-------------+|Direct operating profit 1) |MEUR |-14 to -5 |-14 to -1 |+-------------------------------+-----+---------------+-------------+|EPRA Earnings 1) |MEUR |-12 to -3 |-14 to -1 |+-------------------------------+-----+---------------+-------------+ 1) Change compared to the previous year These estimates are based on the existing property portfolio and on the prevailing level of inflation, the EUR–SEK and EUR–NOK exchange rates, and current interest rates. Guidance for 2018 includes around EUR -5 million impact from weaker currencies. Premises taken offline for planned or ongoing (re)development projects reduce net rental income during the year. EVENTS AFTER THE REPORTING PERIODNo material events after the reporting period. AUDIOCASTCitycon's investor, analyst and press conference call and live audiocast will be arranged on Thursday 18 October 2018 at 10 am EEST. The audiocast can be participated by calling in and followed live at: https://citycon.videosync.fi/2018-q3-interim-reportConference call numbers are:Participants from Europe +44 3333 000 804                              PIN: 20016107#Participants from the US +1 6319 131 422                                  PIN: 20016107# For more investor information, please visit the company’s website at www.citycon.com. Espoo, 17 October 2018Citycon OyjBoard of Directors For further information, please contact:Eero SihvonenExecutive VP and CFOTel. +358 50 557 9137eero.sihvonen@citycon.com Mikko PohjalaIR and Communications DirectorTel. +358 40 838 0709mikko.pohjala@citycon.com Citycon is a leading owner, manager and developer of urban, grocery-anchored shopping centres in the Nordic region, managing assets that total approximately EUR 4.5 billion. Citycon is No. 1 shopping centre owner in Finland and among the market leaders in Norway, Sweden and Estonia. Citycon has also established a foothold in Denmark.Citycon has investment-grade credit ratings from Moody's (Baa2) and Standard & Poor's (BBB). Citycon Oyj’s share is listed in Nasdaq Helsinki.www.citycon.com

SYNOSTE Ltd raises €5.1 million to launch its smart skeletal deformation correction technology

(Helsinki, October 18, 2018) – SYNOSTE Ltd, a Finnish medical device company creates smart solutions for patient-friendly bone-lengthening and bone-deformation correction. The company has raised over five million euros to start clinical investigations and to develop new clinical applications. SYNOSTE ’s patented technology platform provides the basis for further disruptive changes in the treatment of congenital, trauma- and tumour-related limb discrepancies, adult and paediatric deformities, and craniomaxillofacial deformations. The new funding was provided by Lifeline Ventures, a specialist early investor in game-changing technologies and AO Invest, an investment fund backed by the AO Foundation, the world’s largest community and network of musculoskeletal surgeons and scientists. “We are excited to gain funding from two complimentary groups – Lifeline’s forward-thinking mindset and strong entrepreneurial experience combined with AO’s expertise and access to a global network of our target surgeons will empower our development of an expanded portfolio of cutting-edge solutions and enable us to transition them into clinical practice faster”, says SYNOSTE’s Managing Director and co-founder Harri Hallila.  “SYNOSTE is exactly the type of company that interests AO Invest; they have created not just a product but a platform that will enable various intelligent solutions from traditional intramedullary nails to flat plates that can be used in the treatment of extremely painful and psychologically debilitating conditions” comments Michel Orsinger, Chairman of AO Invest. The €5.1M Lifeline and AO investment raises the total equity invested in SYNOSTE to ten million euros. SYNOSTE’s other investors include strategic and financial investors: Evonik Venture Capital, a German materials company; High-Tech Gründerfonds, Germany’s largest seed investor; Innovestor Ventures, with the largest portfolio of venture backed companies in Finland; and Mectalent, a partner company that provides SYNOSTE component manufacturing and precision mechanics. For further information about SYNOSTE, this investment, and our market opportunities, please contact Harri Hallila (hallila@synoste.com).  About AO InvestAO Invest  is a newly established investment fund focused on start-ups active in the field of musculoskeletal disorders. The fund is backed by the AO Foundation , a 60-year old non-profit organization, which boasts the world’s largest network of more than 19'000 surgeons and scientists in orthopedics and trauma. The goal of AO Invest is to invest in start-ups related to the AO Foundation's core expertise, and use the Foundation's unique reach and expertise to help their companies achieve their full potential. About Lifeline VenturesLifeline Ventures is a team of serial entrepreneurs who invest in the sectors where they have explicit and comprehensive knowledge, know how, and experiences. As start-up specialists the team at Lifeline start working with a fledgling companies before they have launched their first products. The company credo is to be “FIRST” in the heart and mind of the partnering entrepreneur to support them in both times of trouble and joy. Lifeline’s notable investments include e.g. Supercell (acquired by Softbank), Moves (acquired by Facebook), Oncos Therapeutics, ZenRobotics and Applifier (acquired by Unity). For more information, please visit http://www.lifelineventures.com

Ahlstrom-Munksjö completes the acquisition of Caieiras specialty paper mill in Brazil

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE OCTOBER 18, 2018 at 9:10 Ahlstrom-Munksjö has completed the acquisition of MD Papéis’ Caieiras specialty paper mill in Brazil for a debt free purchase price of about EUR 98 million*. The acquisition significantly strengthens Ahlstrom-Munksjö’s offering in South America and provides further growth opportunities. The acquired business had net sales of about EUR 76 million and comparable EBITDA of EUR 12 million in 2017. Annual synergy benefits of up to EUR 6 million are estimated, mainly arising from optimization of overlapping businesses. The agreement was announced on April 24, 2018. The Caieiras product offering is an excellent match for Ahlstrom-Munksjö with 80% of sales being in line with the company’s current portfolio. The plant gives access to local production of decor paper, thus strengthening Ahlstrom-Munksjö’s offering and partnership with existing customers, who have so far relied on imports. Ahlstrom-Munksjö is already a global leader in tape materials, serving both local and global customers and this position is further strengthened through the acquisition. In addition, production and delivery capabilities as well as competitiveness are improved by combining Caieiras with the company’s operation in nearby Jacarei. Daniele Borlatto, EVP of Industrial Solutions Business Area, comments: “The Caieiras business is an excellent addition to our global platform, and drives our ambition to maintain a leading position in selected niches of the global fiber-based solutions market that offers growth. Our existing as well as new specialty paper customers will benefit from a stronger offering coupled with our well-established excellent customer service. This transaction is another significant milestone in the execution of our strategy. I welcome the Caieiras employees to Ahlstrom-Munksjö.”Ahlstrom-Munksjö operates three plants near Sao Paolo, employing over 700 people with revenues of approximately of EUR 200 million following the acquisition. *Assuming EUR/BRL exchange rate of 1 to 4.32 For further information, please contact:

NeuroVive presents first preclinical NV354 efficacy results in a model for mitochondrial disease

The presentation at the CSHL Meeting on October 19 will include in vivo efficacy data from an advanced experimental model for acute energy crisis involving complex I dysfunction. The initial results show that NV354 restores tissue succinate levels and reduces lactate levels. Further NV354 efficacy studies are ongoing using both short- and long-term treatment regimens. A parallel evaluation of NV354 drug properties in a separate set of experiments demonstrated high oral bioavailability and efficient brain delivery. Based on these data, NeuroVive will broaden the further preclinical development of NV354 as a chronic therapy for conditions associated with genetic mitochondrial disease, in addition to a therapy for acute energy crisis. The focus on severe pediatric conditions, such as Leigh syndrome, involving dysfunction of mitochondrial respiratory complex I, will continue.  “This is indeed very promising first efficacy data in a model highly relevant to patients with mitochondrial disease. We expect additional ongoing efficacy studies to provide further guidance for future clinical development, including the extensive studies planned at the Children’s Hospital of Philadelphia,” said Magnus Hansson, NeuroVive’s Chief Medical Officer and Vice President Preclinical and Clinical Development. “The most exciting finding from the ongoing studies is that through its drug properties, NV354 demonstrates potential to treat not only acute, but also chronic conditions in patients with mitochondrial disease, which expands therapeutic opportunities as well as commercial potential,” said NeuroVive’s CEO Erik Kinnman. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CEST on 18 October 2018 For more information please contact:Catharina Johansson, CFO, IR & Communications+46 (0)46-275 62 21, ir@neurovive.com NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard)info@neurovive.com, www.neurovive.comFor news subscription, please visit http://www.neurovive.com/press-releases/subscription-page/   About NV354One of the most common causes of mitochondrial diseases relates to Complex I dysfunction, i.e. when energy conversion in the first of the five protein complexes in the mitochondrion that are essential for effective energy conversion does not function normally. This is apparent in disorders including Leigh syndrome and MELAS, both of which are very serious diseases with symptoms such as muscle weakness, epileptic fits and other severe neurological manifestations. The NVP015 project is based on a NeuroVive innovation in which the body’s own energy substrate, succinate, is made available in the cell via a prodrug technology. A prodrug is an inactive drug that is activated first when it enters the body by the transformation of its chemical structure. Within the project a lead compound, NV354, has been selected for further development in the program based on tolerability, oral bioavailability, plasma stability and organ delivery, specifically to the brain. In 2017 NeuroVive received a research grant from the Swedish innovation agency, Vinnova, for developing the succinate prodrugs as a new treatment for genetic mitochondrial diseases. About genetic mitochondrial diseasesGenetic mitochondrial diseases are metabolic diseases that affect the ability of cells to convert energy. The disorders can manifest differently depending on the organs affected by the genetic defects and are viewed as syndromes. An estimated 12 in every 100,000 people suffer from a mitochondrial disease. Mitochondrial diseases often present in early childhood and lead to severe symptoms, such as mental retardation, heart failure and rhythm disturbances, dementia, movement disorders, stroke-like episodes, deafness, blindness, droopy eyelids, limited mobility of the eyes, vomiting and seizures. About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio also consists of projects for genetic mitochondrial disorders, cancer and NASH. The company advances drugs for rare diseases through clinical development into the market. For projects for common indications the goal is out-licensing in the preclinical phase. A subset of compounds under NeuroVive’s NVP015 program has been licenced to Fortify Therapeutics, a BridgeBio company, for local treatment development of Leber’s Hereditary Optic Neuropathy (LHON). NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF). 

Enea Wins Layer123 Network Transformation Award

STOCKHOLM, Sweden, Oct. 18, 2018 – Enea® (NASDAQ Stockholm: ENEA), a global supplier of network software platforms and world class services, today announced that Enea® NFV Access won the prestigious Layer123  Network Transformation Award (NetTA) as the Best NFVi Platform 2018. Enea NFV Access features a lightweight virtualization software runtime platform - without the need for OpenStack - designed for deployment on edge devices at the customer premise. It is streamlined for high networking performance with minimal RAM footprint for both platforms and VNFs. Enea NFV Access provides a foundation for uCPE and SD-WAN agility, reducing cost and complexity for computing at the network edge. "We saw at an early stage that the network edge offered challenges in terms of cost-effectiveness combined with high performance", said Karl Mörner, SVP R&D and Product Management at Enea's NFV Business Unit. "These are problems that Enea has traditionally been really good at solving. Thanks to our experience in providing operating systems for the most demanding environments, we were able to develop Enea NFV Access – a lightweight, high-performance, virtualization software platform for uCPE and SD-WAN use cases." The award was presented on October 10th at the SDN NFV World Congress, one of the largest events in the carrier network transformation industry with more than 2000 executives and decision makers. Awards are judged independently by a panel of leading analysts invited from SDN NFV Congress Analyst Partners. All submissions are assessed against published criteria and graded using a weighted points system to ensure consistency, depth of analysis and rigor. A random matrix process is used to ensure a credible, fair and unbiased assessment of all submissions. For more information, please visit https://www.enea.com/enea-nfv-access Additional Resources NFV Access Datasheet https://www.enea.com/globalassets/downloads/nfvi-platforms/enea-nfv-access/enea-nfv-access-datasheet.pdf Evaluation Request for NFV Access https://www.enea.com/products/nfv-virtualization-platforms/enea-nfv-access/eval-request-enea-nfv-access/ Media Contact Erik Larsson, SVP Marketing & Communication, Enea Phone: +33 1 70 81 19 00 E-mail: erik.larsson@enea.com About NetTA – Network Transformation Awards  Network Transformation Awards recognize achievement in advancing the industry, celebrate innovation founded on SDN and NFV, and inspire determination for future progress. Network Transformation Awards, part of this year's SDN NFV World Congress, highlight the industry's most innovative people and companies by recognizing their most significant achievements in accelerating Network Transformation over the last 12 months. NetTA shortlist and winners are selected using a transparent and robust process, and judged independently by a panel of leading analysts invited from SDN NFV Congress Analyst Partners. NetTA Winners can be confident in receiving an authentic Award that highlights their leadership and achievement, and gives credit to themselves, their work and their company. For more information: https://www.layer123.com/awards About Enea Enea develops the software foundation for the connected society. We provide solutions for mobile traffic optimization, subscriber data management, network virtualization, traffic classification, embedded operating systems, and professional services. Solution vendors, systems integrators, and service providers use Enea to create new world-leading networking products and services. More than 3 billion people around the globe already rely on Enea technologies in their daily lives. Enea is listed on Nasdaq Stockholm. For more information: www.enea.com  Enea®, Enea OSE®, Netbricks®, Polyhedra®, and Enea® Element are registered trademarks of Enea AB and its subsidiaries. Enea OSE®ck, Polyhedra® Lite, Enea® ElementCenter, Enea® On-device Management, Enea® NFV Core, and Enea® NFV Access are unregistered trademarks of Enea AB or its subsidiaries. Any other company, product or service names mentioned above are the registered or unregistered trademarks of their respective owner. All rights reserved. © Enea AB 2018.  

Getinge publishes Interim Report for January-September 2018

Getinge’s growth is continuing at a high pace – net sales for the quarter increased by close to 15%, almost half of which was organic growth. The order intake increased by slightly more than 8%, of which just under 1% was organic.This was in line with expectations due to a strong third quarter in 2017. Market and product mix effects in the form of robust growth in capital goods and in emerging markets are continuing to have an adverse effect on the gross margin. As stated earlier, these effects were foreseen and are natural in a phase of growth, and they are expected to support future sales of consumables linked to the use of our capital goods. In addition, the gross margin was negatively impacted by Getinge actively securing a number of large business opportunities in emerging markets at lower margins. Cash flow improved significantly, as a result of more efficient management of our working capital. The operating profit for the quarter was strongly negatively affected by a provision of SEK 1.8 billion, intended to cover future costs for claims related to hernia mesh products in North America, which we communicated on October 14. On October 18, 2018, an agreement to divest the surgical mesh business was signed. The biosurgery business has been a relatively small segment within Getinge’s overall portfolio and the only therapeutic asset in the general surgery field. The divestment is a strategic desicion in order to focus on core therapeutic solutions. The deal is expected to close in the fourth quarter of this year subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions.    July – September 2018 in brief ·  Order intake rose organically by 0.9% and net sales increased organically by 7.2% primarily due to the continued favorable trend in capital goods and in emerging markets.   ·  Adjusted EBITA amounted to SEK 438 M (544), negatively affected by a lower gross margin due to the product and market mix.   ·  Currency effects had an impact of SEK +383 M on net sales, SEK +129 M on gross profit and SEK -24 M on EBITA. ·  Adjusted earnings per share amounted to SEK 0.78 (1.20). ·  A provision of SEK 1.8 B was made to cover costs related to lawsuits in North America related to surgical mesh implants. The provision is recognized as items affecting comparability in operating profit. ·  The TSO3 distribution agreement for low temperature sterilization ended, resulting in an item affecting comparability of SEK -126 M in operating profit. ·  Cash flow after net investments amounted to SEK 801 M (182). Conference callA conference call will be held on October 18 at 3:00 – 4:00 p.m. CEST hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO. Please find dial in details to join the conference call here . Media contact:Jeanette Hedén Carlsson, Executive Vice President Communications & Brand ManagementPhone: +46 (0)10 335 1003Email: Jeanette.hedencarlsson@getinge.com Lars Mattsson, Head of Investor RelationsPhone: +46 (0)10 335 0043E-mail: lars.mattsson@getinge.comThis information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on October 18, 2018, at 13:00 CEST. 

Qliro Group sets new financial targets

“Qliro Group has for some time been operating the three subsidiaries as independent units. CDON Marketplace is focusing on external merchants and is phasing out sales from own inventory, mainly consumer electronics with low margin. Qliro Financial Services focuses on attracting new external merchants and utilizing economies of scale. Nelly will benefit from its strong brand and digital marketing to boost its profitable growth in the Nordic,” says Marcus Lindqvist, CEO and President of Qliro Group. Qliro Financial Services focuses on e-commerce volumes and loan book growthQliro Financial Services strategy is to offer an attractive payment solution to merchants and to take advantage of the volumes to offer digital financial services to consumers. Since its inception, the company has built its offering of financial services and will focus on leveraging economies of scale and capitalizing on existing service offerings.   To strengthen its position as an independent company, Qliro Financial Services is increasing its commercial initiatives and recruiting personnel working with attracting and integrating new merchants. The financial development is dependent on the transaction volumes and the recruitment of new external merchants. During 2019 volumes will be negatively affected by the fact that CDON Marketplace is phasing out sales from own inventory as a part of its transformation to a marketplace. Qliro Financial Services new financial target: · Achieve an operating income before depreciation and amortization of SEK 100 – 125 million in 2019 Qliro Financial Services previous long-term financial targets was to achieve an operating income before depreciation and amortization of at least SEK 150 million in 2019. CDON Marketplace focuses on growing with external merchantsCDON Marketplace strategy is to be the leading marketplace in the Nordic region for external merchants. To strengthen its position as an independent company, CDON Marketplace accelerates its transformation by focusing on external merchants while phasing out sales from own inventory, especially within consumer electronics, a segment with low margin. This provides the right long-term conditions for a strong market position and profitable growth. We estimate that operating income before depreciation and amortization will be positive for the full year 2019.  CDON Marketplace new financial targets:  · Achieve a growth rate in external gross merchandize value of above 20 percent per year   · Achieve an operating margin before depreciation and amortization above 3 percent of net sales per year  CDON Marketplace previous long-term financial targets was to attain a level of organic growth in total gross merchandise value of an average of 10 per cent per year (that is, external and own sales) and generate operating income before depreciation and amortization of 1– 2 percent of gross merchandise value (that is, not ordinary operating margin before depreciation, amortization and impairment). Nelly focuses on its own brandsNelly’s strategy is to develop its position as a leader in online fashion for young people in the Nordic region. At its core is its own brands, complemented by a well-curated portfolio of approximately 200 external brands. The company benefits from its strong own brand and digital marketing. An important driver is that a growing proportion of sales comes from clothing and accessory of Nelly’s own design. Based on its strong market position, Nelly’s target for growth is now raised with an unchanged target for operating margin. Nelly’s new financial targets:   · Achieve an organic growth in net sales above 10 percent per year · Achieve an operating margin before depreciation and amortization above 6 percent per year Nelly’s previous long-term financial targets was to attain a level of organic growth of an average of 8 per cent per year and generate an operating margin before depreciation and amortization of at least 6 percent. Qliro Group publishes its interim report for January-September 2018 on Friday, October 19 at 8:00 am. A telephone conference will be held at 10:00 am the same day. The conference call will also be available at www.qlirogroup.com.  This information is information that Qliro Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication by the contact person below for publication on October 18, 2018, at 7.15 pm. For more information, please visit www.qlirogroup.com or contact:Niklas Alm, telephone: +46 70 824 40 88, ir@qlirogroup.com  About Qliro Group Qliro Group is a leading Nordic e-commerce group in consumer goods and related financial services. Qliro Group operates CDON.COM, the leading Nordic online marketplace, the fashion brand Nelly.com and Qliro Financial Services, offering financial services to merchants and consumers. In 2017 the Group had sales of SEK 3.4 billion. Qliro Group’s shares are listed on the Nasdaq Stockholm MidCap segment under the ticker symbol QLRO.

Saab Receives Order from Boeing for the Advanced Pilot Training Aircraft T-X

Saab and Boeing were selected by the U.S. Air Force on 27 September for the T-X programme, a new era in Saab and Boeing’s partnership going forward.    The T-X programme is divided into multiple phases. This order concerns the first phase, EMD, in which Saab and Boeing industrialise the T-X aircraft together with the customer. EMD includes testing, U.S. military flight certification and delivery of five jets. The EMD phase will be followed by a serial production phase.   “This order is an exciting step towards a whole new era when it comes to trainer jets. It lays the foundation for our joint work for many years to come. We look forward to taking these next steps together with Boeing,” says Håkan Buskhe, President and CEO of Saab. Saab and Boeing have developed the T-X aircraft together. Saab is a risk-sharing partner with Boeing in the development. Boeing is the designated prime contractor for the advanced pilot training system acquisition by the U.S. Air Force. For more information on the T-X aircraft, please visit: https://saab.com/tx https://mediaportal.saabgroup.com/ For further information, please contact: Saab Press Centre Ann Wolgers, Press Officer +46 (0)734 180 018 presscentre@saabgroup.com www.saabgroup.com www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Telia Company Interim report January-September 2018

BETTER EARNINGS MOMENTUM     Third quarter summary · Net sales in local currencies, excluding acquisitions and disposals rose 0.1 percent. In reported currency, net sales rose 5.5 percent to SEK 20,685 million (19,614). Service revenues in local currencies, excluding acquisitions and disposals, declined 1.9 percent. · Adjusted EBITDA rose 1.8 percent in local currencies, excluding acquisitions and disposals. In reported currency, adjusted EBITDA rose 6.4 percent to SEK 6,977 million (6,556). The adjusted EBITDA margin rose to 33.7 percent (33.4). · Adjusted operating income rose 5.3 percent to SEK 3,964 million (3,763). · Total net income amounted to SEK 3,026 million (2,585). Total net income attributable to the owners of the parent was SEK 2,825 million (2,310). · Free cash flow from continuing and discontinued operations was SEK 2,963 million (-1,281). Comparable figures were impacted by the payment related to the settlement regarding the Uzbekistan investigations. Operational free cash flow from continuing operations was SEK 2,569 million (2,808). · The acquisition of Get and TDC Norway was completed on October 15. · Outlook for adjusted EBITDA 2018 is revised up. Nine months summary · Net sales in local currencies, excluding acquisitions and disposals increased 0.5 percent. In reported currency, net sales increased 4.6 percent to SEK 61,351 million (58,627). · Adjusted operating income rose 0.5 percent to SEK 11,153 million (11,102). · Total net income amounted to SEK 4,670 million (9,438). Total net income attributable to the owners of the parent declined to SEK 4,275 million (8,913). · Operational free cash flow from continuing operations was SEK 9,399 million (8,883). Comments by Johan Dennelind, President & CEO    “Dear shareholders and Telia followers, the third quarter of 2018 gives us further comfort as our focus and dedication to deliver on our cost agenda and operational free cash flow ambition for the year is paying off. We are clearly on track to deliver the net cost reduction of SEK 1.1 billion that we have set out as a priority for the year. Our operational free cash flow continues to be strong, having generated SEK 10.2 billion over the last 12 months. Our adjusted EBITDA is growing in six out of seven countries, with Finland, Norway as well as our central units being the main drivers. The performance is a combination of strong execution of the cost ambition as well as delivering synergies and stronger propositions to customers from the acquisitions we have done in recent years.     In early October we obtained the approval on our acquisition of TDC Norway and Get. The transaction closed October 15, and I would like to take the opportunity to give a warm welcome to all the customers and staff to the Telia Company family. Together we create a strong convergent operator with a lot of attractive new products and services for both our consumer and enterprise customers. Regarding the Bonnier Broadcasting transaction, we are in dialogue with the EU Commission and aim to complete the merger filings around the end of the first quarter next year. The closing is therefore still expected for the second half of 2019.    Sweden had, as expected, a slower EBITDA quarter compared to previous quarters, partly explained by expected tougher comparisons, but also due to costs related to thunderstorms and negative currency effects. Even though we have reduced costs year-to-date in Sweden under the cost program, we are still not happy with the pace of the turn-around. We know there is clear large potential for improvements over the years to come. The new CEO in Sweden Anders Olsson has taken substantial steps in building a stronger commercial roadmap and improving the efficiency. Part of this will be executed already from January 1, as we go live with our updated operating model. Initially the new model will be implemented between our new unit Common Products and Services (under the Group COO Magnus Zetterberg) and Sweden. The new model includes Sweden's IT and product platforms and around 500 employees being moved into Common Products and Services. The other countries will follow at a later stage, adding further structural efficiencies. Since the transformation is delayed and the real significant benefits are to come in 2020 rather than as expected in 2019, part of the turn-around in Sweden is to tighten the execution of the transformation and also to improve cost efficiency in other areas.    In Finland we reported a mobile B2B growth of 7 percent adding some large wins in the quarter. Our position in this segment has been strengthened during recent years through acquisitions and it is very satisfying that we continue to deliver value from the acquisitions that we have made. Equally satisfying is that the Telia Helsinki Data Center has come out flying from the starting blocks having signed an important agreement with Nokia almost immediately after launch. The Finnish ice hockey league started its season in September. We have had a good start and see the asset as a key differentiator in the market. We see a clear opportunity to further capitalize on these rights.    Our team in Norway has shown excellent execution of the Phonero acquisition and at the same time shown cost control in a flattish market, which resulted in strong EBITDA growth. Our Baltic operations continue with their strong performance.    During the quarter we have launched a pre-commercial 5G network in the city center of Helsinki. Full scale commercial operations will be available in 2019 when we can utilize the spectrum acquired in the recent 3.5 GHz auction. This is in line with our 5G strategy to be early out in understanding what 5G will bring in terms of potential for our customers. We reiterate that 5G related investments will be limited before 2020 and thereafter gradually replace current 4G related investments.    Sustainability is key for our strategy and value creation. We strive to be a transparent, trusted partner for all our stakeholders. To further increase our transparency, we are now publishing the sustainability highlights alongside the quarterly financial reports. Log on to our website and read about Telia Company’s new human rights policy, our work with children’s rights and how we, so far, have engaged half of our employees to volunteer on various projects where digitalization is used to improve lives in our society.    Today our shares will open trading excluding the second part of the 2017 dividend of SEK 1.15, to be distributed in a few days. As of last week, we have bought back shares for SEK 2.7 billion under our current buy-back program. We remain committed to our capital allocation ambitions and balance sheet targets.    No doubt comparisons will continue to be tough in the fourth quarter, especially in Sweden. Still, given the performance so far, with adjusted EBITDA having grown by 4 percent excluding currency effects, we up our full year EBITDA guidance from “in line or slightly above the 2017 level” to “slightly above the 2017 level”. The outlook for operational free cash flow being above SEK 9.7 billion is left unchanged. Finally, I want to thank my team for a solid delivery in the quarter.”    Johan Dennelind, President and CEO       This information is information that Telia Company AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.00 CET on October 19, 2018.      For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany  .       Forward-Looking StatementsStatements made in the press release relating to future status or circumstances, including future performance and other trend projections are forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Telia Company.       We’re Telia Company, the New Generation Telco. Our approximately 20,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com

Volvo Group – the third quarter 2018

· In Q3 2018 net sales increased by 21% to SEK 92.3 billion (76.4). Adjusted for currency movements and acquired and divested units sales increased by 13%. · The adjusted operating income amounted to SEK 10,247 M (6,937), corresponding to an adjusted operating margin of 11.1% (9.1). · Reported operating income amounted to SEK 10,247 M (7,337). · Currency movements had a positive impact on operating income of SEK 423 M. · Diluted earnings per share amounted to SEK 3.67 (2.66). · Operating cash flow in the Industrial Operations amounted to SEK 1.3 billion (0.6). October 19, 2018 Press and Analyst Conference. An on-line presentation of the report, followed by a question-and-answer session will be webcast starting at 09.00 CET. More information under Investors on www.volvogroup.com Aktiebolaget Contact Media Relations: Volvo (publ) 556012-5790           Investor Claes Eliasson +46 765 53 72 29Relations, VHQ  SE-405 08 Göteborg,SwedenTel +46 31 66 00 00 Contacts Investor Relations: www.volvogroup.com Christer Johansson +46 31 66 13 34  Johan Bartler +46 739 02 21 93 Anders Christensson +46 31 66 11 91  This information is information that AB Volvo (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 7.20 CEST on October 19, 2018. For more information, please visit volvogroup.com/press   The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs almost 100,000 people, has production facilities in 18 countries and sells its products in more than 190 markets. In 2017 the Volvo Group’s sales amounted to about SEK 335 billion (EUR 35 billion). The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden. Volvo shares are listed on Nasdaq Stockholm.

Strong organic sales growth

Third quarter · Net sales increased by 15% to SEK 21,191 M (18,499), with organic growth of 5% (3) and acquired net growth of 2% (2) · Strong sales growth in Global Technologies and Americas and good growth in Entrance Systems. Sales in EMEA and Asia Pacific were stable · Three acquisitions have been signed with combined expected annual sales of about SEK 1,200 M · Operating income (EBIT)amounted to SEK 3,424 M (3,080), with an operating margin of 16.2% (16.7) · Net income amounted to SEK 2,384 M (2,153) · Earnings per share amounted to SEK 2.15 (1.94) · Operating cash flow increased by 13% to SEK 3,004 M (2,654). Sales and income +----------------------------------+------+------++---++------+----------+--+| |Third quarter|| ||January-September| |+----------------------------------+------+------++---++------+----------+--+| | 2017| 2018|| Δ|| 2017| 2018| Δ|+----------------------------------+------+------++---++------+----------+--+|Sales, SEK M |18,499|21,191||15%||56,028| 60,881|9%|+----------------------------------+------+------++---++------+----------+--+|Of which: | | || || | | |+----------------------------------+------+------++---++------+----------+--+|Organic growth | 590| 960|| 5%|| 1,956| 2,620|5%|+----------------------------------+------+------++---++------+----------+--+|Acquisitions and divestments | 373| 446|| 2%|| 1,273| 1,079|2%|+----------------------------------+------+------++---++------+----------+--+|Exchange-rate effects | –488| 1,286|| 8%|| 990| 1,154|2%|+----------------------------------+------+------++---++------+----------+--+|Operating income (EBIT) [1], SEK M| 3,080| 3,424||11%|| 8,982| 9,164|2%|+----------------------------------+------+------++---++------+----------+--+|Operating margin (EBITA) [1], % | 16.9%| 16.6%|| || 16.3%| 15.5%| |+----------------------------------+------+------++---++------+----------+--+|Operating margin (EBIT) [1], % | 16.7%| 16.2%|| || 16.0%| 15.1%| |+----------------------------------+------+------++---++------+----------+--+|Income before tax [1], SEK M | 2,910| 3,221||11%|| 8,447| 8,595|2%|+----------------------------------+------+------++---++------+----------+--+|Net income [1], SEK M | 2,153| 2,384||11%|| 6,250| 6,396|2%|+----------------------------------+------+------++---++------+----------+--+|Operating cash flow, SEK M | 2,654| 3,004||13%|| 6,053| 6,435|6%|+----------------------------------+------+------++---++------+----------+--+|Earnings per share [1], SEK | 1.94| 2.15||11%|| 5.63| 5.76  |2%|+----------------------------------+------+------++---++------+----------+--+ [1]Excluding impairment of goodwill and other intangible assets of SEK -5,595 M in the second quarter of 2018. The effect on net income from the impairment of intangible assets was SEK –5,268 M. Comments by the President and CEOStrong organic sales growth in the quarterThe third quarter continued with strong organic growth of 5%. Organic growth was very strong in Global Technologies (12%) and Americas (10%) and continued to be good in Entrance Systems (4%), while EMEA and Asia Pacific reported stable organic sales growth of 2% and 1% respectively. Accelerated growth in Global Technologies and continued strong growth in AmericasThe demand for our products continued to grow at a good level in most of our markets during the third quarter and in the Global Technologies and Americas divisions in particular. Following a strong start to the year for Global Technologies, the growth accelerated during the third quarter. During the last five years ASSA ABLOY Hospitality’s performance has been very impressive, with innovative new solutions, combined with a solid financial development. The business has expanded from offering solutions for hotels and marine cruise ships into solutions for other verticals such as elderly care, student accommodation and logistics. As a result of this transformation, the Hospitality organization will now evolve under a new name, ASSA ABLOY Global Solutions, where we will develop the existing business and look for new opportunities to build global solutions for our customers. HID Global is also developing positively. Two years ago ASSA ABLOY set a target to double HID’s revenue in five years’ time through organic sales and acquisitions. With the recent announcement of the acquisition of Crossmatch, we are on track to reach this target. Crossmatch allows us to offer biometric identity in critical applications and complements our total offering. In Americas the growth was mainly driven by the development in the US. It is very encouraging that both the commercial and residential markets grew well during the quarter. In both segments our electromechanical products are market leaders and we note a strong demand for our innovative new solutions. Strong operating income and cash flowThe third quarter’s operating income improved strongly by 11% year-on-year to SEK 3,424 M, corresponding to an operating margin of 16.2%. Due to higher raw material costs and negative currency effects the margin declined compared to last year, but we continue to work hard on further offsetting these material price increases. Operating cash flow was strong in the third quarter and increased by 13% to SEK 3,004 M. New CFO appointedLast but not least, we have recently announced that Erik Pieder has been appointed as Chief Financial Officer. He will join ASSA ABLOY in January 2019.I would like to thank Carolina Dybeck Happe for her invaluable contribution to ASSA ABLOY over the last 16 years and wish her great success in her new position. Stockholm, 19 October 2018 Nico DelvauxPresident and CEO Further information can be obtained from:Nico Delvaux,President and CEO, Tel: +46 8 506 485 82 Carolina Dybeck Happe,Chief Financial Officer, Tel: +46 8 506 485 72 ASSA ABLOY is holding a telephone and web conference at 10.00 today which can be followed on the Internet at www.assaabloy.com.It is possible to submit questions by telephone on:+46 8–566 193 53, +44 203 008 9806 or +1 855 831 5945 This information is information that ASSA ABLOY AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on 19 October 2018.

Interim report January – September 2018

Kai Wärn, President and CEO:“The third quarter was largely characterized by a continuation of the warm and dry weather in central and northern Europe, that had a subdued effect on demand for lawn mowing products and services, while demand for watering products was positively affected. This was reflected in the decrease of net sales adjusted for changes in exchange rates in Husqvarna Division by 5% and the increase by 23% in Gardena Division. Net sales for the total Group increased 1% adjusted for changes in exchange rates. Operating income for the Group, excluding items affecting comparability* referring to restructuring related costs, declined to SEK 225m (433). The lower income was affected by low demand for higher margin lawn mowing products and parts in the Husqvarna Division. Gardena benefitted from the warm and dry European weather that helped to prolong the season for watering products. Consumer Brands reported a slightly lower operating income affected by challenging raw material prices related to tariffs. Operating income for Construction was higher, however adjusted for prior year’s integration costs the operating income was unchanged. As previously announced, we are now taking firm actions to address the underperforming Consumer Brands Division by exiting certain low-margin petrol-powered products mainly in North America and adjusting manufacturing capacity and central resources to reflect the less complex and more focused Group. The measures are expected to be accretive to the Group´s financial performance already from next year. The actions will also release resources and energy that can be focused on building on our strengths in premium offerings under the core brands of Husqvarna and Gardena in areas such as robotic lawnmowers, digitization and technology for battery powered products. Following several years of strong financial improvements, 2018 will deviate from that trend. Hence, the highest priority for 2019 is to restore the improvement momentum. Key deliverables to accomplish this include realizing price increases, restoring the balance between the efficiency programs and costs for profitable growth activities and delivering the savings of the restructuring of Consumer Brands Division. A successful execution of these deliverables form the base to achieve the 10% operating margin target in 2019.” Third quarter 2018 · Net sales increased to SEK 8,042m (7,449), corresponding to a currency adjusted* increase of 1%. · Group operating income, excluding items affecting comparability* of SEK -349m referring to restructuring, decreased to SEK 225m (433). · Operating cash flow* declined to SEK 628m (1,132). · Restructuring measures related to Consumer Brands Division being executed (see page 5). Telephone conferenceA combined press and telephone conference, hosted by Kai Wärn, President and CEO, and Jan Ytterberg, CFO, will be held at Husqvarna Group’s office, Regeringsgatan 28, Stockholm at 10:00 CET on October 19, 2018. To participate, please dial +46 (0) 8 566 184 30 (Sweden) or +44 (0) 8 448 228 902 (UK) ten minutes prior to the start of the conference. Conference ID: Husqvarna or 1693525. The conference call will also be audio cast live on www.husqvarnagroup.com/ir . A replay will be available later the same day.

Smooth sailing for Stena Line's battery hybrid vessel

“It's really exciting to be running with electrical power on the Stena Jutlandica. This project is an important part of our focused efforts to find ways of reducing our impact on the environment. As both the size and cost of batteries decrease, battery operation is becoming a very attractive alternative to traditional fuel for shipping since emissions should be possible to completely eliminate in the future,” says Erik Lewenhaupt, Head of Sustainability at Stena Line. The project to convert Stena Jutlandica on the Gothenburg-Frederikshavn route to a battery hybrid vessel is being carried out in steps. Step one, which is presently underway, is about switching to electrical operation to reduce the use of diesel generators, as well as for maneuvering and powering the bow thrusters when the ship is in port. In the second step, battery power will be connected to two of the four primary machines, which means that the Stena Jutlandica will be able to run on electrical power for about 10 nautical miles inside the Gothenburg archipelago out to Vinga Lighthouse. In step three, all four primary machines will be connected to the batteries and the ship will be able to cover the 50 nautical miles between Sweden and Denmark solely on electrical power. Positive effects have already been noted after just one month. “As an example, we've been able to strongly reduce our use of the diesel generators and now only need to use one instead of three. Another positive effect concerns safety; by having constant access to electricity, we minimize the risk for power outages”, says Johan Stranne, Senior Chief Engineer on the Stena Jutlandica. Only in step one, the environmental savings from using battery power for reduced generator usage and maneuvering in port amounts to about 500 tons of fuel, 1,500 tons of CO2. This in turn corresponds to the annual emissions from approximately 600 cars. The reason for execution in multiple steps is to enable testing and assessment while the project is underway. If the project is successful, battery power can be considered for other vessels within the Stena Line fleet. Work with step two has begun and the goal is for implementation within about three years. The technical solutions in the first step have been developed by Stena Teknik in collaboration with the Callenberg Technology Group, with half of the funding for the project coming from the Swedish Transport Administration and the EU.

Lehto Group Plc: Lehto declines its financial outlook for the year 2018

Updated outlook 19 October 2018: Lehto estimates that the Group’s net sales for 2018 will grow by about 20-25% from 2017 (EUR 597.6 million in 2017) and operating profit is expected to be approximately 5-6% of net sales (2017: 10.8%). The decrease in the estimated operating profit is due to further decreased project margins, particularly in the ‘Social Care and Educational Premises’ and ‘Building Renovation’ service areas, and slightly lower estimate in the Group’s net sales. The declined net sales estimate is mainly due to delay of project starts in ‘Social Care and Educational Premises’ service area. Business in Housing and Business Premises service areas is progressing as planned. In ’Building Renovation’ service area Lehto operates on pipeline renovations and complete renovations. In complete renovation unit projects have not progressed as planned and regardless of the corrective actions the project margins have further declined and there are many loss-making projects in the unit. Complete renovation operations have altogether a significant negative effect on Lehto Group’s operating profit in 2018. Lehto is rapidly seeking alternative solutions in order to abandon the unprofitable parts of ’Building Renovation’ service area. The decisions are communicated latest by the end of this year. In the ‘Social Care and Educational Premises’ service area project margins have developed negatively too and there are also loss-making projects. The new management of the service area, appointed in August this year, has taken actions to develop project management. In addition, operations are more clearly focused on developing product concepts and utilizing more efficiently Lehto’s own manufacturing. These actions are supposed to gradually improve project margins. The profitability of the year 2018 also loaded by the non-recurring costs caused by the expansion of factory capacity and higher than estimated material and subcontracting costs. The outlook is based on the information on the progress of ongoing construction projects and the company’s estimate of construction projects to be started and sold in 2018. The main risks associated with the development of net sales and operating profit are related to the completion of ongoing projects within the estimated timeframe and costs and the development of the apartment sales. The previous outlook, published on 9th August 2018 in half-year financial report, was as follows: Lehto estimates that the Group’s net sales for 2018 will grow by about 20-30% from 2017 (EUR 597.6 million in 2017), and operating profit is expected to be approximately 8-9% of net sales (10.8% in 2017).